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Abstract
The stratum corneum (SC) of the skin functions as a barrier between the body and the
environment. Surfactants such as Sodium Dodecyl Sulfate (SDS) are used in skin cleansers and
in skin-care formulations because of their ability to stabilize oil-water emulsions and clean the
surface of the skin. However, they also have adverse effects on the skin barrier, including
enhancing skin barrier perturbation which may lead to a disruption of the protective functions
carried out by the skin barrier. On the other hand, humectants, such as Glycerol, which maintain
the natural water content of the skin and preserve the skin barrier, have been shown to mitigate
surfactant-induced skin barrier perturbation. The primary objective of this thesis was to develop
a mechanistic understanding, including visualization and quantification, of: (i) how aqueous
surfactant solutions, once in contact with the skin, can induce skin barrier perturbation, and (ii)
how surfactant-induced skin barrier perturbation can be effectively mitigated through the
addition of humectants to the aqueous surfactant contacting solutions.
SDS monomers self-assemble to form micelles at a SDS concentration above the Critical
Micelle Concentration (CMC). The SDS skin penetration and associated skin barrier perturbation
is dose-dependent, that is, it increases with an increase in the total SDS concentration above the
CMC of SDS. However, when Glycerol was added to the aqueous SDS contacting solution,
through in vitro quantitative skin radioactivity assays using 14C radiolabeled SDS, I found that
the dose-dependence in SDS skin penetration was almost completely eliminated. This is because
the addition of Glycerol hinders the ability of the SDS micelles to penetrate into the skin barrier
through aqueous pores that exist in the SC. In vitro Mannitol skin permeability and average skin
electrical resistivity measurements, in the context of a hindered-transport aqueous porous
pathway model of the SC, demonstrated that the addition of 10 wt% Glycerol: (1) reduces the
average aqueous pore radius resulting from exposure of the skin to the aqueous SDS contacting
solution from 33±5A to 20+5A, such that a SDS micelle of radius 18.5±1 A (as determined using
dynamic light scattering (DLS) measurements) experiences significant steric hindrance and
cannot penetrate into the SC, and (2) reduces the porosity-to-tortuosity ratio of the aqueous pores
in the SC by more than 50%, thereby further reducing the ability of the SDS micelles to penetrate
into the SC and perturb the skin barrier.
In vitro skin electrical current measurements can be used effectively to rank aqueous
contacting solutions containing surfactants and humectants (the enhancer), relative to a PBS
aqueous contacting solution (the control), based on their ability to perturb the skin aqueous
pores. Specifically, an in vitro ranking metric was introduced using the enhancement in the skin
electrical current induced by an enhancer relative to the control. For this study, I considered
aqueous contacting solutions of the following chemicals: (1) humectants - Glycerol and
Propylene Glycol, (2) surfactants - SDS and C12E6 (Dodecyl Hexa (Ethylene Oxide)), and (3) a
control - PBS. Utilizing the in vitro ranking metric, the aqueous solutions above contacting the
skin were ranked as follows (from the mildest to the harshest): Glycerol < Propylene Glycol <
PBS < C12E6 < SDS. In order to further develop this ranking methodology, which can potentially
lead to the reduction of several costly operations associated with identifying
surfactant/humectant systems which are mild to the skin, such as, in vivo clinical testing and
trial-and-error screening, it was important to correlate the in vitro ranking metric findings with
direct in vivo skin barrier measurements. For this purpose, in vivo soap chamber measurements
were carried out on human subjects, using the aqueous surfactant/humectant solutions described
above. The results of these in vivo measurements of skin barrier perturbation were found to be
consistent with the ranking results obtained using the in vitro ranking metric for the aqueous
surfactant and humectant contacting solutions considered. In addition, in vivo soap chamber
measurements were carried out for aqueous SDS+Glycerol contacting solutions. These in vivo
measurements indicated that adding Glycerol to a SDS aqueous contacting solution significantly
mitigates SDS-induced in vivo skin barrier perturbation, which is consistent with the results of
my in vitro skin electrical current and Mannitol skin permeability measurements.
In order to visualize the effects of aqueous surfactant/humectant systems on the skin
barrier, an in vitro dual-channel two-photon fluorescence microscopy (TPM) visualization study
was carried out. TPM is a non-invasive imaging technique based on two-photon induced
nonlinear excitations of fluorophores, with the capability for deep-tissue imaging (up to several
hundred micrometers). The following aqueous surfactant and humectant contacting solutions
were studied: (i) SDS, (ii) SDS+Glycerol, (iii) SCI (a mild surfactant), (iv) PBS control, and (v)
Glycerol. Sulforhodamine B (SRB), which is a hydrophilic fluorescent probe, was used to probe
the effect of aqueous contacting solutions (i)-(v) on the skin barrier morphology. The results of
this TPM visualization study revealed that SDS induces corneocyte damage by denaturing
keratins and creating intra-corneocyte penetration pathways. On the other hand, SDS+Glycerol
did not significantly induce corneocyte damage. The dual-channel TPM images corresponding to
aqueous contacting solutions (iii)-(v) showed low SRB penetration into the corneocytes, as well
as localization of the SRB probe within the lipid bilayers surrounding the corneocytes of the SC.
Through a quantification of the amount of SRB that penetrated into the skin as a function of the
skin depth, I found that adding Glycerol to SDS could significantly reduce the SDS-induced
penetration depth of SRB, which provides evidence of the ability of Glycerol to mitigate SDS-
induced skin barrier perturbation.
The fundamental understanding of surfactant-induced skin barrier perturbation in the
presence of humectants developed in this thesis is of particular relevance to the cosmetic industry
in enabling the formulation of mild, non-drying, skin-care products that contain surfactants and
humectants. The novel TPM studies that visualize, as well as quantify, skin morphology upon
exposure of the skin to surfactant/humectant systems, has the potential to be developed into a
high-throughput imaging tool for the screening of new skin-care formulations. Such a strategy
can simultaneously screen the skin-mildness potential of many skin-care formulations, thereby
significantly speeding up the effort and time required to bring new skin-care formulations to the
market. In addition to the practical impact on the formulation of mild skin-care products, this
thesis has also advanced fundamental research carried out in the investigative dermatology and
related health disciplines.
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Chapter 1
1. Introduction
1.1. Research Motivation and Goals
Surfactants are used in skin care formulations because: (1) they can stabilize oil-in-water
emulsions, and (2) being surface active, they can cleanse the surface of the skin. However,
surfactants commonly encountered in skin care formulations can interact with the skin barrier in
a variety of ways. They may first act on the skin surface, then penetrate into the deeper skin
layers, and finally enter the general body circulation through blood capillaries in the dermis (see
Section 1.5 for a discussion of the effects of surfactants on the skin). Since people use skin
cleansers and skin care formulations repeatedly, and at times, very frequently, skin barrier insults
due to surfactants are repetitive and frequent, and can induce a significant extent of skin barrier
perturbation (1-5). A significant extent of skin barrier perturbation can, in turn, lead to a loss of
the skin barrier protective functions, which can lead to various pathophysiological consequences
(see Section 1.5). According to an estimate of the US Department of Labor, compensation
benefits from skin diseases accounted for almost $200 million in California alone in 1990, and
this figure has increased steadily in recent years (2). In a separate study, the economic burden of
diseases pertaining to the skin and the skin barrier in the United States alone was estimated to be
$35.9 billion in 1997 (3). In fact, it is widely accepted that skin diseases and disorders are the
second highest of all occupational illnesses reported in the United States (3). However, it is also
believed that skin diseases can, and should, be prevented (1-5). One possible way to achieve this
goal is to develop a fundamental, mechanistic understanding of the skin barrier responsible for
the protective functions of the skin, whose disruption, for example, by surfactants in skin care
products, may lead to various pathological and health conditions associated with the skin. In this
thesis, I have carried out a mechanistic investigation of how surfactants may perturb the skin
barrier, which may be of particular relevance to the cosmetic industry in enabling the
formulation of milder, non-drying, skin care products that contain surfactants.
Research aimed at pursing the goal of minimizing surfactant-induced skin barrier
perturbation has shown that humectants,' when present in a formulation with surfactants, can
mitigate deleterious effects of surfactants on the skin barrier (6-15). Such a strategy is of
tremendous practical relevance to a formulator interested in the formulation of milder surfactant-
based skin care products. In order to create surfactant formulations containing humectants that
are milder, or less irritating, to the skin, a fundamental understanding of surfactant-induced skin
barrier perturbation and its mitigation in the presence of humectants must be developed. In this
thesis, I have investigated the mechanism through which aqueous surfactant/humectant systems
may induce a lower extent of skin barrier perturbation when compared to an aqueous contacting
solution containing the surfactant at a similar concentration. Such an understanding will allow
the rational design of new skin care formulations containing appropriate amounts of surfactants
and humectants, or the modification of existing ones, based on fundamental knowledge of what
will induce skin barrier perturbation, and how a surfactant/humectant system can be tuned to
increase the mildness of the formulation.
Humectants are small molecular weight poly-hydroxy compounds that have the ability to maintain, as well as to
enhance, the water-holding capacity of the skin (13). Typical examples of humectants used in skin care formulations
include Glycerol and Propylene Glycol, whose effects on the skin barrier have been studied in this thesis.
The central objective of my thesis involves investigating the physical modification of the
morphology of the skin barrier induced by surfactants, humectants, and their mixtures. In this
thesis, I have developed quantitative and visual criteria to assess the physical state of the skin
barrier and its modification upon exposure to surfactants, humectants, and their mixtures (see
Section 1.7.1). Surfactants, such as Sodium Dodecyl Sulfate (SDS), have been shown to promote
a clinically harsh reaction (erythema, or skin redness) in the skin, while other surfactants, such as
Dodecyl Hexa (Ethylene Oxide) C12E6, promote a clinically mild reaction (skin dryness) in the
skin. In addition, other surfactants, such as Sodium Cocoyl Isethionate (SCI), have been shown
to induce minimal erythema and skin dryness. On the other hand, humectants, which aid in
maintaining the water-holding capacity of the skin, have been shown to mitigate surfactant-
induced biological epidermal injury response, that is, erythema and skin dryness, in vivo.
Presently, no clear mechanisms exist that can unambiguously explain the observed surfactant-
skin and humectant-skin interactions. This lack of understanding can be attributed to the very
complex biochemical reactions that surfactants and humectants may trigger once they are able to
penetrate the skin barrier. However, if one was to analyze the simpler process of skin penetration
by surfactants in the presence/absence of humectants (which is upstream to the more complex
biological epidermal injury response), then, more clear mechanisms may be identified to describe
and rationalize the skin penetration of these chemicals. The identification of such mechanisms,
which would involve understanding how these chemicals affect the transport properties of the
skin barrier in addition to understanding the solution properties of the chemicals themselves,
would then allow: (i) predicting if a particular surfactant in the presence of a humectant can
potentially penetrate into the skin barrier and induce a biological epidermal injury response, and
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(ii) devising strategies to minimize skin penetration of surfactants, thereby also mitigating the
biological epidermal injury response.
Because a chemical has to first penetrate into the stratum corneum (SC), 2 and at times,
across it, before it can induce biological epidermal injury to the skin, I have focused my
investigation on the skin penetration process of these chemicals. My investigation has also
involved visualization of skin morphological modifications induced by these chemicals, on the
corneocytes and the lipid bilayers which comprise the SC, using two-photon fluorescence
microscopy (TPM) (see Chapter 5). In addition, as part of this thesis, I will present in vivo patch
tests on human volunteers (see Chapter 4) to substantiate the results of the in vitro studies
presented in Chapters 2, 3, and 5.
The central goal of this thesis requires pursuing the following sub-goals:
a) Investigation of the role of the surfactant solution physical chemistry, in the absence and in
the presence of a humectant, in inducing skin barrier perturbation (see Chapter 2).
b) Development of an experimental and a theoretical framework for analyzing the skin barrier
perturbation potential of a mild surfactant, and comparing it to those of a harsh surfactant and
of an appropriate control (see Chapter 3).
c) Ranking of surfactants and humectants relative to an appropriate control based on an in vitro
metric that quantifies the ability of these chemicals to perturb the skin barrier, and comparing
these in vitro ranking results to the ranking obtained using in vivo patch measurements (see
Chapter 4).
d) Visualization of skin barrier perturbation induced by surfactants in the presence/absence of a
humectant using Two-Photon Fluorescence Microscopy (TPM) (see Chapter 5).
2 The stratum corneum is the primary constituent of the skin barrier, as discussed in Section 1.4.
e) Development of a theoretical pore size distribution model to quantify the modification of the
inherent skin barrier morphology induced by a surfactant in the presence/absence of a
humectant (see Chapter 6).
In order to understand the following arguments concerning how humectants may modify
the skin barrier perturbation potential of surfactant solutions, a brief review of the physico-
chemical characteristics of aqueous surfactant and humectant solutions is presented in Sections
1.2 and 1.3 respectively. Section 1.4 provides a description of the morphology of the skin barrier
where transdermal aqueous porous pathways exist to allow passage of hydrophilic permeants,
including a brick-and-mortar representation of this barrier. Subsequently, in Sections 1.5 and
1.6, I discuss what is known about the effects of surfactants and humectants on the skin barrier,
both in vitro and in vivo. Finally, in Section 1.7, I present an overview of the thesis, specifically,
of: (i) the experiments conducted (see Section 1.7.1), (ii) the theoretical framework developed
(see Section 1.7.2), and (iii) an outline of the remaining chapters of the thesis (see Section 1.7.3).
1.2. Surfactant Physico-Chemical Characteristics
Surfactants belong to a class of molecules called amphiphiles (16, 17). These molecules
consist of a hydrophilic, or 'water-loving', head, and a hydrophobic, or 'water-fearing', tail (see
Figure 1-1). The hydrophobic tail of surfactants is typically a hydrocarbon, such as an alkyl
chain or an alkyl-phenyl chain. Common tails include straight chain alkanes, benzyl-alkanes,
and methyl-branched alkanes. The tails typically consist of at least 8 carbon atoms, resulting in a
distinct domain that is poorly soluble in water (16, 17, 48). Figure 1-1 shows a schematic
representation of the surfactant Sodium Dodecyl Sulfate (SDS), with a tail containing 12 carbon
atoms, and an anionic sulfate head.
SDS Monomer
Hydrophobic Tail (C12)
Preference for the non-
cellular, lipid bilayers in the
skin barrier
Hydrophilic Head (Sulfate)
Preference for the cellular,
protein domains like corneocytes
in the skin barrier
SDS Micelle
Hydrophilic Surface
Hydrophobic Core
Figure 1-1. Schematic representation of a Sodium Dodecyl Sulfate (SDS) surfactant monomer
and a SDS micelle.
In this thesis, in addition to SDS, I have studied the effect of Sodium Cocoyl Isethionate
(SCI), which is also an anionic surfactant, on the skin barrier (see Chapter 3). Other types of
hydrophilic heads for surfactants include: (i) cationic, (ii) nonionic, and (iii) amphoteric or
zwitterionic (16, 17, 48). Cationic surfactants have a positively-charged head, such as an
ammonium ion, bonded to the tail. Nonionic surfactants, such as Dodecyl Hexa (Ethylene
Oxide) or C12E6 studied in this thesis, have a polar group that is soluble in water, such as a poly
(ethylene oxide) group, as their head (48). Amphoteric, or zwitterionic, surfactants have no net
charge, but have an internal charge separation. For example, in a betaine head, there is a
negatively-charged carboxylate group separated from a positively-charged quaternary
ammonium group that is covalently bonded to the surfactant tail (16, 48). As shown in Figure 1-
1, the surfactant head, being hydrophilic in nature, has an affinity for the hydrophilic cellular
protein domains of the skin barrier, while the surfactant tail, being hydrophobic in nature, binds
to the hydrophobic lipoidal domains of the skin barrier (see Section 1.4 for a description of the
morphology of the skin barrier). The surfactant heads, being ionic or polar in character, are
soluble in water while the surfactant tails, being non-polar, are not. Accordingly, there are
competing aqueous solubility tendencies for the surfactant molecules. These competing aqueous
solubility tendencies cause the amphiphilic molecules to display interesting solution behavior in
water (17). Our group has developed molecular-thermodynamic theories to describe and
quantitatively predict the effects of the surfactant chemical structure and the solution conditions
on the surfactant solution physical chemistry for both single and mixed surfactant systems (18,
20), as well as for surfactants mixed with nonionic polymers (21). These theories can predict the
behavior of aqueous solutions containing ionic, nonionic, and even amphoteric linear-chain
surfactants. Of particular relevance to this thesis is the ability to predict the concentrations and
------- r~~;r;·-~r~·-r~----·--··~IWUP·*.r ·;
compositions of the surfactant monomers and of the micelles, for ionic surfactants (SDS, SCI) as
well as for nonionic surfactants (C12E6), requiring only the molecular structures of the surfactants
involved and the solution conditions as inputs. Throughout the research presented in this thesis,
our surfactant modeling capabilities were used as a tool to predict the surfactant solution
conditions, such as the monomer concentrations and compositions, and these conditions were
then related to the results of in vitro and in vivo skin barrier perturbation measurements.
One of the most important characteristics of surfactants is the formation of aggregates of
surfactant molecules, called micelles, above a threshold surfactant concentration, known as the
critical micelle concentration or CMC (see Figure 1-2). At concentrations below the CMC, the
surfactant molecules do not aggregate with each other, and are instead free in solution. These
free surfactant molecules are referred to as surfactant monomers. When the surfactant
concentration exceeds the CMC, it becomes more free-energetically favorable for the surfactant
molecules to aggregate into micelles than to remain in solution as surfactant monomers (16, 17).
The onset of micellization occurs in a fairly sharp manner at the CMC, shown in Figure 1-2,
such that below the CMC there are essentially no micellar species, while above the CMC
micelles coexist with surfactant monomers, with the surfactant monomer concentration
remaining approximately constant. Accordingly, as the total surfactant concentration is
increased beyond the CMC, the concentration of the surfactant monomers remains essentially
flat, while the concentration of the micellar surfactant increases steadily, as depicted
schematically in Figure 1-2.
CMC
2rjJ
Total Surfactant Concentration
Figure 1-2. The concentration of surfactant monomers as a function of the total surfactant
concentration, both below and above the Critical Micelle Concentration (CMC), in an aqueous
surfactant solution.
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The main driving force responsible for surfactant micellization in water is a phenomenon
known as the hydrophobic effect (17). The hydrophobic effect is the result of the hydrophobic
tails of the surfactants disrupting the structure of liquid water, forcing the water molecules to
adopt a free-energetically unfavorable structured shell around these tails. Micelles are formed
with the hydrophobic tails residing in the interior of the aggregates, referred to as the core of the
micelle, with the hydrophilic heads residing at the micelle surfaces, as shown for an SDS micelle
in Figure 1-1. This minimizes the contact between the surfactant hydrophobic tails and water,
thereby releasing the water molecules that were in the structured shell around the hydrophobic
tails, which in turn increases the entropy (or equivalently, decreases the free energy) of the
surfactant solution (17). Competing with this increase in entropy due to the hydrophobic effect,
the free-energy considerations that inhibit micellization include the entropic loss of localizing
several surfactant molecules and any bound counterions (in the case of ionic surfactants like SDS
and SCI) in the micelle, the interfacial free energy between the hydrophobic micelle core and
water, and the repulsions of electrostatic and steric origin between the surfactant heads and any
bound counterions (in the case of ionic surfactants like SDS and SCI) residing at the micelle
core-water interface (17-24).
1.3. Humectant Physico-Chemical Characteristics
Humectants used as moisturizers are chemicals which attract water, mimicking the role of
the dermal glycosaminoglycans and other hydrophilic components of the SC, such as Glycerol
and amino acids (11). Any polyhydroxy small molecular weight organic compound has
humectant properties, for example, Sorbitol, Propylene Glycol, and Glycerol (13). Humectants
can diffuse into the SC from an aqueous solution contacting the skin, and once absorbed within
the SC, attract water and increase hydration. Humectants draw water largely from the dermis to
the viable epidermis and the stratum corneum and rarely from the environment, when conditions
of relative humidity exceed 70%. Since the ability of the skin to hold moisture varies with the
relative humidity, humectants enable the skin to maintain a higher than normal equilibrium
moisture content. Rhein et al. have determined the effect of Glycerol on a model lipid system
(12). Their studies showed that Glycerol maintained the liquid crystalline state of the lipids at a
relative humidity of 6%. In the absence of Glycerol, the model lipids showed substantial
crystallization and exhibited multiple phases. Therefore, humectants such as Glycerol can
preserve normal hydration of the skin under dry environmental conditions by maintaining the
liquid crystalline structure of the lipid bilayers of the SC.
1.4. The Skin Barrier
Human skin is the largest organ in the body, measuring 1.85 m2 in the average man and 1.6
m2 in the average woman, and constitutes about 16% of the total body weight (1). The skin is the
primary interface between the body and the surrounding environment, and as such, is the most
important organ of protection. Its protective functions include: (i) water loss prevention, (ii)
maintenance of body temperature, (iii) absorption of harmful UV radiation, (iv) prevention of
carcinogens, for example, chemicals like PAH (poly cyclic aromatic hydrocarbons), from
penetrating into the body, (v) mediation of inflammation through cutaneous metabolism, and (vi)
protection against microbial insults by antimicrobial systems like lipids and iron-binding proteins
(1, 2, 4, 5). These skin protective functions are carried out by the keratinizing epithelium tissue,
which constitutes the skin barrier between the body and the surrounding environment (4, 5).
1.4.1. The Constituents of the Skin Barrier
Human skin consists of three stratified layers, as shown in Figure 1-3. The top most layer
of the skin is called the stratum corneum (SC). The SC is a horny layer made up of non-
nucleated, dead cells called corneocytes, which are embedded in a matrix of highly-ordered lipid
lamellae. These lipid lamellae consist of lipid bilayers alternating with hydrophilic layers. The
repeat distance between two lipid bilayers is 65 A, with the two layers of lipid headgroups
separated by about 10-20 A (29) which is the size of a typical aqueous porous channel (see
Section 1.4.2). The thickness of the SC ranges between 10-20 ýtm, and typically consists of 15
interlocking layers of corneocytes (30). These corneocytes are mainly flat and hexagonal in
shape, are made up of tough keratin filaments, and are surrounded by a thick, proteinaceous
envelope called the corneocyte envelope. The interlocking of the flat corneocytes with the lipid
lamellae gives rise to the ordered brick-and-mortar structure of the SC (see Figure 1-4. ) and
makes it a very effective permeability barrier (1, 4, 28, 30, 31).
The layer immediately below the SC is the Viable Epidermis, referred to hereafter as the
VE. The VE is a cellular and avascular layer having a thickness of 100-150 ýpm and consisting of
living, nucleated cells called keratinocytes (31). These keratinocytes, upon terminal
differentiation, lose their nuclei to form the corneocytes in the SC. The VE constitutes a
hydrophilic environment and is not a major permeability barrier. The keratinizing epithelium,
composed of the SC and the VE, is a perpetually renewing tissue, whose principal function is to
create the SC (1, 4, 28, 31, 69).
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Figure 1-3. Schematic diagram of the skin, showing the three layers of the skin barrier. The
stratum corneum (SC), which has a brick-and-mortar structure, is the primary constituent of this
barrier.
The dermis constitutes the lower most layer of the skin and has a thickness of 2-4 mm
(31). The biological function of the dermis is to mechanically support the epidermis and the
cutaneous appendages, including sweat glands, sebaceous glands, and hair, as well as to supply
nutrients to the basal layer of living cells in the epidermis. Because of its porous and highly-
hydrated structure, the dermis is not a significant permeability barrier (especially to hydrophilic
molecules) (1, 4, 28, 30, 31, 69). The dermis is well networked by blood capillaries, providing a
transport path from the skin to the blood stream. For this reason, it is generally accepted that a
chemical will enter the blood stream if it can permeate through the SC and the VE, and reach the
dermis (4, 28, 30, 31). As a result, when the transepidermal skin permeability of a solute is
measured experimentally in vitro, often only the SC and the VE are used as the model skin
membrane.
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Figure 1-4. Electron micrograph showing the brick-and-mortar structure of the stratum corneum
(SC), and of the viable epidermis, of formalin-fixed hairless, guinea pig skin (32). Note that the
lipid bilayers in the SC have been stained black, while the corneocytes appear white.
1.4.2. Transdermal Aqueous Porous Pathways in the Stratum Corneum
The highly-ordered structure of the lipid bilayers confers on the SC an impermeable
character. Yu et al. (37, 38) have shown recently, using a novel application of Two-Photon
Fluorescence Microscopy (see Section 1.7.1), that the corneocytes, under passive skin
permeation conditions, essentially act as sinks with respect to the transport of permeants across
the SC. As a result, permeant molecules, under passive skin permeation conditions, do not
traverse the SC through an intra-corneocyte diffusional pathway. Instead, these permeants
traverse the SC by diffusing across the lipid lamellae (27). Although diffusion through lipid
lamellae can explain the permeation of hydrophobic molecules across the SC, it cannot explain
the permeation of small, excessively hydrophilic, or of larger hydrophilic molecules, across the
SC, as observed in some studies (39-41). Indeed, if no aqueous/hydrophilic porous pathways
existed in the SC lipid domain, then aqueous/hydrophilic permeants could not traverse the SC
solely through lipoidal/hydrophobic pathways that may exist in the lipid bilayer domains in the
SC. The observation that hydrophilic molecules are able to permeate across the SC, even under
passive skin permeation conditions, has led researchers to consider the existence of tortuous,
aqueous porous pathways through the intercellular lipid lamellae in the SC. Although no direct
experimental evidence has been provided to support the existence of these transdermal aqueous
porous pathways, diffusion through such pores is viewed as a plausible explanation for the
observed transdermal transport of hydrophilic solutes under passive skin permeation conditions
(39-42).
Menon and Elias (42) have attempted to establish a morphological basis for the existence
of a pore pathway in the mammalian SC. These authors have applied hydrophilic and
hydrophobic tracers in vivo to murine skin under passive skin permeation conditions, and also
under enhanced skin permeation conditions, including chemical enhancers, a lipid synthesis
inhibitor, sonophoresis, and iontophoresis, and following that, they employed Ruthenium
Tetroxide Staining and Microwave Post Fixation methods to visualize the penetration pathways.
Their results showed that both the hydrophobic and the hydrophilic tracers localized to discrete
lacunar domains embedded within the extracellular lipid lamellar domains. These authors have
also observed that while these lacunar domains remained discontinuous under passive skin
permeation conditions, permeation enhancement resulted in these domains gaining structural
continuity. Hence, lacunar domains have been considered by these authors as providing a
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physical basis for the existence of aqueous pores and polar pathways through the lipoidal domain
in the SC.
Under passive skin permeation conditions, the lacunae between two layers of lipid
headgroups in a lipid bilayer within the lipid lamellae domain of the SC may get filled up with
water, and create an aqueous channel (29). Subsequently, the lipid bilayers may align vertically,
causing these aqueous channels between their headgroups to align and form a tortuous,
continuous aqueous porous pathway through the lipid lamellae domain in the SC (see Figure 1-
5). Skin hydration, and application of other skin permeation enhancers, including chemical
enhancers (for example, harsh surfactants, such as, SDS), may cause these lipid headgroups in a
lipid bilayer to move further apart, thereby leading to an increase in the diameter of these
aqueous porous pathways, as shown schematically in Figures 1-6(a) and 1-6(b). This mechanism
of disorder in the regular structure of the bilayer lipid lamellae leading to an increase in the
separation distance between the bilayer lipid headgroups, and consequently, to an increase in the
diameter of the aqueous channels that may exist between these lipid headgroups, may help
explain how some skin permeation enhancers induce an increase in the permeation rate of
hydrophilic solutes through the SC in the skin. On the other hand, humectants such as Glycerol
can mitigate the extent of disorder in the bilayer lipid lamellar structure, thereby reducing the
diameter of the aqueous channels as well as the permeation rate of hydrophilic solutes through
these channels in the SC (see Chapter 3).
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Figure 1-5. Schematic diagram that visualizes a transdermal aqueous porous pathway which
exists between the lipid bilayers surrounding the corneocytes of the SC. The blue dots represent
polar permeants that can penetrate across the SC through this pathway.
A third view, held by many researchers as the basis for the existence of transdermal
aqueous porous pathways, is that imperfections in the SC lipid bilayers may result in pores in the
SC that may connect to form tortuous, porous pathways responsible for the transport of
hydrophilic solutes through the SC in the skin. These imperfections are believed to result in: (i)
separation of grain boundaries, (ii) fault dislocations, (iii) lattice vacancies, and/or (iv) voids due
to missing lipids or steric constraints placed by corneocytes on lamellar lipid domains (41).
Many researchers have used Atomic Force Microscopy (AFM) and X-Ray diffraction of
supported phospholipid bilayers to study structural defects in these lipid lamellar systems. Based
on X-Ray diffraction, defects have been discovered in lipid bilayers under excess water
conditions. Raphael et al. (43) have postulated that the temporary localized disordering of lipids
may be the cause of lipid bilayer defects. Through AFM images of supported lipid bilayers,
Corneocyte -
(Brick)
Malghani et al. (44) have reported the existence of lipid bilayer defects. These studies support
the view that bilayer imperfections may lead to tortuous, aqueous porous pathways in the SC in
the skin.
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Figure 1-6 (a). Aqueous porous pathway around a corneocyte, which results from the separation
between two layers of lipid headgroups under passive permeation conditions.
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Figure 1-6 (b). Aqueous porous pathway around a corneocyte, which results from the separation
between two layers of lipid headgroups under permeation enhancement conditions.
The transdermal aqueous porous pathways can be viewed as tortuous, cylindrical pores
through the intercellular lipid lamellar domain in the SC, with the permeant molecules modeled
as hard spheres in motion through these pores (see Figure 1-5). The main aqueous pore pathway
parameters of interest in this thesis are: (i) the aqueous pore radius, (ii) the porosity, which is
defined as the fraction of cross-sectional SC area occupied by the aqueous pores, and (iii) the
tortuosity, which is defined as the ratio of the tortuous length of the aqueous pore to the thickness
of the SC (25, 39-41).
1.5. Effect of Surfactants on the Skin Barrier
The skin barrier is exposed to numerous, frequent, and repeated insults by surfactants
present in skin cleansers and in skin care formulations. These chemicals, due to their surface
activity, can clean the skin surface by removing dirt, but in so doing, are also known to penetrate
into the SC and induce skin barrier perturbation (48-50, 61, 62, 71, 72, 78-81). Surfactant-
induced skin barrier perturbation can lead to a loss of the skin barrier protective functions,
which, in turn, can lead to various pathophysiological consequences, as illustrated in Figure 1-7.
The anionic surfactant, SDS (see Figure 1-1), encountered in skin cleansing formulations,
is a harsh skin agent (see below for a definition of a harsh skin agent), and is known to perturb
the skin barrier, to denature keratins, and to compromise the skin barrier resistance (48, 61, 78,
80). Therefore, chemicals which are toxic to the skin, and which under normal circumstances
would be prevented from penetrating into the skin by the skin barrier, are able to penetrate into
skin whose barrier has been compromised by SDS. Accordingly, this compromised skin barrier
resistance can lead to the associated problem of skin irritation. Skin irritation, in turn, may result
in: (i) abnormal skin growth, for example, in parakeratosis - the retention of nuclei by the
corneocytes, (ii) skin redness or erythema, and (iii) highly chapped and scaly skin (48). On the
other hand, some mild skin agents (see below for a definition of a mild skin agent), such as the
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nonionic surfactant C12E6, do not elicit a strong irritation response, yet induce skin dryness (48).
Furthermore, there are still milder agents, for example, the anionic surfactant Sodium Cocoyl
Isethionate (SCI), which do not induce either a strong irritation response or a significant extent of
skin dryness (see Chapter 3) (61, 62, 79).
Figure 1-7. Schematic illustration of various pathophysiological downstream manifestations of
skin epithelial barrier damage induced by surfactants. The epidermis depicted here is composed
of the stratum corneum and the viable epidermis, which together, constitute the keratinizing
epithelial tissue (49).
The SDS-induced dermatitis model is widely used in experimental dermatology as a
model for skin irritation. Moore et al. (48, 71) have investigated the skin barrier damaging
properties of SDS above the CMC. Their studies have shown that SDS-induced skin barrier
damage continues above the CMC. They have attributed this effect to the size of the SDS
micelles by hypothesizing that the SDS micelles are small enough to penetrate into the SC
through the aqueous pores (see Section 1.4.2). Moreover, they have also demonstrated that once
these SDS micelles are complexed with poly (ethylene oxide) chains, they are sterically hindered
from accessing these aqueous pores and, hence, can no longer induce SC barrier damage. Their
studies have unambiguously shown that in addition to the SDS monomers, SDS micelles can also
lead to SC barrier damage provided that they are small enough to penetrate into the SC through
the aqueous pores. However, their studies did not demonstrate how these SDS monomers and
SDS micelles, once inside the SC, induce barrier damage. Specifically, it is still unknown if the
SDS monomers and the SDS micelles, once inside the SC, interact with the keratins and the
corneocytes, and/or if they also partition into the lipid bilayers, thereby disordering the lipid
bilayers in the SC (see Chapter 5 for a TPM visualization study that sheds light on some of these
issues).
The skin irritation response may be modulated by two distinct mechanisms: (i) the direct
interaction of a penetrating skin agent with the keratinocytes in the epidermis, and (ii) SC barrier
disruption induced by the skin agent. Berardesca et al. (72) have hypothesized that SDS-induced
dermatitis proceeds via mechanism (i), that is, by disruption in the secondary and tertiary
structures of keratin in the keratinocytes by SDS, rather than by a delipidization of the SC lipid
bilayers. Wood et al. (73) have found that SC barrier disruption induced by acetone or by tape
stripping can stimulate cytokine production and promote skin inflammation. Their studies have
shown that mechanism (ii), described above, can activate biochemical signals leading to irritant
dermatitis. It is reasonable to assume that in most cases of skin irritation induced by surfactants
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encountered in skin care products and detergents, mechanisms (i) and (ii) both play a role, with
their relative importance being determined by: (a) the self-assembling characteristics of the
surfactant, (b) the hydrophobicity/hydrophilicity of the surfactant, (c) the skin membrane
characteristics, including changes in the aqueous pore radius and in the porosity-to-tortuosity
ratio upon exposure to the surfactant solution, and (d) the skin penetration characteristics and the
transdermal permeability of the surfactant.
Mild skin agents will be referred to, throughout this thesis, as those inducing little or no
skin irritation response/erythema upon exposure to the skin (and, consequently, little or no SC
barrier disruption through lipid extraction and interaction with keratin in the keratinocytes and in
the corneocytes). The nonionic surfactant, C12E6, has been shown: (1) not to induce significant
scaling and skin-roughness upon skin exposure (79), and (2) to be clinically mild to the skin
without eliciting an erythema response, although it may induce skin dryness (48, 80, 81). Harsh
skin agents will be referred to as those inducing a significant irritation response/erythema upon
exposure to the skin (and, consequently, significant barrier damage and/or interaction with
keratin in the keratinocytes and the corneocytes). In particular, SDS has been selected as a model
harsh skin agent for the experiments to be conducted as part of this thesis (48-51, 61, 71, 72, 78-
81). Through the work conducted as part of this thesis, I have investigated, at a fundamental
level, the causes of skin barrier perturbation, that may lead to skin dryness and erythema, through
a consideration of: (i) the molecular and self-assembling characteristics of a harsh and a mild
surfactant, (ii) changes in the skin membrane characteristics (specifically, of the aqueous porous
pathway characteristics) upon exposure to these agents, (iii) the transdermal permeability
characteristics of these agents, and (iv) the partitioning of these agents within the SC following
their penetration into the SC. Utilizing this fundamental understanding, I have also investigated
effective practical strategies to mitigate skin barrier perturbation induced by these surfactants,
and therefore, to prevent skin dryness and irritation symptoms, such as irritant contact dermatitis
(see Chapter 2).
1.6. Effect of Humectants on the Skin Barrier
The cosmetic industry is interested in the optimal delivery of certain active ingredients to
the skin. Active ingredients, for example, humectants like Glycerol, when delivered to the skin in
the appropriate amount can result in: (i) enhancement in the moisture retentive ability of the skin,
(ii) healing of erythema, (iii) general skin lightening and toning, (iv) SC barrier repair, and (v)
healing of acne (6-15, 74-77). Specifically, cosmetic scientists and researchers have focused on
Glycerol to mitigate/recover the skin barrier damage induced by surfactants because: (1)
Glycerol is a major determinant of SC water retention, and of the mechanical and the
biosynthetic functions of the skin (74), (2) SDS-induced erythema and acanthosis (the benign
thickening of the horny layer in the skin) in guinea pig skin is fully reversed by Glycerol
treatment (75), (3) Loden et al.(76) have observed patients with atopic dermatitis to exhibit
significantly less adverse skin reactions such as smarting (a sharp local superficial sensation)
upon treatment with a 20% glycerin cream compared to a urea-saline cream, and (4) Glycerol
can be regarded as a skin barrier stabilizing and moisturizing compound because it creates a
stimulus for skin barrier repair and improves SC hydration after SC barrier damage induced by
tape stripping and repeated washing with SDS (6).
The importance of Glycerol (or glycerin) in skin care products is well established, and
Glycerol is widely used in cosmetic and pharmaceutical formulations. To explain its benefits,
studies have focused on its humectant and smoothing effects (7), and on its protective functions
in emulsion systems against skin irritation (8). Researchers have shown that Glycerol diffuses
into the SC, increases skin hydration, and relieves clinical signs of dryness (9-13). However, the
mechanisms by which Glycerol mitigates SC barrier damage and relieves skin irritation and
dryness are currently not well understood. One of the viewpoints held by researchers today is
that Glycerol may influence the crystalline arrangement of the intercellular lipid bilayers. The
bulk of the bilamellar lipid sheets are proposed to be in crystalline/gel domains bordered by
lipids in a fluid crystalline state. In skin exhibiting SC barrier damage, the proportion of lipids in
the solid state may be elevated, and subsequent skin exposure to Glycerol may help maintain
these lipids in a liquid crystalline state at low relative humidity, thereby enhancing SC barrier
function and decreasing SC water permeability (14). A second prevalent viewpoint is that
Glycerol may increase the rate of corneocyte loss from the upper layers of the SC, through a
keratolytical effect due to enhanced desmosome degradation, thereby reducing scaliness of dry
skin and maintaining SC barrier (13, 15) A third, more recent viewpoint proposed by Fluhr et al.
(6) is based on the hygroscopic property of Glycerol. Glycerol, by virtue of its high transdermal
diffusivity, can penetrate into the SC, and, by virtue of its hygroscopic property, is able to bind
water and reduce water evaporation. Therefore, Glycerol, by absorbing water, may modulate
water fluxes in the SC, which, in turn, may lead to a stimulus for SC barrier repair.
As discussed in Section 1.4.1, the brick-and-mortar structure of the SC, with its periodic
interlocking of comeocytes and lipid lamellae, presents the strongest barrier to the delivery of
Glycerol to the skin. Diffusion through the multilamellar lipid domains cannot explain Glycerol
transport to the deeper layers of the skin, including the dermis, because the lipid domains are
hydrophobic while Glycerol is strongly hydrophilic. Hence, it is useful to invoke the existence of
transdermal aqueous porous pathways (see Section 1.4.2) to explain the skin penetration of such
agents. One of the central goals of this thesis is the analysis of surfactant-skin penetration in the
presence of Glycerol in the aqueous contacting solution, and how such an analysis may help
explain mitigation of surfactant-induced skin barrier perturbation in the presence of Glycerol.
1.7. Thesis Overview
Having defined the overall goal of this thesis along with the thesis objectives, I proceed
next to consider the experimental and theoretical procedures that I have pursued, as part of this
research effort, to achieve these objectives. This section concludes with a brief discussion of the
subsequent thesis chapters, including a discussion of the implications of the central results in
each thesis chapter.
1.7.1. Experimental Framework
Bioengineering Assays to Quantitatively Determine the Macroscopic Extent of Skin
Barrier Perturbation
Skin electrical current has been shown to be a useful quantitative indicator of the
macroscopic extent of skin barrier perturbation induced by aqueous contacting solutions (25, 26,
41, 46-48, 53, 54, 84). An in vitro skin electrical current assay, based on the measurement of
electrical current across pig full-thickness skin (p-FTS) that was exposed to aqueous contacting
solutions of surfactants and humectants in diffusion cells was used to determine the macroscopic
extent of skin barrier perturbation (see Chapter 2). The basis for these measurements is as
follows: the higher the measured current for identical voltage signals, the lower is the skin barrier
resistance, and hence, the greater is the extent of skin barrier perturbation (see Chapter 2).
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Similar to skin electrical currents, permeability of the skin barrier to some permeants, for
example, hydrophilic permeants, such as, Mannitol, can serve as a quantitative indicator of the
integrity of the skin barrier (25, 26, 41, 46-48, 53, 54). Mannitol is: (1) a low molecular weight
monosaccharide (MW=182 Da) (25, 39), and (2) a highly hydrophilic (log Ko/w = -3.1) chemical
(25, 39), which is not metabolized by the body, and hence, if desired, can also be used for in vivo
skin permeation studies (25, 39). Being small in size and highly hydrophilic, Mannitol can access
similar aqueous pores as do ions in order to transport across the skin barrier. This, in turn, makes
Mannitol a suitable permeant to study in the context of the hindered-transport porous pathway
model of the SC (25, 39, 40, 41, 63). In fact, these experiments quantitatively determine the
cumulative amount of permeant (in our case, Mannitol) that has crossed p-FTS in a given time,
and thereby, characterize the extent of skin barrier perturbation (see Chapter 2). These in vitro
skin permeability assays use '4C radiolabeled Mannitol and detect scintillation counts (number of
radioactive disintegrations per unit time) by a scintillation counter, to quantify the radioactive
permeant concentration in the receiver solution once the permeant has crossed the p-FTS
membrane. These measurements can yield important information about transport characteristics
of the skin barrier, and how these characteristics may be modified upon exposure to aqueous
contacting solutions of surfactants and humectants.
Previous research in this area has shown that surfactants, such as SDS, can induce skin
barrier perturbation upon penetrating into the skin barrier. Hence, if one can quantify the amount
of SDS that may penetrate into the skin barrier upon exposing p-FTS to an aqueous contacting
solution containing SDS, one can estimate the extent of skin barrier perturbation and barrier
integrity. Such a surfactant skin penetration assay determines the extent of skin barrier
perturbation through direct measurement of the amount of surfactant, in our case SDS, that can
penetrate into the skin barrier from an aqueous contacting solution (48, 71, 78, 83). Specifically,
I have used 14C radiolabeled SDS that can penetrate into p-FTS upon exposing p-FTS in
diffusion cells to aqueous contacting solutions containing SDS (see Chapter 2 for a description of
the diffusion cell setup used for this purpose). The viable epidermis (VE) along with the stratum
corneum (SC) was heat-stripped following exposure to the aqueous SDS contacting solution. The
heat-stripped VE+SC was then dissolved using a tissue solubilizer, and the amount of 14C
radiolabeled SDS bound to the VE+SC was determined using scintillation counts by a
scintillation counter as before (see Chapter 2).
In addition to the in vitro skin electrical current, Mannitol skin permeability, and skin
radioactivity assays discussed above, in vivo measurements were also pursued as part of this
thesis. Specifically, Chapter 4 reports in vivo patch measurements carried out on volar forearm
of human volunteers exposed to test solutions of surfactants, humectants, and their mixtures.
Evaluation of the extent of erythema and skin dryness was carried out by: (i) expert grader
assessments, as well as by (ii) chromameter assessments (85). Transepidermal water loss
(TEWL) measurements, which quantify the extent of skin barrier perturbation in vivo, were
obtained through evaporimeter measurements (86). Skin conductance measurements using a
Skicon conductance meter were carried out to determine the extent of modification of skin
surface hydration upon exposure to the surfactant and humectant solutions contained in the
patches (87). Further details, including the protocol followed, along with a statistical analysis of
these measurements in the context of the in vitro skin assays, will be reported in Chapter 4.
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Visualization of Skin Barrier Morphology Using Two-Photon Fluorescence
Microscopy
Traditional biopsies of tissues, such as human skin and p-FTS, can provide tissue
morphological information with sub-cellular details, and is one of the principal tissue
pathological analysis methods. However, this method has some inherent limitations: (1) the
method involves tissue excision, fixation, and imaging to obtain useful morphological
information, and as such, is of an invasive nature, and (2) much of the cellular biochemical
information is inevitably lost during the surgical and fixation procedures (33). In addition, most
of these imaging methods can only achieve two-dimensional images that do not capture three-
dimensional structures like blood capillaries and sebaceous glands in complex tissues, such as,
the keratinizing epithelium in human skin. Confocal laser scanning microscopy, that can address
some of these limitations, is limited by: (a) a low penetration depth of scanning due to light
scattering effects, and (b) an accrued tissue sample photo-bleaching and photo-damage due to
repeated laser scanning (34, 35). Electron microscopy, such as, Scanning Electron Microscopy,
has the ability to image with sub-micrometer detail, but this method does not delineate specific
structural morphology using cell-specific markers, such as, fluorescently-labeled antibodies (35).
Two-Photon Fluorescence Microscopy (TPM), an important invention in biological
imaging (36), has overcome these diagnostic limitations. TPM is a non-invasive, three-
dimensional imaging technology based on two-photon induced nonlinear excitation of
fluorophores (see Chapter 5). It has the capability for deep-tissue imaging (up to several hundred
micrometers) and reduced photo-damage, even for opaque and highly scattering tissues, such as,
human skin (33-38). In the past, studies have demonstrated the viability of using TPM as a new,
exciting tool to study skin barrier morphology (37, 38). Because the inherent skin chromophores,
such as, NADH and flavoproteins, fluoresce in the green spectrum, while the Rhodamine-based
fluorescent probes, such as Sulforhodamine B (SRB), fluoresce in the red spectrum, an
appropriate filter set can be used to collect the skin autofluorescence signal in the green channel
and the probe fluorescence signal in the red channel (see Chapter 5). With this in mind, using
dual-channel TPM, the inherent skin barrier morphology detection in the green channel has been
shown to provide a fingerprint relative to the fluorescent probe spatial distribution, as detected in
the red channel, in the same piece of skin (see Chapter 5). Hence, not only does such an imaging
procedure provide a novel approach to visualize the skin barrier, but it also provides an exciting
way to visualize the spatial distribution of model fluorescent probes, such as Sulforhodamine B
(SRB), in the skin barrier. In Chapter 5, dual-channel TPM was used to visualize the morphology
of the skin barrier upon exposure to aqueous contacting solutions of surfactants and humectants,
followed by exposure to aqueous SRB contacting solutions. In addition, Chapter 5 provides
experimental details, including a schematic of the TPM apparatus.
1.7.2. Theoretical Framework
Although surfactant-induced skin barrier perturbation is a well-accepted phenomenon of
biological and medical significance, no satisfactory quantitative models presently exist that can
characterize and subsequently predict the extent of skin barrier perturbation and associated
damage that may result from exposure to surfactants. Hence, most of the research accomplished
in pharmaceutical and cosmetic laboratories, and biological laboratories in universities, across
this country relies heavily on trial-and-error screening studies. In addition, lack of predictive
models results in a significant amount of costly and time-consuming in vivo testing operations on
human subjects as well as on animals, which can be potentially minimized through the
development of integrated models which have the capability of determining, as well as of
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predicting, the extent of skin barrier perturbation induced upon exposure to a surfactant solution
of a certain concentration.
Humectants, such as Glycerol, have been shown to mitigate surfactant-induced skin
barrier perturbation (see Section 1.6). It is not only an important fundamental problem, but it is
also one of great practical significance to develop models that can quantify, as well as predict,
the extent of skin barrier perturbation induced by surfactants, in the absence as well as in the
presence of humectants. Such a prediction may shed light on the mechanisms through which
humectants, such as Glycerol, can mitigate surfactant-induced skin barrier perturbation. The
identification of such mechanisms can also provide useful guidelines to formulating
pharmaceutical and cosmetic products that are mild to the skin barrier and that do not induce
erythema or skin dryness.
These novel, integrated models have been developed utilizing a fundamental
understanding of surfactant solution physical chemistry, in the absence and in the presence of
humectants, along with transport characteristics of the skin barrier (25, 39-41, 63-68). For this
purpose, hindered-transport aqueous porous pathway models that employ a distribution of pore
sizes to quantify the extent of skin barrier perturbation have been developed and validated in
Chapter 6 of this thesis.
1.7.3. Outline of the Thesis Chapters
The remainder of this thesis is divided into the following chapters. Chapter 2 describes the
results of an in vitro investigation that determines how SDS affects the skin barrier properties in
the presence of Glycerol. In this chapter, I have proposed a plausible hypothesis for how
Glycerol may mitigate SDS-induced skin barrier perturbation that is based on the relative sizes of
the SDS micelles and the skin aqueous pores. Chapter 3 develops an experimental/theoretical
framework for analyzing the skin barrier perturbation potential of SCI, a mild surfactant,
including explaining its well-known skin mildness characteristics in vivo. Chapter 4 presents the
development of an in vitro ranking metric to rank surfactants (SDS and C12E6), the control
(PBS), and humectants (Glycerol and Propylene Glycol) based on their ability to perturb the skin
barrier. The in vitro ranking metric developed in Chapter 4 was compared with in vivo patch
measurements that were carried out to clinically determine the extent of erythema and visual
dryness induced by aqueous solutions of the control, the surfactant, and the humectant solutions
considered above. In Chapter 5, dual-channel TPM was used to visualize the morphology of the
skin barrier upon contact with aqueous solutions of: (i) SDS, (ii) SCI, (iii) Glycerol, (iv)
SDS+Glycerol, and (v) PBS (the control). The TPM visualization studies provided direct visual
evidence that SDS could interact with the keratins of the corneocytes in the SC and induce
corneocyte damage, which resulted in the creation of localized transport regions, LTRs. Upon
adding Glycerol to a SDS aqueous contacting solution, the ability of SDS to penetrate into the
SC and to induce corneocyte damage was significantly minimized. An analysis of the amount of
fluorescent probe that penetrated into the SC as a function of the depth of the SC upon contacting
p-FTS separately with the five aqueous contacting solutions considered showed that SDS
enhanced the probe partition coefficient the most, and that the extent of SC barrier perturbation
induced by these chemicals follows the order: (iii) < (v) < (ii) < (iv) < (i), which is consistent
with the results of the ranking study presented in Chapter 4. In Chapter 6, a pore size distribution
model was developed to gain more fundamental insight, beyond that attained through the
average pore radius analysis presented in Chapter 2, into the nature of the pores induced by SDS
and by SDS+Glycerol aqueous contacting solutions. The pore size distribution model results
revealed that adding Glycerol to the SDS aqueous contacting solution induces a shift in the pore
size distribution - from one having larger pores to one having smaller pores. Finally, Chapter 7
summarizes the important results of this thesis, and discusses future research directions in the
area of skin barrier perturbation induced by surfactants in the presence of humectants.
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Chapter 2
2. The Role of Sodium Dodecyl Sulfate Micelles in
Inducing Skin Barrier Perturbation in the
Presence of Glycerol
2.1. Introduction and Significance
Human skin consists of three stratified layers, the stratum corneum, the viable epidermis,
and the dermis (1). The stratum corneum (SC), which is the top most layer of the skin, possesses
an ordered brick-and-mortar structure, which consists of the flat comeocytes (the cellular bricks),
interlocked with the lipid lamellae (the intercellular mortar) (2-5). Compared to the porous
structure of the viable epidermis and the porous-and-hydrated structure of the dermis, the rigid
and ordered structure of the stratum corneum makes it a very effective permeability barrier that
is primarily responsible for the skin barrier function (2-4). The lipid lamellae of the SC consist of
lipid bilayers alternating with aqueous, hydrophilic layers (1-4). Under passive skin permeation
conditions, permeants traverse the SC through diffusion across the lipid lamellae. Although
diffusion through the "oily" lipid lamellae can explain the permeation of hydrophobic molecules
across the SC, it cannot explain the permeation of hydrophilic molecules across the SC, as
observed in many earlier studies (6-9).
Indeed, if no aqueous/hydrophilic transport pathways existed within the SC oily lipid
domain, then aqueous/hydrophilic permeants, for example Mannitol (6-9), could not traverse the
SC solely through the lipoidal/hydrophobic pathways that exist in the lipid bilayer domains in the
SC. The observation that hydrophilic solutes are able to permeate across the SC, even under
passive skin permeation conditions, has led researchers to propose the existence of tortuous,
aqueous porous pathways through the intercellular lipid lamellae in the SC. In fact, Menon and
Elias have established a morphological basis for the existence of a pore pathway in the
mammalian SC (10). Menon and Elias applied hydrophilic and hydrophobic tracers in vivo to
murine skin under passive skin permeation conditions, and also under enhanced skin permeation
conditions, including chemical enhancers, a lipid synthesis inhibitor, sonophoresis, and
iontophoresis, and following that, utilized Ruthenium Tetroxide Staining and Microwave Post
Fixation methods to visualize the resulting penetration pathways (10). Their results revealed that
both the hydrophobic and the hydrophilic tracers localized to discrete lacunar domains
embedded within the extracellular lipid lamellar domains (10). Menon and Elias also observed
that under skin permeation enhancement conditions, the lacunar domains exhibited an increasing
extent of structural continuity when compared to passive skin permeation conditions (10). Hence,
structurally continuous lacunar domains have been considered by Menon and Elias as providing
a physical basis for the existence of aqueous pores and polar pathways through the intercellular
lipoidal mortar in the SC (10). These aqueous pores in the SC provide the primary skin barrier
penetration and transport pathways for hydrophilic chemicals, which would otherwise not be
able to penetrate into the skin barrier through the lipoidal, hydrophobic pathways that exist in the
SC (6-11).
In general, surfactants commonly encountered in skin-care formulations are known to
reduce the barrier properties of the skin (11-15). It is well-accepted that surfactants have to first
penetrate into the skin barrier before they can reduce the skin barrier properties. Therefore, if a
formulator can minimize surfactant-skin penetration, this should also minimize the ability of the
surfactant to reduce the skin barrier properties. Sodium Dodecyl Sulfate (SDS), an anionic
surfactant and a model skin irritant, penetrates into and disrupts the skin barrier upon contacting
it from an aqueous solution. The SDS monomers self-assemble to form micelles at
concentrations above the Critical Micelle Concentration (CMC). Studies show, both in vitro and
in vivo, that the SDS-induced skin barrier disruption is dose-dependent, and that it increases with
an increase in the total SDS concentration above the CMC of SDS (11-13). This important
observation contradicts the well-accepted Monomer Penetration Model (MPM), which attempts
to explain surfactant-skin penetration by considering solely the role of the surfactant monomers
which can penetrate the skin barrier through the aqueous pores in the SC (11-23). The MPM
does not consider the possibility that surfactant micelles may also contribute to surfactant-skin
penetration, and consequently, to surfactant-skin barrier disruption, since it considers the
micelles to be too large to penetrate through the aqueous pores that exist in the SC. In her
comprehensive review of surfactant-skin interactions, Rhein stated that the observed dose
dependence of surfactant-induced skin irritation beyond the CMC cannot be explained solely by
the contribution of the monomeric surfactant (14). Indeed, Agner and Serup had earlier observed
that the severity of the transepidermal water loss (TEWL) induced by SDS increased as the SDS
concentration increased beyond the CMC of SDS (8.7 mM) (13). In separate studies,
Ananthapadmanabhan et al. (15) and Faucher et al. (16) observed that as the SDS concentration
increased beyond the CMC, the extent of SDS-skin penetration also increased.
Through in vitro SDS-skin penetration studies, Moore et al. (11) provided substantial
evidence which indicates that the amount of SDS that can penetrate into the skin barrier is dose-
dependent, and furthermore, that the SDS surfactant in micellar form also contributes to SDS-
skin penetration. In addition, Moore et al. demonstrated conclusively that the contribution of the
SDS micelles to SDS-skin penetration dominates that of the SDS monomers at concentrations
above the CMC, which are typically encountered in skin-care formulations (11).
In this chapter, I have further investigated, from a mechanistic perspective, how SDS
micelles may contribute to SDS-skin penetration, thereby leading to the previously observed
dose-dependence of SDS-induced skin barrier perturbation (11-23). Specifically, I will provide
new evidence, through in vitro transdermal permeability and skin electrical current
measurements, in the context of a hindered-transport porous pathway model of the SC (6-9, 42),
that the aqueous pores in the SC increase both in size and in porosity-to-tortuosity ratio when
skin is exposed to an aqueous SDS contacting solution, such that the average pore radius is larger
than the SDS micelle radius. As a result, SDS micelles, contrary to the view put forward by the
MPM, are not sterically hindered from penetrating into the skin barrier through these pores.
Inspired by the proposed mechanistic understanding of how SDS micelles may contribute
to SDS-induced skin barrier perturbation, I have also investigated in vitro whether the addition of
Glycerol, a well-known humectant and skin beneficial agent, to the aqueous SDS contacting
solution can minimize the observed contribution of the SDS micelles to SDS-skin penetration.
Although not within the scope of this chapter, if shown to be valid in vivo, such a strategy can
also significantly reduce the amount of SDS that can penetrate into the skin barrier and induce
skin barrier perturbation in vivo. The in vitro results presented in this chapter are compared with
in vivo results in Chapter 4.
My approach considers exposing skin in vitro to aqueous mixtures of Glycerol and SDS.
The importance of Glycerol (or glycerin) in skin care products is well established, and Glycerol
is widely used in cosmetic and pharmaceutical formulations (24-31). To explain its in vivo
benefits, studies have focused on its humectant and smoothing effects (25) and on its protective
functions in emulsion systems against skin irritation (26). Researchers have shown that Glycerol
diffuses into the SC, increases skin hydration, and relieves clinical signs of dryness (27-29). One
of the views regarding the effect of Glycerol on the skin held by researchers today is that
Glycerol may influence the crystalline arrangement of the intercellular lipid bilayers. The bulk of
the bilamellar lipid sheets are proposed to be in crystalline/gel domains bordered by lipids in a
fluid crystalline state. In skin exhibiting SC barrier damage, the proportion of lipids in the solid
state may be elevated, and subsequent skin exposure to Glycerol may help maintain these lipids
in a liquid crystalline state at low relative humidity, thereby enhancing SC barrier function and
decreasing SC water permeability (30). A second prevalent view is that Glycerol may increase
the rate of corneocyte loss from the upper layers of the SC, through a keratolytical effect due to
enhanced desmosome degradation, thereby reducing scaliness of dry skin and maintaining SC
barrier (31). A third, more recent view advanced by Fluhr et al. is based on the hygroscopic
property of Glycerol (24). Glycerol, by virtue of its high transdermal diffusivity, can penetrate
into the SC, and, by virtue of its hygroscopic property, is able to bind water and thus reduce
water evaporation. Therefore, Glycerol, by absorbing water, may modulate water fluxes in the
SC, which, in turn, may lead to a stimulus for SC barrier repair.
However, it is still not well understood how Glycerol may mitigate surfactant-induced SC
barrier perturbation induced by a formulation containing aqueous mixtures of Glycerol and a
surfactant, such as SDS. Most of the studies discussed above (24-31) considered the application
of Glycerol to forearm skin in vivo, either: (1) as dilute aqueous solutions containing 5-15 wt%
Glycerol, or (2) as cosmetic formulations, such as barrier creams, containing a similar range of
Glycerol concentrations. With this in mind, using such an aqueous mixture of SDS and 10 wt%
Glycerol, I will demonstrate in vitro that the addition of Glycerol eliminates almost completely
the contribution of the SDS micelles to SDS-skin penetration. Using dynamic light scattering
(DLS) measurements, I will show that the addition of 10 wt% Glycerol to an aqueous SDS
contacting solution does not increase the size of the SDS micelles, which if increased, could
explain the observed reduced ability of SDS (present in the larger SDS micelles) to penetrate into
the skin and induce less skin barrier perturbation in the presence of Glycerol. Furthermore, using
surface tension measurements, I will show that the addition of 10 wt% Glycerol to an aqueous
SDS contacting solution does not decrease the CMC, and hence, does not reduce the
concentration of the SDS monomers contacting the skin, which if reduced, could explain the
observed reduced ability of SDS (present in monomeric form) to penetrate into the skin and
induce less skin barrier perturbation in the presence of Glycerol. Finally, using in vitro Mannitol
skin permeability and skin electrical current measurements, in the context of a hindered-transport
porous pathway model of the SC (6-9, 42), I will show that a plausible explanation of my
findings is that the addition of 10 wt% Glycerol to an aqueous SDS contacting solution reduces
the size and the porosity-to-tortuosity ratio of the aqueous pores in the SC relative to the SDS
micelle size, such that the SDS micelles present in the contacting solution are sterically hindered
from penetrating into the SC. This, in turn, leads to significantly less SDS-induced skin barrier
perturbation upon the addition of 10 wt% Glycerol.
2.2. Experimental
2.2.1. Materials
Sodium Dodecyl Sulfate (SDS) was purchased from Sigma Chemicals (St. Louis, MO).
Aralytical-grade Glycerol was purchased from VWR Chemicals (Cambridge, MA). 14C_
radiolabeled SDS and 3H-radiolabeled Mannitol were purchased from American Radiolabeled
Chemicals (St. Louis, MO). All these chemicals were used as received. Water was filtered using
a Millipore Academic water filter (Bedford, MA). Phosphate buffered saline (PBS) was prepared
using PBS tablets from Sigma Chemicals (St. Louis, MO) and Millipore filtered water, such that
a phosphate concentration of 0.01 M along with a NaCl concentration of 0.137 M were obtained
at a pH of 7.2.
2.2.2. Preparation of the Skin Samples
Female Yorkshire pigs (40-45kg) were purchased from local farms, and the skin (back)
was harvested within one hour after sacrificing the animal. The subcutaneous fat was trimmed
off using a razor blade, and the full-thickness pig skin was cut into small pieces (2cm x 2cm) and
stored in a -80 'C freezer for up to 2 months. The surfactant penetration experiments were
performed using pig full-thickness skin, referred to hereafter as p-FTS.
2.2.3. In Vitro Transdermal Permeability Measurements
Vertical Franz diffusion cells (Permegear Inc., Riegelsville, PA) were utilized in the in
vitro transdermal permeability measurements (see Figure 2-1). All the experiments were
performed at room temperature (25 0C). Prior to each experiment, a p-FTS sample was mounted
in the diffusion cell with the SC facing the donor compartment. Both the donor and the receiver
compartments were filled with PBS, and the p-FTS sample was left to hydrate for 1 hour before
the beginning of the experiment to allow the skin initial barrier property to reach steady state. At
this point, the skin electrical current across the p-FTS sample was measured (see below), and
only p-FTS samples with an initial skin current < 3 ýtA were utilized in the permeation studies (a
well-accepted criterion for selecting suitable in vitro skin samples (6, 7)). The PBS in the donor
compartment was then replaced with either 1.5 ml of an SDS aqueous solution or 1.5 ml of an
SDS+10 wt% Glycerol aqueous solution. The solution in the donor compartment, referred to
hereafter as the contacting solution, contacted the p-FTS sample for 5 hours. Note that a 5-hour
exposure of the skin was chosen because this is a sufficiently long time to allow significant SDS-
skin penetration, yet a short enough time to prevent the saturation of the skin with SDS.
Subsequently, the contacting solution was removed and the donor compartment along with the p-
FTS sample were rinsed 4 times with 2 ml of PBS to remove any trace chemical left on the skin
surface and in the donor compartment. The receiver compartment was stirred with a magnetic
stirrer at a speed of 400 rpm throughout the experiment to eliminate permeant bulk concentration
gradients.
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Figure 2-1. Vertical Franz diffusion cell experimental setup to measure Mannitol skin
permeability, skin electrical current, and/or skin radioactivity in vitro.
Following the SDS and the SDS+10 wt% Glycerol aqueous contacting solutions
treatments of the skin, the p-FTS samples in the diffusion cells were exposed to a contacting
solution of 3H-radiolabeled Mannitol in PBS (1-10 jiCi/ml) for 24 hours. Mannitol is: (1) a low
molecular weight monosaccharide (MW=182 Da) (6, 7), and (2) a highly hydrophilic (log Ko/w
= -3.1) chemical (7), which is not metabolized by the body, and hence, if desired, can also be
used for in vivo skin permeation studies (6, 7). Being small in size and highly hydrophilic,
Mannitol can access similar aqueous pores as do ions in order to transport across the skin barrier.
This, in turn, makes Mannitol a suitable permeant to study in the context of the hindered-
transport porous pathway model of the SC (6-9). Pretreatment of p-FTS with (1) SDS or (2)
SDS+10 wt% Glycerol aqueous contacting solutions in this manner, followed by passive
Mannitol skin permeation, allowed for a controlled comparison of the skin barrier perturbation
potential of solutions (1) and (2) at fixed exposure times of 5 hours. Throughout these
experiments, solution samples were withdrawn from both the receiver (r) and the donor (d)
compartments every two hours, and the concentrations of the radiolabeled permeant (Mannitol)
in the two compartments (Cr and Cd, respectively) were measured using a liquid scintillation
counter (Packard, Sheldon, CT). When the transport of Mannitol attained steady state, the
Mannitol skin permeability, P, was calculated as follows (6, 7):
P= A Kd( ) (1)
where V,r is the volume of the receiver compartment, A = (1.77 cm 2) is the area of the SC
exposed to the Mannitol solution in the donor compartment, and t is the exposure time.
Equation (1) is based on the following two assumptions: (i) the concentration of the
permeant in the donor compartment is high, and does not deplete with time, and (ii) the
concentration of the permeant in the donor compartment is always much higher than that in the
receiver compartment. In the experiments reported here, assumptions (i) and (ii) were both
satisfied because less than 2% of Mannitol in the contacting solution permeated across the p-FTS
samples.
2.2.4. In Vitro Skin Electrical Current and Skin Electrical Resistivity
Measurements
During each skin permeation experiment, two Ag/AgCl electrodes (E242, In Vivo
Metrics, Healdsburg, CA) were placed in the donor and in the receiver compartments to measure
the electrical current and the electrical resistivity across the p-FTS sample (see Figure 2-1). A
100 mV AC voltage (RMS) at 10 Hz was generated by a signal generator (Hewlett-Packard,
Atlanta, GA), and was applied across the two electrodes for 5 s. The electrical current across the
skin was measured using an Ammeter (Hewlett-Packard, Atlanta, GA). This ammeter was used
to measure low AC currents and was accurate in the 0.1 ptA range. The electrical resistance of
the p-FTS sample was then calculated from Ohm's law (7). Because the measured skin electrical
resistance is the sum of the actual skin electrical resistance and the background PBS electrical
resistance, the latter was subtracted from the measured skin electrical resistance to obtain the
actual skin electrical resistance. The skin electrical resistivity was then obtained by multiplying
the actual skin electrical resistance by the skin area (A=1.77 cm 2). The skin electrical resistivity,
being an intrinsic electrical property of the skin membrane, is a preferred measure in this analysis
over the skin electrical resistance which is an extensive electrical property of the skin membrane
(33). Therefore, by using the skin electrical resistivity, it will be easier to compare differences in
the electrical properties of the skin barrier upon exposure of the skin to the SDS and to the
SDS+10 wt% Glycerol aqueous contacting solutions. Skin electrical current and resistivity
measurements were carried out before and during the permeation experiments at each
predetermined sampling point. For each p-FTS sample, an average skin electrical resistivity was
determined over the same time period for which the steady-state skin permeability, P, was
calculated using Eq.(1). This average skin electrical resistivity, R, was then analyzed along with
the corresponding skin permeability, P, in the context of the theoretical framework presented
below in the Theoretical Section.
2.2.5. In Vitro Skin Radioactivity Measurements
The p-FTS samples were mounted in vertical Franz diffusion cells, as was done in the
case of the skin transdermal permeability measurements described above. Following a similar
protocol, p-FTS samples were now exposed to aqueous contacting solutions containing 1.5 ml of
SDS or 1.5 ml of SDS+10 wt% Glycerol. Each of these contacting solutions also contained about
1 p.Ci/ml of 14C-SDS.
Diffusion of SDS into the skin took place for 5 hours, as before, and subsequently, the
aqueous contacting solutions were removed and the donor compartment along with the p-FTS
sample were rinsed 4 times with 2 ml of PBS to remove any trace chemical left on the skin
surface and in the donor compartment. The p-FTS samples were then heat-stripped following a
well-known procedure (11). Briefly, a p-FTS sample was placed in a water bath at 600 C for two
minutes, and subsequently, the epidermis (the SC and the viable epidermis) that was exposed to
the contacting solution was peeled off from the dermis. The exposed epidermis was then dried
for two days in a fume hood and weighed. The dried epidermis was dissolved overnight in 1.5
ml of Soluene-350 (Packard, Meriden, CT). After the epidermis dissolved, 10 ml of Hionic
Fluor scintillation cocktail (Packard) was added to the Soluene-350, and the concentration of
radiolabeled SDS was determined using the Packard scintillation counter. Note that we did verify
that the concentration of radiolabeled SDS in the contacting solution did not change appreciably
during the 5-hour exposure to the skin. The concentration of radiolabeled SDS in the contacting
solution was determined by using approximately 100 dtl of the contacting solution and assaying
for the radioactivity of 14C-SDS using the scintillation cocktail assay described above.
Knowing the concentration of SDS in the contacting solution, CSDS, the radioactivity of
the contacting solution, Crad,donor , the dry weight of the epidermis, m , and the radioactivity of the
epidermis, Crad,skin, I was able to determine the concentration of SDS in the dried epidermis,
CSDS,skin, using the following equation (11):
C Crad,skin SS (2)
Crad,donor
2.2.6. Dynamic Light Scattering Measurements
The aqueous SDS and SDS+10wt% Glycerol solutions were prepared in Millipore
filtered water with 100 mM of added NaC1. Note that 100 mM NaCl was added to screen
potential electrostatic repulsions between the negatively-charged SDS micelles while performing
the Dynamic Light Scattering (DLS) measurements (11, 34, 36-39). After mixing, the solutions
were filtered through a 0.02 gm Anotop 10 syringe filter (Whatman International, Maidstone,
England) directly into a cylindrical-scattering cell to remove any dust from the solution, and then
sealed until use. Dynamic Light Scattering (34) was performed at 25 0C and a 900 scattering
angle on a Brookhaven BI-200SM system (Brookhaven, Holtsville, NY) using a 2017 Stabilite
argon-ion laser (Spectra Physics) at 488 nm. The autocorrelation function was analyzed using
the CONTIN program provided by the BIC Dynamic Light Scattering software (Brookhaven,
Holtsville, NY), which determines the effective hydrodynamic radius, Rh, of the scattering
entities using the Stokes-Einstein relation (35):
kBT
Rh = - (3)
where kB is the Boltzmann constant, T is the absolute temperature, 9r is the viscosity of the
aqueous salt solution, and D is the mean diffusion coefficient of the scattering entities.
In order to measure the size of the SDS micelles in the aqueous SDS and in the SDS+10
wt% Glycerol solutions, while eliminating the effects of interparticle interactions, the effective
hydrodynamic radii were determined at several different SDS concentrations, and then
extrapolated to a zero micelle concentration, which corresponds to the CMC of SDS, 8.7 mM
(11, 34, 36-39). Note that the viscosity of a 10 wt% Glycerol aqueous solution is similar to that
of water, and hence, viscosity effects did not play a significant role in these measurements.
2.2.7. Surface Tension Measurements
We utilized surface tension measurements to determine the critical micelle concentration,
CMC, of the SDS and of the SDS+10 wt% Glycerol aqueous micellar solutions. It is well-known
that as the surfactant concentration, X, is increased, both the hydrophobicity of the surfactant
tails and the high water-air surface free energy promote the adsorption of the surfactant
molecules onto the surface (40). The increase in the surface pressure due to surfactant surface
adsorption leads to a lowering of the surface tension, a. Beyond a certain threshold surfactant
concentration, the CMC, it becomes more favorable, from a free energy point of view, for the
surfactant molecules added to the solution to form micelles, rather than to continue to adsorb at
the surface. This is reflected in a negligible change in surface tension, o, with increasing
surfactant concentration, X, beyond the CMC. The "break" in the a versus X curve, therefore,
approximates the concentration at which micellization first takes place (40). In order to
determine this "break", the equilibrium surface tensions of SDS in water and of SDS in water+1 0
wt% Glycerol were measured as a function of the logarithm of the SDS solution concentration
using a Kruss K-11 tensiometer (Charlotte, NC) with a platinum plate. Additional experimental
details can be found in reference (41). The experimental uncertainty in the surface tension
measurements was approximately 0.05 dyn/cm. The temperature was held constant at
25.0±0. 10C by a thermostatically-controlled jacket around the sample.
A plot of c as a function of the logarithm of the surfactant concentration, X, was
generated using the procedure outlined above for the SDS and for the SDS+10 wt% Glycerol
aqueous micellar solutions. Linear regression was utilized to determine the best fit line on either
side of the break in the curve, and the value of the SDS concentration at the intersection of these
two best-fit lines was taken as the experimental CMC value.
2.3. Theoretical
2.3.1. Determination of the Radius and the Porosity-to-Tortuosity Ratio of the
Skin Aqueous Pores Using Hindered-Transport Theory
Tang et al. (7) have recently demonstrated the existence of a linear-log relationship
between the Mannitol skin permeability, P, and the average skin electrical resistivity, R.
Specifically, within statistical error, the following relation holds (7):
log P = log C - log R (4)
where C = (kBT/2z2 Fcioneo)*(Dp H(Ap)/Di, H(2Ao,,)) is a constant that depends on the average
skin aqueous pore radius, rpore, through H(Xp) and H( 0ion), as follows (7, 8, 63): 3
H(,)= (1 - 2.1044, + 2.089W4 - 0.948W ), for ki:O.4 (5)
3 It is noteworthy that the skin aqueous pores have a distribution of pore radii (41). In this chapter, we imply the
average pore radius to be the mean of this distribution of pore radii, and denote this as the radius of the aqueous
pores.
where i = p (permeant, in our case, Mannitol) or ion, rpore = pore radius, Xi = ri/rpore , and Oi (the
partition coefficient of i) = (1-Li)2 . Note that Eq.(5) considers only steric, hard-sphere particle (p
or ion)-pore wall interactions, and does not account for longer-range interactions, such as,
electrostatic and van der Waals interactions (7). Although the ions (and the permeant molecules)
in the contacting solutions may be charged, Tang et al. have shown that Eq.(5) is valid provided
that the Debye-Hiickel screening length - the length scale associated with the screening of
electrostatic interactions between the ions (or between the charged permeants) and the
negatively-charged skin aqueous pore walls - is much smaller than the average skin aqueous
pore radius, rpore (7). Tang et al. also showed that for the PBS control contacting solution
containing Na+ and Cf ions, and also for the Mannitol aqueous solution, the Debye-Hiickel
screening length < 7 A, which is much smaller than the typical average skin aqueous pore radii,
that is, than the sizes of the aqueous pores, of approximately 15-25 A (7). The quantities,
D, and D1,, , appearing in C refer to the permeant and to the ion infinite-dilution diffusion
coefficients, respectively (note that these quantities correspond typically to the bulk diffusion
coefficients of the permeant and of the ion in the dilute donor contacting solutions used in the in
vitro transdermal permeability and electrical resistivity measurements).
According to the hindered-transport theory (42), the hindrance factor for permeant or ion
transport, H(Xi), is a function of both the permeant/ion type and of the skin membrane
characteristics. The four intrinsic membrane characteristics of the skin barrier are: (1) the
porosity, e, which is the fraction of the skin area occupied by the aqueous pores, (2) the
tortuosity, r, which is the ratio of the permeant diffusion path length within the skin barrier to the
skin barrier thickness, (3) the average pore radius, rpore, and (4) the skin barrier thickness, AX.
Based on these four membrane characteristics, one can express the permeability, P, of a
hydrophilic permeant, such as, Mannitol, through the skin aqueous pores as follows (6, 7, 42):
P = (6)AX
Therefore, from Eqs. (4)-(6), once one can determine P and R upon exposure of p-FTS to
contacting aqueous solutions of SDS and SDS+10 wt% Glycerol, one can also determine the
radius of the aqueous pores as the average skin pore radius, rpore, and the ratio of porosity-to-
tortuosity, defined as s/r, if all the other parameters, such as AX, are known (see the appendix,
where we illustrate how to deduce rpore and s/t when p-FTS is contacted with SDS aqueous
solutions). The porosity-to-tortuosity ratio, s/r, is proportional to the number of tortuous
aqueous pores per unit cross sectional area of the SC, that is, to the pore number density (see
Chapter 4). In the context of the hindered-transport aqueous porous pathway model of the SC, an
increase in the porosity, e, and/or a decrease in the tortuosity, t, which increases the porosity-to-
tortuosity ratio, s/r, of the aqueous pores can be interpreted as an increase in the number of
tortuous aqueous pores per unit cross sectional area of the SC (see Chapter 4).4
A harsh surfactant like SDS can induce skin barrier perturbation by modifying the SC
aqueous porous pathways as follows: (1) increasing the size of the existing aqueous pores in the
SC, and/or (2) increasing the number density of the existing aqueous pores in the SC, or both. It
then follows, in the context of the hindered-transport aqueous porous pathway model, that
mechanism (1) involves increasing rpore, while mechanism (2) involves increasing
c/r (6-9, 42). In Table 2-1, I report rpore values resulting from the exposure of p-FTS to
4 This statement is true provided that the increase in the porosity-to-tortuosity ratio, s/r, of the aqueous pores is not
due to a significant increase in the average aqueous pore radius, rpore (see Chapter 4).
contacting solutions of: (a) SDS in water, (b) SDS+10 wt% Glycerol in water, (c) PBS control,
and (d) 10 wt% Glycerol in water. Note that in Table 2-1, I have reported the O/r values resulting
from the exposure of p-FTS to the contacting solutions (a)-(d) normalized by the 6/t value
resulting from the exposure of p-FTS to contacting solution (c), which I have denoted as
(/'t)nomnal. It then follows that when (./t)normal >1, it indicates that the contacting solution creates
more aqueous pores in the SC relative to those created by the PBS control, while when (E/t)normal
< 1, it indicates that the contacting solution creates fewer aqueous pores relative to those created
by the PBS control.
2.4. Results and Discussion
2.4.1. Effect of Glycerol on SDS-Induced Skin Barrier Perturbation
In order to quantify the effect of the SDS concentration in the skin aqueous contacting
solution on the skin barrier in the absence and in the presence of Glycerol, I utilized the in vitro
transdermal permeability and the skin electrical current measurements discussed above. The
physical basis for these measurements is as follows: a large skin electrical current or transdermal
permeability, which results from a high transfer rate of permeant molecules (Mannitol in our
case) or of ions, respectively, across the skin, is indicative of a large extent of skin barrier
perturbation in vitro (1-7). Therefore, if upon exposure of the skin to an aqueous contacting
solution of SDS or of SDS+10 wt% Glycerol, one observes a high skin electrical current
(corresponding to a low average skin electrical resistivity) or permeability, one may conclude
that the contacting solution has induced skin barrier perturbation, thereby compromising the skin
barrier.
With the above expectation in mind, I conducted skin electrical current measurements for
aqueous contacting solutions of SDS ranging in SDS concentrations from 1 mM to 200 mM.5
The results of these measurements are shown as striped bars in Figure 2-2. As can be seen, the
extent of skin barrier perturbation, quantified in terms of the skin electrical current, continues to
increase with an increase in the SDS concentration in the contacting solution above the CMC of
SDS (8.7 mM).6 According to the monomer penetration model (MPM) adopted by many
researchers in the past, only the surfactant monomers are able to penetrate into the skin barrier
and induce skin barrier perturbation, while the micelles, due to their larger size relative to that of
the monomers, are not able to do so. Hence, according to the MPM, the skin barrier perturbation
induced by a surfactant contacting solution should not increase significantly upon increasing the
total surfactant concentration above the CMC.7 However, the skin electrical current results
clearly show that an increase in the SDS concentration in the contacting solution above the CMC
induces a significant increase in the skin electrical current (see Figure 2-2). This observation is
consistent with the results reported by other researchers in previous studies (11-19). For
example, Moore et al. (11) found that SDS micelles contribute to SDS-skin penetration.
Therefore, it is natural that SDS micelles should also contribute to skin barrier perturbation, as I
have demonstrated experimentally through these skin electrical current measurements. Indeed,
5 Note that 1 wt% SDS = 35mM, and that the CMC of SDS = 8.7mM = 0.25wt%.
6 Recall that the CMC is the threshold total surfactant concentration above which the concentration of the surfactant
monomers remains approximately constant, while that of the surfactant micelles increases upon increasing the total
surfactant concentration. This is because, above the CMC, any new surfactant molecules added to the solution self-
assemble to form micelles, a process that is thermodynamically more favorable than to remain as free monomers in
the surfactant solution.
7 This statement implies that a surfactant monomer, or a micelle, has to first penetrate into the skin barrier in order to
induce skin barrier perturbation. Consequently, if one can minimize, or prevent altogether, penetration of surfactant
into the skin, one should be able to minimize skin barrier perturbation induced by the surfactant monomers or by the
micelles.
these measurements indicate unequivocally that SDS micelles contribute to skin barrier
perturbation, as reflected in the observed increase in the skin electrical current above the CMC. 8
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Figure 2-2. Comparison of the in vitro skin electrical currents induced by SDS aqueous
contacting solutions (striped bars) and by SDS+1 0 wt% Glycerol aqueous contacting solutions
(filled bars). The error bars represent standard errors based on 6-10 p-FTS samples.
8 It is noteworthy that the skin electrical current induced by PBS (phosphate buffered saline), which served as the
control for these experiments, was 11±4 pA, which is comparable to that induced by a 1 mM SDS solution (see
Figure 2-2).
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Next, I measured skin electrical currents upon exposing p-FTS to aqueous contacting solutions of
SDS (1-200 mM) + 10 wt% Glycerol. The results of these measurements are shown as filled bars
in Figure 2-2 (see above).
Figure 2-2 clearly shows that the filled bars (corresponding to the skin electrical currents
induced by the SDS+10 wt% Glycerol aqueous contacting solutions) are much shorter than the
striped bars (corresponding to the skin electrical currents induced by the SDS aqueous contacting
solutions). This important finding clearly shows that the addition of 10 wt% Glycerol to an SDS
aqueous contacting solution significantly reduces SDS-induced skin barrier perturbation, as
quantified by the skin electrical currents.
Finally, I measured in vitro Mannitol skin permeabilities upon exposing p-FTS samples
to aqueous contacting solutions of SDS(1-200 mM) and of SDS(1-200 mM)+10 wt% Glycerol.
The results of these measurements are shown in Figure 2-3. In Figure 2-3, the diamonds
correspond to the permeability values resulting from exposure to the SDS aqueous contacting
solutions, and the triangles correspond to the permeability values resulting from exposure to the
SDS+10 wt% Glycerol aqueous contacting solutions. These measurements seem to indicate that:
(1) the SDS micelles, in general, do contribute to skin barrier perturbation, as reflected in the
increasing P values with increasing SDS concentration above the CMC of SDS (8.7 mM), and
(2) the addition of Glycerol minimizes SDS micelle-induced skin barrier perturbation, as
reflected in the triangles lying below the diamonds in Figure 2-3.
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Figure 2-3. Comparison of the in vitro Mannitol skin permeability induced by SDS aqueous
contacting solutions (diamonds) and by SDS+10 wt% Glycerol aqueous contacting solutions
(triangles). The dotted vertical line at an SDS concentration of 8.7 mM denotes the CMC of
SDS. The error bars represent standard errors based on 6-10 p-FTS samples.
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2.4.2. Effect of Glycerol on SDS-Skin Penetration
I developed the skin radioactivity assay discussed above to directly quantify the amount
of SDS that can penetrate into the skin barrier from an SDS aqueous contacting solution in the
absence and in the presence of 10 wt% Glycerol (see Section 2.2.5). Use of this assay allows one
to directly measure the contribution of the SDS micelles, in the absence and in the presence of 10
wt% Glycerol, to SDS-skin penetration. The results of our measurements are shown in Figure 2-
4.
The concentrations of SDS in the skin barrier (in wt%) resulting from the exposure of p-
FTS to aqueous contacting solutions of SDS (1-200 mM) correspond to the diamonds in Figure
2-4. One can clearly see that upon increasing the total SDS concentration in the contacting
solution above the CMC (8.7 mM), the concentration of SDS in the skin barrier increases
significantly. In Figure 2-4, the contribution of the SDS monomers to SDS skin penetration
above the CMC remains approximately constant above 8.7 mM (the CMC value), and
corresponds to the horizontal solid line. On the other hand, the total SDS contribution to SDS
skin penetration increases above the CMC, and corresponds to the dashed line, drawn as a guide
to the eye. Clearly, the difference between the dashed and the solid lines at any given total SDS
concentration corresponds to the contribution of the SDS micelles to SDS skin penetration. Note
that below the CMC, only the SDS monomers are available for penetration into the skin.
Consequently, the diamonds and the triangles overlap below the CMC (see Figure 2-4). These
results are in excellent agreement with the SDS-skin penetration results reported by Moore et al.
(11). Indeed, these authors showed earlier that: (i) there is a significant SDS micellar
contribution to SDS skin penetration, and (ii) the SDS micellar contribution increases with an
increase in the total SDS concentration above the CMC.
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Figure 2-4. Comparison of SDS-skin penetration in vitro induced by aqueous contacting
solutions of SDS (diamonds) and of SDS+10 wt% Glycerol (triangles). The dotted vertical line at
an SDS concentration of 8.7 mM denotes the CMC of SDS. The dashed line passing through the
diamonds is drawn as a guide to the eye. The error bars represent a standard error based on 6-10
p-FTS samples.
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However, in this chapter, I have demonstrated in vitro, for the first time, that the
significant SDS micellar contribution to SDS-skin penetration also leads to a large extent of SDS
skin barrier perturbation, as quantified by the observed increases in the skin electrical currents
and in the Mannitol skin permeabilities (see Figures 2-2 and 2-3, respectively). These in vitro
results suggest, from a practical, formulation design point of view, that any strategy designed to
minimize skin barrier perturbation induced by surfactants like SDS, in addition to minimizing the
penetration of the surfactant monomers into the skin, as was done in the past, may also benefit
from minimizing the penetration of the surfactant micelles into the skin. In this chapter, I have
investigated in vitro such a simple and useful practical strategy by using mixtures of SDS and
Glycerol, which we discuss next.
Specifically, I conducted skin radioactivity assays using 14C-SDS in the presence of 10
wt% added Glycerol in aqueous solution to measure the amount of SDS that may penetrate into
the skin barrier in the presence of Glycerol (corresponding to the triangles in Figure 2-4). It is
interesting to observe that the triangles and the diamonds overlap below the CMC in Figure 2-4.
At an SDS concentration below the CMC of SDS (8.7 mM), the SDS aqueous contacting
solution essentially consists of SDS monomers contacting the skin. Therefore, upon adding 10
wt% Glycerol to the SDS aqueous contacting solution, one can observe that the SDS monomers
are not hindered from penetrating into the skin. However, the addition of 10 wt% Glycerol to the
SDS aqueous contacting solution at concentrations above the CMC significantly impacts SDS-
skin penetration. Indeed, as can be seen, the presence of 10 wt% Glycerol in the SDS contacting
solution eliminates almost completely the amount of SDS that can penetrate into the skin barrier
from the high SDS concentration contacting solutions. The significant difference between the
diamonds (or the dashed line) and the triangles (which lie very close to the SDS monomer
contribution corresponding to the solid line) clearly shows that SDS micelles, which would have
contributed to skin penetration in the absence of 10 w%/o Glycerol, cannot do so in the presence of
10 wt% Glycerol in the contacting solution. These in vitro results suggest that the addition of 10
wt% Glycerol to the SDS contacting solutions may also represent a simple, yet very useful,
practical strategy to mitigate SDS-induced skin barrier perturbation in vivo by preventing the
SDS micelles from penetrating into the skin barrier.
In Section 2.4.3, I put forward several hypotheses to explain, from a mechanistic
viewpoint, why Glycerol, without affecting the skin penetration ability of the SDS monomers, is
able to significantly reduce the ability of the SDS micelles to contribute to SDS-skin penetration
in vitro.
2.4.3. Possible Hypotheses to Explain the Effect of Glycerol on the Observed
In Vitro Dose-Independence of SDS-Skin Penetration
Using micelle stability arguments put forward by Patist et al. (43), Moore et al. have
shown that the kinetics of micelle dissolution cannot be invoked to explain the observed dose-
dependence of SDS-skin penetration (11). Moore et al. have also compared the time constant for
the breakup of SDS micelles to replenish the decreased SDS monomer supply to the SC as the
SDS molecules penetrate into the skin with the time constant for SDS diffusion across the skin.
This comparison has unambiguously shown that the rate-determining step for SDS-skin
penetration is governed by the diffusion, or the penetration, through the SC and not by the
micelle kinetics (11). Furthermore, Moore et al. have shown that micelle disintegration upon
impinging on the SC and subsequent absorption by the skin barrier also does not seem to be a
plausible mechanism to explain the observed dose-dependence of SDS-skin penetration (11, 44,
45). With all of the above in mind, according to Moore et al., a consistent hypothesis to explain
the observed dose-dependence of SDS-skin penetration considers the ability of SDS micelles to
penetrate into the SC, based on a size limitation (11). Without directly measuring the skin
aqueous pore radius, rpore , and the porosity-to-tortuosity ratio, c/r, Moore et al. hypothesized 9
that a free SDS micelle, being smaller than the aqueous pore, is able to penetrate into the SC,
while a PEO-bound SDS micelle, being larger then the aqueous pore, is not able to do so (11).
My hypothesis to explain the observed dose-dependence of SDS-skin penetration in the absence
of Glycerol is similar to that of Moore et al. (11), the difference being that I have further
substantiated this hypothesis by directly determining the average skin aqueous pore radius, rpore,
and the pore number density, c/-, of the skin aqueous pores induced by SDS.
Considering the skin penetration of both the SDS monomers and the SDS micelles, I have
investigated in vitro the following three hypotheses to explain the ability of Glycerol to minimize
the contribution of SDS micelles to SDS-skin penetration: (1) the addition of 10 wt% Glycerol to
the SDS aqueous contacting solution reduces the concentration of the SDS monomers contacting
the skin, and/or (2) the addition of 10 wt% Glycerol to the SDS aqueous contacting solution
increases the SDS micelle size relative to that of the skin aqueous pores, such that the larger SDS
micelles can no longer penetrate through these aqueous pores into the SC, and/or (3) the addition
of 10 wt% Glycerol to the SDS aqueous contacting solution reduces the radius, rpore, and the
porosity-to-tortuosity ratio, c/-r, of the skin aqueous pores, such that the SDS micelles, which are
on average larger than the skin aqueous pores, can no longer penetrate into the SC and contribute
to SDS-skin penetration. According to Hypothesis 3, in addition to the decrease in the radius of
9 Note that Moore et al. (11), to their credit, compared micelle sizes for free SDS micelles and PEO-bound SDS
micelles, using DLS measurements similar to those reported here, and found that the PEO-bound SDS micelle had a
larger hydrodynamic radius than the free SDS micelle. This observation, along with the observation that the PEO-
bound SDS micelle, unlike the free SDS micelle, did not contribute to SDS-skin penetration, formed the basis for
their hypothesis that SDS micelles can penetrate into the SC, based on a size limitation. However, Moore et al. did
not measure the effect of SDS on the radius and on the porosity-to-tortuosity ratio of the skin aqueous pores directly,
as is done here.
the aqueous pores, the decrease in the porosity-to-tortuosity ratio should further limit the ability
of the SDS micelles to penetrate into the SC through these aqueous pores.
I have investigated Hypothesis (1) by conducting surface tension measurements (see
Section 2.2.7) to deduce the CMC of SDS in aqueous solution in the absence and in the presence
of 10 wt% Glycerol. Hypothesis (2) was investigated through DLS measurements to determine
the SDS micelle hydrodynamic radius in aqueous solution in the absence and in the presence of
10 wt% Glycerol (see Section 2.4.5). Finally, I investigated Hypothesis (3) by determining the
radius and the porosity-to-tortuosity ratio of the skin aqueous pores induced by aqueous SDS
contacting solutions in the absence and in the presence of 10 wt% Glycerol through the average
skin electrical resistivity and Mannitol skin permeability measurements, in the context of the
hindered-transport porous aqueous pathway model (see Sections 2.2.3, 2.2.4, and 2.3.1). I
discuss the results of studies (1)-(3) above in the following three sections.
2.4.4. Results from the Surface Tension Measurements to Determine the CMC
Recall that the CMC of a SDS aqueous contacting solution is the threshold total SDS
concentration above which the concentration of the SDS monomers remains approximately
constant, while that of the SDS micelles continues to increase upon increasing the total SDS
concentration. Therefore, if the addition of 10 wt% Glycerol to the SDS aqueous contacting
solution results in a lowering of the CMC, one may conclude that the number of SDS monomers
contacting the skin decreases in the presence of Glycerol, which may explain why Glycerol
reduces SDS-skin penetration. However, my surface tension results indicate that the CMC of
SDS in the presence of 10 wt% Glycerol is 9.2 mM, which is slightly larger than the CMC of
SDS in the absence of Glycerol (8.7 mM). Our CMC value in the presence of Glycerol is in
excellent agreement with previously reported CMC values of SDS in water/glycerol binary
mixtures (46). Therefore, based on the CMC values of SDS in water and in a 10 wt% Glycerol
aqueous solution, one may conclude that Hypothesis 1 is not valid, and therefore, cannot explain
the observed ability of Glycerol to reduce SDS-skin penetration.
2.4.5. Results from the Dynamic Light Scattering (DLS) Measurements to
Determine the Size of the SDS Micelles
Using DLS, I determined the sizes of the SDS micelles in aqueous solutions, in the
absence and in the presence of 10 wt% Glycerol. Figure 2-5 shows the results of the DLS
measurements in terms of the SDS micelle hydrodynamic radii in: (a) water and (b) 10 wt%
Glycerol aqueous solutions. The SDS micelle hydrodynamic radii were determined by
extrapolation to a zero micelle concentration, which corresponds to the CMCs of SDS solutions
corresponding to (a), 8.7 mM (see the diamonds in Figure 2-5), and to (b), 9.2 mM (see the
triangles in Figure 2-5). Using a linear regression analysis, I determined that the hydrodynamic
radius of the free SDS micelles corresponding to (a) is 19.5flA, while that corresponding to (b)
is 18.5±1A. The SDS micelle hydrodynamic radii corresponding to (a) reported here are in
excellent agreement with the values reported previously by Moore et al. (11) and by Almgren et
al. (47). Therefore, these results indicate that the SDS micelle size is slightly smaller, not
larger, in the SDS aqueous solution with 10 wt% added Glycerol, and hence, cannot explain how
Glycerol minimizes the SDS micellar contribution to SDS-skin penetration. In other words,
Hypothesis 2 is not valid either.
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Figure 2-5. Measured effective radii of SDS micelles in aqueous solutions in the absence
(diamonds) and in the presence (triangles) of 10 wt% Glycerol plotted versus the SDS
concentration minus the CMC, which corresponds to the concentration of the SDS micelles,
using DLS measurements at 250C. The SDS micelle radii were determined using a CONTIN
analysis. The error bars reflect standard errors based on 6 samples at each SDS concentration.
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2.4.6. Results from an Analysis of the Hindered-Transport Aqueous Porous
Pathway Model to Determine the Radius and the Porosity-to-Tortuosity Ratio
of the Skin Aqueous Pores
I quantified the extent of skin barrier perturbation using the average aqueous pore radius
and the porosity-to-tortuosity ratio, as quantitative descriptors of the SC morphological changes
upon exposure to: (a) an aqueous solution of SDS (1-200 mM) and (b) an aqueous solution of
SDS (1-200 mM)+10wt% Glycerol. Specifically, an increase in the radius and/or in the porosity-
to-tortuosity ratio of the aqueous pores corresponds to an increased perturbation in the skin
barrier (1, 6, 7, 10, 42). The radius and the porosity-to-tortuosity ratio of the skin aqueous pores
resulting from the exposure to contacting solutions (a) and (b) above were determined using the
hindered-transport model of the skin aqueous porous pathways, along with the in vitro Mannitol
transdermal permeability and the average skin electrical resistivity measurements. For
completeness, I also conducted similar measurements on p-FTS which was exposed to: (c) the
PBS control, and to (d) 10 wt% Glycerol aqueous contacting solutions.
In Figure 2-6, I have plotted the log of the Mannitol skin permeability, P (cm/h), against
the log of the average skin electrical resistivity, R (kohm-cm2 ), over the same exposure time,
exhibited by p-FTS samples exposed to solutions (a), the diamonds, and (b), the triangles, above.
Each diamond/triangle represents a log P value of one p-FTS sample at steady state and the
corresponding log R (the log of the average skin electrical resistivity value). The slopes of the
best-fit curves resulting from linear regressions, the dashed line for (a) and the solid line for (b),
are not statistically different from the theoretically predicted slope value of -1, thereby indicating
consistency with the hindered-transport aqueous porous pathway model analysis for p-FTS
samples exposed to contacting solutions (a) and (b) above (6, 7). Also, note that the dashed line
has a larger intercept value than that corresponding to the solid line, which reflects a larger
average pore radius, rpore, for p-FTS samples exposed to (a) than to (b).
Having determined rpore, the porosity-to-tortuosity ratio, E/r, was determined using Eq.(6),
in which all the parameters, except E/t are known in advance (recall that AX=15ýtm) (6, 7).
Using the model described above, I found that the average pore radius does not depend on the SC
thickness, AX, while the porosity-to-tortuosity ratio is directly proportional to AX. The aqueous
porosity-to-tortuosity ratio, Er, values resulting from exposure of the p-FTS samples to
contacting solutions (a)-(d) above were normalized by the E/t value resulting from exposure of
the p-FTS samples to the PBS control solution, solution (c), which served as the baseline, and
have been denoted as (E/T)normal (see the Appendix, where I illustrate how to obtain rpore and
(E/t)normal for p-FTS samples exposed to (a)).
The deduced values of rpore and (E/T)normai corresponding to solutions (a)-(d) above are
reported in Table 2-1. As can be seen, the average pore radius, rpore , corresponding to (a) is
33±5A, while that corresponding to (b) is 20f5A, which is similar to the average pore radius
corresponding to (c), 20f3A. In addition, the normalized porosity-to-tortuosity ratio, (E/T)norma ,
corresponding to (a), 7+1, is about twice that corresponding to (b), 3±1. Interestingly, one can
also see that a 10 wt% Glycerol aqueous solution (contacting solution d) reduces rpore and
(E/t)normal by about 50% relative to the PBS control.
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Figure 2-6. Experimental correlation between the in vitro Mannitol transdermal permeability, P
(cm/h), and the in vitro skin electrical resistivity, R (kohm-cm2), exhibited by p-FTS samples
exposed to an aqueous solution of SDS (1-200 mM), the diamonds, and to an aqueous solution of
SDS (1-200 mM)+10 wt% Glycerol, the triangles. Each data point corresponds to a log P value
of one p-FTS sample at steady state and the associated log R, the log of the average skin
electrical resistivity value over the same time period. The slopes of the best-fit curves resulting
from a linear regression are: (1) -0.98±0.06 for SDS (1-200 mM), with R2=0.9636, shown as the
dashed line, and (2) -1.05±0.06 for SDS (1-200 mM)+10 wt% Glycerol, with R2=0.9653, shown
as the solid line. Note that these slope values are not statistically different from the theoretically
predicted value of -1.
The results in Table 2-1 indicate that a SDS aqueous contacting solution containing
micelles, in the presence of 10 wt% Glycerol, induces a lower extent of skin barrier perturbation,
as reflected in the lower average pore radius and normalized porosity-to-tortuosity ratio, when
compared to an SDS aqueous contacting solution, in the absence of Glycerol. In fact, in the
absence of Glycerol, a SDS micelle of 19.5±14 hydrodynamic radius experiences no steric
hindrance in penetrating through aqueous pores in the SC that have an average pore radius of
33.5. (see Table 2-1). However, in the presence of 10 wt% Glycerol, a SDS micelle of 18.5±l1•
hydrodynamic radius experiences significant steric hindrance in penetrating through smaller
aqueous pores in the SC that have an average pore radius of 20±5A (see Table 2-1).
Table 2-1. Skin aqueous pore characteristics induced by various aqueous contacting solutions:
(a) SDS, (b) SDS+10 wt% Glycerol, (c) PBS Control, and (d) 10 wt% Glycerol. Note that we
have reported c/t values resulting from the exposure of p-FTS to the contacting solutions (a)-(d)
normalized by the E/t value resulting from the exposure of p-FTS to contacting solution (c),
which we have denoted as (/t)no,,na.
Type of Aqueous Average Pore Normalized Porosity-to-
Contacting Solution Radius, rpore (A) Tortuosity Ratio, (E/r)nomai
(a) SDS 33±5 7±1
(b) SDS + 10 wt% Glycerol 20±5 3±1
(c) PBS Control 20±3 1
(d) 10 wt% Glycerol 11±4 0.5±0.1
Moreover, the presence of 10 wt% added Glycerol in the SDS aqueous contacting
solutionreduces the (E/r)normal value from 7±1 to 3+1, which is more than a 50% reduction in the
normalized porosity-to-tortuosity ratio. Hence, adding 10 wt% Glycerol to an aqueous SDS
micellar contacting solution minimizes the micellar contribution to SDS-skin penetration in vitro
by minimizing both the average pore radius and the porosity-to-tortuosity ratio of the skin
aqueous pores.
The results of this study indicate that the data is consistent with Hypothesis 3: Glycerol
reduces both the radius of the aqueous pores in the SC relative to that of the SDS micelles, as
well as the porosity-to-tortuosity ratio, which if not reduced, would allow SDS micelles to
contribute to SDS-skin penetration in vitro.
2.4.7. Possible Structural Modes of Interaction of Glycerol and SDS with the
Skin Barrier
These results indicate that the addition of 10 wt% Glycerol to an aqueous contacting
solution of SDS mitigates skin barrier perturbation in vitro by reducing the skin aqueous pore
radius and the aqueous porosity-to-tortuosity ratio. I propose two scenarios to rationalize these
results. According to the first scenario, it is well-accepted that because of its strong hygroscopic
property and ability to modulate water fluxes in the SC, Glycerol can diffuse into the SC and
bind water within the SC (24, 28, 29). In fact, researchers have observed a significant positive
correlation in vivo between the skin-moisturizing ability of Glycerol, as determined through skin
conductance measurements, and the corresponding amount of Glycerol found in the skin barrier
(52). As a result, water-binding by Glycerol in the SC reduces the mobility of water within the
SC. The limited mobility of water within the SC may result in lacunar domains, as observed by
Menon and Elias (10), losing structural continuity, partially or completely, within the
extracellular lipid bilayers of the SC. I suggest that a partial loss in the structural continuity of
lacunar domains is responsible for a reduction in the radius of the corresponding aqueous pores,
while a complete loss in continuity of lacunar domains is responsible for the elimination or
closing of the corresponding aqueous pores, that is, for a reduction in the overall number density
(or equivalently, the porosity-to-tortuosity ratio) (see Chapter 4) of the aqueous pores in the SC.
Figure 2-7 illustrates schematically a combination of lacunae that are continuous under normal
skin hydration conditions, resulting in an aqueous pore, but may become discontinuous upon
exposure of the skin to Glycerol, thereby resulting in a size reduction, or a closing, of the
aqueous pore. A second scenario describing how Glycerol may result in partial, or complete, loss
of the structural continuity of lacunar domains considers the ability of Glycerol to maintain the
intercellular lipid mortar in a liquid crystalline state, as opposed to a solid crystalline state (30).
Froebe et al. have shown that addition of 10 wt% Glycerol to a mixture of SC lipids in vitro
inhibited the transition from liquid to solid crystals, which could maintain the intercellular lipid
mortar in the SC and potentially minimize the size, as well as the continuity, of the lacunar
domains within the SC (30). Most likely, both scenarios may play a role in inducing partial,
and/or complete, loss of structural continuity of the lacunar domains, thereby resulting in a
reduction in the radius, and/or in the number density, and thereby the porosity-to-tortuosity ratio,
of the aqueous pores in the SC. On the other hand, in vitro as well as in vivo studies document
that surfactants like SDS have an opposite effect on the SC lipids and on the corneocyte keratins.
SDS has been shown to induce direct alteration to the structure of the intercellular lipid mortar
(48, 49), as well as to disrupt the keratin structure of the corneocytes in the SC (16, 50, 51). Both
of these effects can induce the formation of additional lacunar domains, as well as enhance the
structural continuity of existing lacunar domains.
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Figure 2-7. Schematic illustration of possible structural modes of interaction of aqueous lacunar
domains in the hydrated skin barrier with Glycerol. Aqueous lacunar domains, shown in grey,
gain structural continuity in hydrated skin to form an aqueous pore. However, when Glycerol is
added to the hydrated skin barrier, lacunar domains shown in black lose structural continuity due
to Glycerol binding water and minimizing water mobility, either partially, resulting in a smaller
aqueous pore, or completely, resulting in a closed aqueous pore.
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This is how SDS may induce an increase in the radius, and/or in the porosity-to-tortuosity
ratio, of the aqueous pores in the SC. A mixture of SDS and Glycerol in an aqueous contacting
solution will result in: (1) Glycerol reducing, while (2) SDS increasing the radius and the
porosity-to-tortuosity ratio of the aqueous pores in the SC. These considerations may help
rationalize how adding 10 wt% Glycerol to a SDS aqueous contacting solution can reduce the
radius and the porosity-to-tortuosity ratio of the aqueous pores induced by SDS in the SC.
2.5. Conclusions
According to a well-accepted view in the cosmetics literature, surfactant micelles cannot
penetrate into the skin due to size limitations, and as a result, surfactant-induced skin barrier
perturbation should be determined solely by the concentration of the surfactant monomers (11-
23). Moore et al. (11) have recently shown that this is not the case for a model skin irritant, the
surfactant SDS. Instead, they hypothesized that SDS micelles can penetrate into the skin barrier
and induce skin barrier perturbation. In this chapter, for the first time, using Mannitol
transdermal permeability and average skin electrical resistivity measurements in the context of a
hindered-transport aqueous porous pathway model, I have demonstrated in vitro that SDS
induces an increase in the average radius of the skin aqueous pores, from 20±3A to 33±5A, such
that the SDS micelles of size 19.5±14 can penetrate into the SC through these aqueous pores. In
addition, SDS induces a 7-fold increase in the porosity-to-tortuosity ratio of these aqueous pores,
thereby significantly enhancing the SDS micellar contribution to SDS-skin penetration and to
skin barrier perturbation in vitro.
Using in vitro skin radioactivity measurements, I demonstrated that adding 10 wt%
Glycerol to an aqueous SDS micellar contacting solution significantly reduces: (i) the total extent
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of SDS-skin penetration, and (ii) the SDS micelle contribution to SDS-skin penetration. This is
due to the fact that Glycerol eliminates almost completely the contribution of the SDS micelles
to SDS-skin penetration. Through Dynamic Light Scattering measurements, I have verified that
Glycerol does not increase the size of the SDS micelles, which if increased, could have
minimized the SDS micellar contribution to SDS-skin penetration. In addition, through surface
tension measurements that were used to determine the CMC values of SDS in water and in a 10
wt% Glycerol aqueous solution, I have shown that Glycerol does not reduce the concentration of
the SDS monomers contacting the skin, which if reduced, could have minimized the SDS
monomeric contribution to SDS-skin penetration. Using in vitro transdermal permeability and
average skin electrical resistivity measurements upon exposure of the skin to aqueous contacting
solutions of SDS and of SDS+10 wt% added Glycerol, in the context of a hindered-transport
aqueous porous pathway model, I have conclusively demonstrated that the addition of 10 wt%
Glycerol prevents SDS micelles from penetrating into the skin barrier by: (1) reducing the radius
of the skin aqueous pores induced by the SDS aqueous contacting solution, from 33±5A to
20.±5A, such that a SDS micelle of radius 18.5±1A in an aqueous SDS micellar solution with 10
wt% added Glycerol experiences steric hindrance and cannot penetrate into the SC, and (2)
reducing the porosity-to-tortuosity ratio of the skin aqueous pores by more than 50%, thereby
further reducing the ability of the SDS micelles to penetrate into the SC and induce skin barrier
perturbation.
In the next chapter, Chapter 3, I investigate the well-known skin mildness of the anionic
surfactant, Sodium Cococyl Isethionate (SCI), used in syndet (synthetic detergent) bars, by
examining the size of the SCI micelles relative to that of the skin aqueous pores.
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2.6. Appendix
2.6.1. Determination of the Radius and the Porosity-to-Tortuosity Ratio of the
Skin Aqueous Pores Resulting from Exposure of p-FTS to SDS Aqueous
Contacting Solutions
Average skin electrical resistivities, R, and Mannitol skin permeabilities, P, were
measured upon exposure of p-FTS to SDS aqueous contacting solutions, as discussed in the text,
and the resulting log P vs. log R plot is shown in Figure 2-6 (see diamonds and the dashed line).
It is noteworthy that the slope of the best-fit straight line (the dashed line) through the
diamonds in Figure 2-6 is 0.98±0.06, which is statistically similar to the theoretical value of -1
(see Eq.(4)). The R2 value is 0.96, which is close to 1. Hence, these results lend further support to
the validity of the hindered-transport skin aqueous porous pathway model developed by Tang et
al. (7). The intercept value in Figure 2-6 is -2.90±0.03.
The infinite-dilution diffusion coefficient of Mannitol, Dp, is 0.672x 10-5 cm 2/s at 250 C
(6, 7). The hydrodynamic radius of Mannitol, rp, is 4.44A (6, 7). Because skin electrical currents
were measured in PBS that contained Na+ and Cl- as the dominant ions, the Na+ ions were used
to model the current carrying ions present in the solution. The infinite-dilution diffusion
coefficient of the Na+ ions, Dio , is 1.33x10 -5 cm 2/s at 250 C (7). The hydrodynamic radius of the
Na+ ion, rion, is 2.2A (7). In addition, I have used the following parameter values in C (see Eq.(4)
in the Theoretical section): kB=1.38x10-23 J/K (Boltzmann constant), T=298 K, F=9.6485x 104
C/mol (Faraday constant), z = 1 (in the PBS solution, since NaCl is the dominant electrolyte),
cion=0.137 M, and eo=1.6x10-19 C. Using these parameter values, along with the experimentally
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determined value of C, I was able to determine the value of the ratio: H(,p)/H(jion) (see the
expression for C in Section 2.3.1). Next, using: (i) Eq.(5), (ii) the hydrodynamic radii values of
Mannitol and Na+, that is, 4.44 and 2.2A, and (iii) the value of the ratio H(,p)/H(,ion), I was able
to numerically solve for the average pore radius, rpore. The average pore radius, rpore, was found to
be 33±5A, which I have taken as the radius of the skin aqueous pores. Note that H(Xp) and
H(Aion) are each less than 0.4, which is necessary for Eq.(5) to be valid (6, 7, 42). Having
determined the aqueous pore radius, rpore , the porosity-to-tortuosity ratio, s/i, was determined
using Eq.(6), in which all the parameters, except for s/t, are known in advance (since AX=15plm)
(6, 7).
The porosity-to-tortuosity ratio, E/i, for p-FTS exposed to the PBS control aqueous
solution was determined using a calculation similar to the one for p-FTS exposed to the SDS
aqueous contacting solutions presented in this appendix. Finally, the porosity-to-tortuosity ratio,
s/T, resulting from the exposure of p-FTS to the SDS aqueous contacting solutions was
normalized by the s/T value resulting from the exposure of p-FTS to the PBS control aqueous
solution. I calculated this normalized value, (e/T)nomai , to be 7±1 (see Table 2-1).
104
2.7. References
1. R.Scheuplein and I.Blank, Permeability of the skin, Physiol. Rev., 51 :p. 702-747 (1971).
2. P.M.Elias, Lipids and the epidermal permeability barrier, Arch. Dermatol. Res., 270:p.
95-117 (1981).
3. P.W.Wertz and D.E.Downing, "Stratum corneum: biological and biochemical
considerations", in Transdermal Drug Delivery: Developmental issues and research
initiatives. J.Hadgraft and R.H.Guy, Eds. (Marcel Dekker, Inc. 1989), pp. 1-22.
4. R.L.Bronaugh and H.I.Maibach, "In vitro models for human percutaneous absorption", in
Models in Dermatology. H.I.Maibach et al., Eds. (Karger, Bassel, 1985), Vol. 2, pp. 178-
188.
5. M.Heisig, R.Lieckfeldt, G.Wittum, G.Mazurkevich, and G.Lee, Non steady-state
descriptions of drug permeation through stratum corneum.1. The biphasic brick-and-
mortar model, Pharm. Res., 13:p. 421-426 (1996).
6. K.D.Peck, A.H. Ghanem, and W.I.Higuchi, Hindered diffusion of polar molecules
through and effective pore radii estimates of intact and ethanol treated human epidermal
membrane, Pharm. Res., 11:p. 1306-1314 (1994).
7. H.Tang, S.Mitragotri, D.Blankschtein, and R.Langer, Theoretical description of
transdermal transport of hydrophilic permeants: Application to low-frequency
sonophoresis, J. Pharm. Sci., 90:p. 545-568 (2001).
8. K.D.Peck, A.H.Ghanem, and W.I.Higuchi, The effect of temperature upon the
permeation of polar and ionic solutes through human epidermal membrane, J. Pharm.
Sci., 84:p. 975-982 (1995).
105
9. A.Tezel, A.Sens, and S.Mitragotri, Description of transdermal transport of hydrophilic
solutes during low-frequency sonophoresis based on a modified porous pathway model,
J. Pharm. Sci., 92:p. 381-393 (2003).
10. G.K.Menon, and P.M.Elias, Morphologic basis for a pore-pathway in mammalian stratum
corneum, Skin Pharmacol., 10:p. 235-246 (1997).
11. P.Moore, S.Puvvada, and D.Blankschtein, Challenging the surfactant monomer skin
penetration model: Penetration of sodium dodecyl sulfate micelles into the epidermis, J.
Cosmet. Sci., 54:p. 29-46 (2003).
12. L.D.Rhein, F.A.Simion, R.L.Hill, R.H.Cagan, J.Mattai, and H.I.Maibach, Human
cutaneous response to a mixed surfactant system: Role of solution phenomenon in
controlling surfactant irritation, Dermatologica, 180:p. 18-23 (1990).
13. T. Agner and J. Serup, Sodium lauryl sulphate for irritant patch testing - A dose-response
study using bioengineering methods for determination of skin irritation, J. Invest.
Dermatol., 95:p. 543-547 (1990).
14. L.D. Rhein, "In vitro interactions: Biochemical and biophysical effects of surfactants on
skin", in Surfactants in Cosmetics, M.M. Rieger and L.D. Rhein, Eds. (Marcel Dekker
Inc, New York, 1997), pp. 397-426.
15. K.P.Ananthapadmanabhan, C.L.Meyers, and M.P.Aronson, Binding of surfactants to
stratum corneum, J. Soc. Cosmet. Chem., 47:p. 185-200 (1996).
16. J.A.Faucher and E.D.Goddard, Interaction of keratinous substrates with sodium lauryl
sulfate: I. Sorption, J. Soc. Cosmet. Chem., 29:p. 323-337 (1978).
106
17. J.A.Faucher and E.D.Goddard, Interaction of keratinous substrates with sodium lauryl
sulfate: II. Permeation through stratum corneum, J. Soc. Cosmet. Chem., 29:p. 339-352
(1978).
18. C.H.Lee and H.I.Maibach, Study of cumulative irritant contact dermatitis in man utilizing
open application on subclinically irritated skin, Contact Dermatitis, 30:p. 271-275
(1994).
19. L.D.Rhein, C.R.Robbins, K.Fernee, and R.Cantore, Surfactant structure effects on
swelling of isolated human stratum corneum, J. Soc. Cosmet. Chem., 37:p. 125-139
(1986).
20. J.Vilaplana, J.M.Mascaro, C.Trullas, J.Coll, C.Romaguera, C.Zemba, and C.Pelejero,
Human irritant response to different qualities and concentrations of
cocoamidopropylbetaines: a possible model of paradoxical irritant response, Contact
Dermatitis, 26:p. 289-294 (1992).
21. K.P.Wilhelm, M.Samblebe, and C.P.Siegers, Quantitative in vitro assessment of N-alkyl
sulphate-induced cytotoxicity in human keratinocytes (HaCaT). Comparison with in vivo
human irritation tests, Br. J. Dermatol., 130:p. 18-23 (1994).
22. K.P.Wilhelm, A.B.Cua, H.H.Wolff, and H.I.Maibach, Surfactant-induced stratum
corneum hydration in vivo: Prediction of the irritation potential of anionic surfactants, J
Invest. Dermatol., 101:p. 310-315 (1993).
23. K.P.Wilhelm, G.Freitag, and H.H. Wolff, Surfactant-induced skin irritation and skin
repair, J. Am. Acad. Dermatol., 30:p. 944-949 (1994).
107
24. J.W.Fluhr, M.Gloor, L.Lehmann, S. Lazzerini, F.Distante, and E.Berardesca, Glycerol
accelerates recovery of barrier function in vivo, Acta Derm Venereol, 79:p. 418-421
(1999).
25. J.Bettinger, M. Gloor, A.Vollert, P.Kleesz, J.Fluhr, and W.Gehring, Comparison of
different non-invasive test methods with respect to the different moisturizers on skin,
Skin Res. Technol., 5:p. 21-27 (1999).
26. A.M.Grunewald, J.Lorenz, M.Gloor, W.Gehring, and P.Kleesz, Lipophilic irritants.
Protective values of urea and glycerol containing oil in water emulsions, Dermatosen,
44:p. 81-86 (1996).
27. M.D.Batt and E.Fairhurst, Hydration of the stratum corneum, Int. J. Cosmet. Sci., 8:p.
253-256 (1986).
28. M.Loden, Urea-containing moisturizers influence barrier properties of normal skin, Arch.
Dermatol. Res., 288:p. 103-107 (1996).
29. D.S.Orth and Y.Appa, "Glycerine: a natural ingredient for moisturizing skin", in Dry skin
and moisturizers: chemistry and function, M.Loden and H.I.Maibach, Eds. (CRC Press,
Boca Raton, 2000), pp. 213-228.
30. C.L.Froebe, F.A.Simion, H.Ohlmeyer, L.D.Rhein, J.Mattai, R.H.Cagan, and S.E.Friberg,
Prevention of stratum corneum lipid phase transitions in vitro by glycerol - An
alternative mechanism for skin moisturization, J. Soc. Cosmet. Chem., 41:p. 51-65
(1990).
31. A.Rawlings, C.Harding, A.Watkinson, J.Banks, C.Ackermann, and R.Sabin, The effect
of glycerol and humidity on desmosome degradation in stratum corneum. Arch.
Dermatol. Res., 287:p. 457-464 (1995).
108
32. G.B.Kasting, L.A.Bowman, DC electrical properties of frozen, excised human skin,
Pharm. Res., 7:p. 134-143 (1990).
33. J.Kushner, D.Blankschtein, and R.Langer, Experimental demonstration of the existence
of highly permeable localized transport regions in low-frequency sonophoresis, J. Pharm.
Sci., 93:p. 2733-2745 (2004).
34. L.Magid, "Light scattering in micellar systems" in Dynamic Light Scattering: The
Method and Some Applications, W. Brown, Ed. (Oxford University Press, Oxford, 1993),
pp. 554-593.
35. A.Einstein, Investigation on the Theory of Brownian Movement, New York: Dover, 58,
(1956).
36. W.Brown, J.Fundin, and M.G. Miguel, Poly(ethylene oxide)-sodium dodecyl sulfate
interactions studied using static and dynamic light scattering, Macromolecules, 2 5 :p.
7192-7198 (1992).
37. P.J.Missel, N.A.Mazer, G.B.Benedek, and M.C. Carey, Influence of chain length of the
sphere-to-rod transition in alkyl sulfate micelles, J. Phys. Chem., 87:p. 1264-1277 (1983).
38. A.Rohde and E.Sackman, Quasieleatic light-scattering studies of micellar sodium
dodecyl sulfate solutions at the low concentration limit, J. Colloid Interface Sci., 70:p.
494-505 (1979).
39. P.L.Dubin, J.H.Grubner, J.Xia, and H. Zhang, The effect of cations on the interaction
between dodecylsulfate micelles and poly(ethyleneoxide), J. Colloid Interface Sci.,
14 8 :p. 35-41 (1992).
109
40. T.R.Carale, Q.T.Pham, and D.Blankschtein, Salt effects on intramicellar interactions and
micellization of nonionic surfactants in aqueous solutions, Langmuir, 10:p. 109-121
(1994).
41. M.Mulqueen and D.Blankschtein, Theoretical and experimental investigation of the
equilibrium oil-water interfacial tensions of solutions containing surfactant mixtures,
Langmuir, 18:p. 365-376 (2002).
42. W.M.Deen, Hindered transport of large molecules in liquid-filled pores, AIChE J., 33:p.
1409-1425 (1987).
43. A.Patist, B.K.Jha, S.G.Oh, and D.O.Shah, Importance of micellar relaxation time on
detergent properties, J. Surf Det., 2:p. 317-324 (1999).
44. D.Dhara and D.O.Shah, Stability of sodium dodecyl sulfate micelles in the presence of a
range of water-soluble polymers: A pressure-jump study, J. Phys. Chem. B, 105:p. 7133-
7138 (2001).
45. D.M.Bloor and E.W.Jones, Kinetic and equilibrium studies associated with the binding of
surface-active agents to macromolecules, Chem. Soc. Farad. Trans. 2, 78:p. 657-669
(1981).
46. D.J.Lee and W.H.Huang, Enthalpy-entropy compensation in micellization of sodium
dodecyl sulphate in water/methanol, water/ethylene glycol and water/glycerol binary
mixtures, Colloid Polym Sci, 24:p. 160-165 (1996).
47. M.Almgren and S.Swarup, Size of sodium dodecyl sulfate micelles in the presence of
additives. 2. Aromatic and saturated hydrocarbons, J. Phys. Chem., 86:p. 4212-4216
(1982).
110
48. J.L.Leveque, J.De Regal, D.Saint-Leger, and D.Billy, How does sodium lauryl sulfate
alter the skin barrier function in man? A multiparametric approach, Skin Pharmacol., 6:p.
111-115 (1993).
49. Y.Kawasaki, D.Quan, K,Sakamota, and H.I.Maibach, Electron resonance studies on the
influence of anionic surfactants on human skin, Dermatology, 194:p. 238-242 (1997).
50. E.Barany, M.Lindburg, and M.Loden, Biophysical characterization of skin damage and
recovery after exposure to different surfactants, Contact Dermatitis, 40:p. 98-103 (1999).
51. M.Loden, The simultaneous penetration of water and sodium lauryl sulfate through
isolated human skin, J Soc. Cosmet. Chem., 41:p. 227-233 (1990).
52. T.Okamoto, H.Inoue, S.Anzai, and H.Nakajima, Skin-moisturizing effect of polyols and
their absorption into human stratum corneum, Preprint of the Annual Scientific Meeting,
Society of Cosmetic Chemists (1997).
111
Chapter 3
3. Why is Sodium Cocoyl Isethionate (SCI) Mild
to the Skin Barrier? An In Vitro Investigation
Based on the Relative Sizes of the SCI Micelles
and the Skin Aqueous Pores
3.1. Introduction
Sodium Cocoyl Isethionate (SCI) is an important surfactant ingredient in personal
washing bars, and is known to be milder, or less irritating, to the skin than harsher skin agents,
such as other anionic surfactants like Sodium Dodecyl Sulfate (SDS) and soap (sodium salts of
fatty acids such as stearic and palmitic acids) (1-8). In vivo and in vitro studies have shown that
SCI does not significantly reduce the barrier properties of the skin (1-23, 39, 41). Several factors
have been proposed to explain the mildness of SCI relative to the harshness of other skin agents
used in skin cleansers, including: (i) a lower critical micelle concentration (CMC) value for SCI
resulting in a lower SCI monomer activity with the skin barrier (1-3, 15), (ii) reduced penetration
of SCI into the skin barrier (1-5), and (iii) decreased binding of SCI to proteins and lipids in the
stratum corneum (SC), which is the primary constituent of the skin barrier, resulting in a lower
skin irritation response (3-9).
112
The interactions of SCI with the SC proteins have been studied extensively (1, 3, 15, 42).
These studies have shown that one of the factors responsible for skin mildness/harshness of a
surfactant solution is the charge density of the surfactant polar head group. For example, it has
been shown that SCI has a lower charge density than SDS, and therefore, binds less strongly to
the SC proteins (1, 42). The CMC of the SCI aqueous solution was considered as another
important factor. Specifically, Ananthapadmanabhan et al. (1) observed that SCI has a lower
CMC than SDS and binds to proteins in the SC only about one-fifth as much as SDS under
similar solution conditions and exposure times. The interaction of SCI with SC lipids has also
been investigated to shed light on the mechanisms of SCI-induced skin barrier perturbation.
Specifically, nonionic surfactants such as alkyl polyglucosides, which do not interact strongly
with SC proteins, have been shown to dissolve stearic acid and cholesterol to a much greater
extent than mild anionic surfactants like SCI (42). Because SCI does not selectively remove fatty
acids and cholesterol from the lipid bilayers in the SC, it does not induce significant biological
damage through the modification of lipid biosynthetic functions due to changes in the relative
levels of various lipids in the SC (17-20).
It is well-accepted that surfactants have to first penetrate into the skin barrier before they
can reduce the skin barrier properties. Therefore, if a formulator can minimize surfactant-skin
penetration, this should also minimize the ability of the surfactant to reduce the skin barrier
properties. Previous research has investigated the process of SDS skin penetration from an
aqueous contacting solution by itself (11), as well as when mixed with: (i) a polymer - Poly
Ethylene Oxide (PEO) (11), (ii) a nonionic surfactant - Dodecyl Hexa (Ethylene Oxide) C12E6
(12), and (iii) a humectant - Glycerol (13). It is well-known that the SDS monomers self-
assemble in aqueous solution to form micelles at SDS concentrations which are greater than the
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CMC of SDS. Due to the hydrophilic nature of the resulting SDS micelles, they are expected to
penetrate into the SC through aqueous pores that exist in the SC (11, 13). These aqueous pores in
the SC are located in the lacunae and other aqueous regions surrounded by polar lipids in the
lipoidal mortar between the corneocyte bricks that comprise the brick-and-mortar structure of
the SC (24, 25). It has been shown recently that the SDS micelles are smaller in radius than the
average radii of these aqueous pores, and therefore, contribute to SDS skin penetration and
induce skin barrier perturbation (11-13). Strong evidence that the SDS micelles do indeed
contribute to SDS skin penetration is also provided by the observed dose dependence of SDS
skin penetration and barrier perturbation, which was found to increase as the total SDS
concentration was increased beyond the CMC of SDS (8-13). In cases (i) and (ii) above, where
PEO and C12E6 were added separately to aqueous SDS contacting solutions, the SDS micelle
radius increased relative to the aqueous pore radius, such that the larger SDS micelles became
sterically hindered from penetrating into the SC through the aqueous pores (11, 12). On the other
hand, in case (iii), when Glycerol was added to an aqueous SDS contacting solution, I found that
the average aqueous pore radius decreased relative to the SDS micelle radius, such that the SDS
micelles became sterically hindered from penetrating into the SC through the smaller aqueous
pores (13).
In this chapter, I hypothesize that the well-documented skin mildness of SCI is due to the
inability of the SCI micelles to contribute to skin penetration and induce skin barrier
perturbation. To test this hypothesis, I have determined the average radius and the porosity-to-
tortuosity ratio, of the aqueous pores in the SC when an aqueous solution of SCI contacts the
skin. To this end, I have conducted in vitro Mannitol skin permeability and skin electrical current
measurements in the context of a hindered-transport aqueous porous pathway model of the SC. I
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have also carried out dynamic light scattering (DLS) measurements to determine the radius of the
SCI micelles present in the aqueous solution contacting the skin. Such a combined in vitro
investigation can explain the well-documented in vivo and in vitro skin mildness of SCI (1-3, 42)
by showing that the radius of an SCI micelle is significantly larger than that of the skin aqueous
pores. As a result, SCI in micellar form is unable to penetrate into the SC through these aqueous
pores. Finally, I have also measured the penetration of SCI into the skin using in vitro 14C-
radiolabeled SCI skin radioactivity assays. Because only the SCI monomers can contribute to
SCI skin penetration, due to the inability of the SCI micelles to do so based on the size limitation
discussed above, I will show that the SCI skin penetration is dose independent, an important
finding which further validates this hypothesis.
3.2. Experimental
3.2.1. Materials
Sodium Cocoyl Isethionate (SCI) from BASF was provided to me by UNILEVER
(Edgewater, NJ). 14C-radiolabeled SCI and 3H-radiolabeled Mannitol were purchased from
American Radiolabeled Chemicals (St. Louis, MO). Sodium Chloride (NaCl) was purchased
from Sigma Chemicals (St. Louis, MO). All these chemicals were used as received. Water was
filtered using a Millipore Academic water filter (Bedford, MA). Phosphate Buffered Saline
(PBS) was prepared using PBS tablets from Sigma Chemicals (St. Louis, MO) and Millipore
filtered water, such that a phosphate concentration of 0.01 M along with a NaCl concentration of
0.137 M were obtained at a pH of 7.2.
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3.2.2. Preparation of the Skin Samples
Female Yorkshire pigs (40-45kg) were purchased from local farms, and the skin (back)
was harvested within one hour after sacrificing the animal. The subcutaneous fat was trimmed
off using a razor blade, and the full-thickness pig skin was cut into small pieces (2cm x 2cm) and
stored in a -80 'C freezer for up to 2 months. The surfactant penetration experiments were
conducted using pig full-thickness skin, referred to hereafter as p-FTS.
3.2.3. In Vitro Transdermal Permeability Measurements
Vertical Franz diffusion cells (Permegear Inc., Riegelsville, PA) were utilized in the in
vitro transdermal permeability measurements (11, 12, 31). Prior to each experiment, a p-FTS
sample was mounted in the diffusion cell with the SC facing the donor compartment. Both the
donor and the receiver compartments were filled with PBS, and the p-FTS sample was left to
hydrate for 1 hour before the beginning of the experiment to allow the skin initial barrier
property to reach steady state. At this point, the skin electrical current across the p-FTS sample
was measured, and only p-FTS samples with an initial skin current < 3 ýtA were utilized in the
permeation studies (11, 12, 28, 31). The PBS in the donor compartment was then replaced with
1.5 ml of an SCI aqueous solution. The diffusion cell was then transferred to a temperature-
controlled oven, with the temperature set at 350 C to prevent SCI precipitation from the
contacting solution in the donor compartment of the diffusion cell (42). The donor compartment
of the diffusion cell was covered by para-film to prevent water evaporation at this temperature.
The SCI aqueous contacting solution in the donor compartment contacted the p-FTS sample for 5
hours (11, 12). Subsequently, the contacting solution was removed and the donor compartment
along with the p-FTS sample were rinsed 4 times with 2 ml of PBS to remove any trace chemical
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left on the skin surface and in the donor compartment. The receiver compartment was stirred
with a magnetic stirrer at a speed of 400 rpm throughout the experiment to eliminate permeant
bulk concentration gradients.
Following the SCI aqueous contacting solution treatments of the skin, the p-FTS samples
in the diffusion cells were exposed to a contacting solution of 3H-radiolabeled Mannitol in PBS
(1-10 p.Ci/ml) for 24 hours (24, 27, 31). Throughout these experiments, solution samples were
withdrawn from both the receiver (r) and the donor (d) compartments every two hours, and the
concentrations of the permeant (Mannitol) in the two compartments (Cr and Cd, respectively)
were measured using a liquid scintillation counter (Packard, Sheldon, CT). When the transport of
Mannitol attained steady state, the Mannitol skin permeability, P, was calculated as follows (24,
27, 31):
P = d(CrVj (2)
where Vr is the volume of the receiver compartment, A is the area of the SC exposed to the
Mannitol solution in the donor compartment, and t is the exposure time.
3.2.4. In Vitro Skin Electrical Current and Skin Electrical Resistivity
Measurements
During each skin permeation experiment, two Ag/AgCl electrodes (E242, In Vivo
Metrics, Healdsburg, CA) were placed in the donor and in the receiver compartments to measure
the electrical current and the electrical resistivity across the p-FTS sample (31). A 100 mV AC
voltage (RMS) at 10 Hz was generated by a signal generator (Hewlett-Packard, Atlanta, GA),
and was applied across the two electrodes for 5 s. The electrical current across the skin was
measured using an Ammeter (Hewlett-Packard, Atlanta, GA). This ammeter was used to
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measure low AC currents and was accurate in the 0.1 tA range. The electrical resistance of the
p-FTS sample was then calculated from Ohm's law (31). Because the measured skin electrical
resistance is the sum of the actual skin electrical resistance and the background PBS electrical
resistance, the latter was subtracted from the measured skin electrical resistance to obtain the
actual skin electrical resistance. The skin electrical resistivity was then obtained by multiplying
the actual skin electrical resistance by the skin area (A=1.77 cm 2). Additional details about this
procedure are provided in (13). Skin electrical current and resistivity measurements were carried
out before and during the permeation experiments at each predetermined sampling point. For
each p-FTS sample, an average skin electrical resistivity was determined over the same time
period for which the steady-state skin permeability, P, was calculated using Eq.(l). This average
skin electrical resistivity, R, was then analyzed along with the corresponding skin permeability,
P, in the context of the hindered-transport aqueous porous pathway model of the SC (26, 27, 31).
3.2.5. In Vitro Skin Radioactivity Measurements
The p-FTS samples were mounted in vertical Franz diffusion cells, as was done in the
case of the skin transdermal permeability measurements described above. Following a similar
protocol, p-FTS samples were now exposed to aqueous contacting solutions containing 1.5 ml of
SCI (see Chapter 2). Each of these contacting solutions also contained about 1 p.Ci/ml of 14C-
SCI. Diffusion of SCI into the skin took place for 5 hours, as before, and subsequently, the
concentration of SCI in the skin barrier was determined using a previously published skin
radioactivity assay protocol (11-13).
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3.2.6. Dynamic Light Scattering Measurements
The aqueous SCI solutions were prepared in Millipore filtered water with 100 mM of
added NaCi. Note that 100 mM NaCl was added to screen potential electrostatic repulsions
between the negatively-charged SCI micelles while performing the Dynamic Light Scattering
(DLS) measurements (11, 13, 35-37). After mixing, the solutions were filtered through a 0.02
ýtm Anotop 10 syringe filter (Whatman International, Maidstone, England) directly into a
cylindrical-scattering cell to remove any dust from the solution, and then sealed until use.
Dynamic Light Scattering was performed at 350C and a 900 scattering angle on a Brookhaven
BI-200SM system (Brookhaven, Holtsville, NY) using a 2017 Stabilite argon-ion laser (Spectra
Physics) at 513.5 nm. The autocorrelation function was analyzed using the CONTIN program
provided by the BIC Dynamic Light Scattering software (Brookhaven, Holtsville, NY), which
determines the effective hydrodynamic radius, Rh, of the scattering entities using the Stokes-
Einstein relation (35):
- kTRh = (2)
where kB is the Boltzmann constant, T is the absolute temperature, 71 is the viscosity of the
aqueous salt solution, and D is the mean diffusion coefficient of the scattering entities. For
simplicity, we refer to Rh as the micelle radius. Additional details can be found in references
(11-13).
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3.3. Theoretical
3.3.1. Determination of the Average Radius and the Porosity-to-Tortuosity
Ratio of the Skin Aqueous Pores in Skin Exposed to the Aqueous SCI
Contacting Solutions
Tang et al. (31) developed a hindered-transport aqueous porous pathway model of the SC
that can be used to determine the average radius and the porosity-to-tortuosity ratio of the
aqueous pores in the SC following exposure of the skin to aqueous solutions containing chemical
enhancers, such as surfactants, or following exposure of the skin to physical enhancers, such as
ultrasound. I have recently utilized this model to determine the average radius and the porosity-
to-tortuosity ratio of the aqueous pores in skin (p-FTS) that was contacted by an aqueous
solution of SDS (see Chapter 2 and (13)). Similarly, I have utilized this model here to determine
the average radius and the porosity-to-tortuosity ratio of the aqueous pores in skin (p-FTS) that
was contacted by an aqueous solution of SCI. A comparison of the values of the average radii
and the porosity-to-tortuosity ratio resulting from skin exposure to: (i) the SCI contacting
solution (referred to hereafter as solution (a)), (ii) the SDS contacting solution (referred to
hereafter as solution (b)), and (iii) the PBS control (referred to hereafter as solution (c)) is
presented in Table 3-1. Note that the average radii and the porosity-to-tortuosity ratio
corresponding to solutions (b) and (c) are reproduced from reference (13) (also see Chapter 2). In
ref. (13), I discussed in detail the application of the hindered-transport aqueous porous pathway
model to determine the average radius and the porosity-to-tortuosity ratio of the aqueous pores
upon skin exposure to surfactant aqueous contacting solutions. With this in mind, here, I will
only summarize briefly the main assumptions and key equations of this model.
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The fundamental underlying assumption of the porous pathway model is that hydrophilic
permeants, such as Mannitol, as well as current-carrying ions, traverse the SC through the same
tortuous, cylindrical aqueous pores. Other model assumptions include: (i) the permeants/ions
behave as hard spheres that experience solely steric, hard-sphere particle (permeant or ion)-pore
wall interactions, and (ii) the anions and the cations in the electrolyte solution have the same
valence, z, and similar diffusion coefficients. Although the ions (and the permeant molecules) in
the contacting solutions may be charged, Tang et al. showed that assumption (i) is valid provided
that the Debye-Hiickel screening length - the length scale associated with the screening of
electrostatic interactions between the ions (or between the charged permeants) and the
negatively-charged skin aqueous pore walls - is much smaller than the average skin aqueous
pore radius, rpore (31). Tang et al. also showed that for the PBS control contacting solution
containing Na+ and C1- ions, and also for the Mannitol aqueous contacting solution, the Debye-
Hiickel screening length < 7 A, which is much smaller than the typical average skin aqueous
pore radii (approximately 15-25 A) (31). Furthermore, because the Na' and the CI ions are the
two dominant current-carrying ions in the PBS electrolyte solution, which have the same valence
and similar diffusion coefficients, assumption (ii) is also satisfied. When assumptions (i) and (ii)
are satisfied, the hindered-transport aqueous porous pathway model indicates the existence of a
linear-log relationship between the Mannitol skin permeability, P, and the average skin electrical
resistivity, R. Specifically, within statistical error, the following relation holds (31):
log P = log C - log R (3)
where C = [kBT/2z2 Fcioneo]*[D H(Ap)/Dio•H(Aiod)] is a constant that depends on the average
skin aqueous pore radius, rpore, through H(kp) and H(ion,,), as follows (24, 27, 31):
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H(Ai)= i (1- 2.10441i + 2.089X3 -0.9481:) , for ki<0.4 (4)
where i = p (permeant, in our case, Mannitol) or ion, ri is the radius of solute i, ki - ri/rpore, H(ki)
is the hindrance factor for permeant or ion transport, and Oi (the partition coefficient of solute i) =
(1-Xi) 2. The quantities, Dp and o,, , appearing in C refer to the permeant and to the ion infinite-
dilution diffusion coefficients, respectively (note that these quantities correspond typically to the
bulk diffusion coefficients of the permeant and the ion in the dilute donor contacting solutions
used in the in vitro transdermal permeability and electrical resistivity measurements). In addition,
in C, kB is the Boltzmann constant (1.38x 10-23 J/K), T is the absolute temperature (298 K), F is
the Faraday constant (9.6485x104 C/mol), Cion is 0.137 M, and eo is 1.6x10 19 C.
According to the hindered-transport theory (26), one can express the permeability, P, of a
hydrophilic permeant, such as, Mannitol, through the skin aqueous pores as follows:
P = (5)
where E is the porosity, which is the fraction of the skin area occupied by the aqueous pores,
r is the tortuosity, which is the ratio of the permeant diffusion path length within the skin barrier
(the SC) to the thickness of the skin barrier (the SC), AX. Therefore, using Eqs.(3)-(5), once P
and R are determined experimentally upon exposure of p-FTS to contacting aqueous solutions of
SCI, one can also determine the average skin aqueous pore radius, rpore, and the ratio of porosity-
to-tortuosity, defined as e/t, if all the other parameters, such as AX, are known (see ref. (13) for
an illustration of how to deduce rpore and c/t when p-FTS is contacted with an aqueous SDS
solution). The porosity-to-tortuosity ratio, s/r, can be related to the pore number density, which
corresponds to the number of tortuous aqueous pores per unit cross-sectional area of the SC (see
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Chapter 4). In the context of the hindered-transport aqueous porous pathway model of the SC, an
increase in the porosity, c, and/or a decrease in the tortuosity, t, which results in an increase in
the porosity-to-tortuosity ratio, c/r, of the aqueous pores can be interpreted as indicating an
increase in the pore number density of the SC (see Chapters 2 and 4, and (13, 24, 27, 31)).
3.4. Results and Discussion
3.4.1. Determination of the Average Radius and the Porosity-to-Tortuosity
Ratio of the Skin Aqueous Pores
I quantified the extent of skin barrier perturbation using the skin average aqueous pore
radius and the porosity-to-tortuosity ratio as quantitative descriptors of the morphological
changes in the SC that occur upon skin exposure to aqueous SCI contacting solutions (0.2-200
mM). 1' Specifically, the average radius and the porosity-to-tortuosity ratio of the skin aqueous
pores were determined using the hindered-transport model of the skin aqueous porous pathways,
along with the in vitro Mannitol transdermal permeability and the average skin electrical
resistivity measurements. To gain additional insight, I have also compared the results
corresponding to the aqueous SCI contacting solution (solution (a)) with those corresponding to
the aqueous SDS contacting solution (solution (b)) and to the PBS control (solution (c)) [see
Table 3-1] (13).
The results of the skin electrical current and the Mannitol transdermal permeability
measurements are shown in Figures 3-1 and 3-2, respectively. Note that a large (or small) skin
electrical current or transdermal permeability, which results from a high (or low) transfer rate of
permeant molecules (Mannitol in our case) or of ions, respectively, across the skin, is indicative
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10 Note that for SCI, I mM=0.03 wt%/o.
of a large (or small) extent of skin barrier perturbation in vitro (3, 13, 27-33). In Figures 3-1 and
3-2, one can clearly see that the values of the skin electrical current and of the Mannitol
transdermal permeability both increase sharply as the SCI concentration increases from 0.2 to 1
mM (the CMC of SCI), but do not continue to increase significantly with an increase in the SCI
concentration in the contacting solution beyond the CMC (1 mM). According to the monomer
penetration model (MPM) adopted by many researchers in the past (1-15), only the surfactant
monomers are able to penetrate into the skin barrier and induce skin barrier perturbation, while
the micelles, due to their larger size relative to that of the monomers, are not able to do so.
Hence, according to the MPM, the skin barrier perturbation induced by a surfactant contacting
solution should not increase significantly upon increasing the total surfactant concentration
beyond the CMC. Therefore, these in vitro measurements clearly show that the skin barrier
perturbation induced by SCI is dose independent and follows the MPM.
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Figure 3-1. Skin electrical currents induced in vitro by SCI aqueous contacting solutions (0.2 to
200 mM). The dashed line passing above the filled bars is drawn as a guide to the eye. There is a
sharp increase in the skin electrical current upon an increase in the SCI concentration from 0.2 to
1.0 mM (the CMC of SCI). However, an additional increase in the SCI concentration beyond the
CMC of 1.0 mM does not result in an increase in the in vitro skin electrical current. The error
bars represent standard errors based on 6 p-FTS samples.
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Figure 3-2. Mannitol skin permeability induced in vitro by SCI aqueous contacting solutions
(triangles). The dotted vertical line at an SCI concentration of 1.0 mM denotes the CMC of SCI.
The dashed line passing close to the triangles is drawn as a guide to the eye. There is a sharp
increase in the Mannitol skin permeability upon an increase in the SCI concentration from 0.2 to
1.0 mM. However, an additional increase in the SCI concentration beyond the CMC of 1.0 mM
does not result in an increase in the Mannitol skin permeability. The error bars represent standard
errors based on 6 p-FTS samples.
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In Figure 3-3, I have plotted the experimental correlation between the Mannitol
transdermal permeability, P (cm/h), and the average skin electrical resistivity, R (kohm-cm 2),
over the same exposure time, exhibited by p-FTS samples exposed to the aqueous SCI contacting
solutions (0.2-200 mM). Each triangle represents a log P value of one p-FTS sample at steady
state and the corresponding log R value (the log of the average skin electrical resistivity value).
The slope of the best-fit curve resulting from a linear regression (R2=0.91) is not statistically
different from the theoretically predicted slope value of -1, thereby indicating the validity of
utilizing the hindered-transport aqueous porous pathway model in the SCI case (13, 27, 31). The
average aqueous pore radius, rpore, was determined from the intercept value of the dashed line
with the log P axis (see Figure 3-3) (13, 27, 31). Having determined rpore, the porosity-to-
tortuosity ratio was determined using Eq.(5), in which all the parameters, except s/T, the
porosity-to-tortuosity ratio, are known [recall that AX=15ýtm] (13, 31). Using the model
described above, I found that the average pore radius does not depend on the SC thickness, AX,
while the porosity-to-tortuosity ratio is directly proportional to AX. The porosity-to-tortuosity
ratio, iE/, resulting from exposure of the p-FTS samples to aqueous SCI contacting solutions
were normalized by the s/T value resulting from exposure of the p-FTS samples to the PBS
control solution, which served as the baseline, and have been denoted as (/T)normai. Note that the
rpore and the E/t values for the aqueous SDS contacting solution (1-200 mM) (solution (b)) and
for the PBS control solution (solution (c)) are reproduced from reference (13) (also see Chapter
2).
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Figure 3-3. Experimental correlation between the Mannitol skin permeability, P (cm/h), and the
average skin electrical resistivity, R (kohm-cm 2), exhibited by p-FTS samples exposed to
aqueous contacting solutions of SCI (0.2-200 mM), the triangles. Each data point corresponds to
a log P value of one p-FTS sample at steady state and the associated log R, the log of the average
skin electrical resistivity value over the same time period. The slope of the best-fit curve
resulting from a linear regression is -0.98+0.06 with R2=0.91, shown as the dashed line. Note
that the slope value is not statistically different from the theoretically predicted value of-1.
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The deduced values of rpore and (s/)norm.a. corresponding to solutions (a)-(c) above are
reported in Table 3-1. Specifically, the deduced average aqueous pore radius, rpore ,
corresponding to solution (a) is 29±5A, which is smaller than the deduced rpore value
corresponding to solution (b) (33S±A). The normalized porosity-to-tortuosity ratio, (e/t)normal,
corresponding to solution (a), 2+_1, is less than half that corresponding to solution (b), 7±1.
Therefore, not only does the mild SCI surfactant induce smaller aqueous pores, but it also results
in a lower porosity-to-tortuosity ratio of these aqueous pores when compared to the harsh SDS
surfactant.
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Table 3-1. Skin aqueous pore characteristics resulting from skin exposure to: (i) the SCI aqueous
contacting solution considered here (solution (a)), and (ii) the SDS aqueous contacting solution
(solution (b)), and the PBS control aqueous contacting solution (solution (c)), along with the
corresponding surfactant solution characteristics, including the micelle radii and the CMCs. Note
that the results for solutions (a) and (b) are reproduced from reference (13). The hindered-
transport aqueous porous pathway model was used, along with the in vitro Mannitol transdermal
permeability and average skin electrical resistivity measurements, to determine the average pore
radius, rpore , and the porosity-to-tortuosity ratio, /tr, resulting from skin exposure to solutions
(a), (b), and (c). Note that I have reported s/t values resulting from the exposure of p-FTS to
contacting solutions (a)-(c) normalized by the s,/rt value resulting from the exposure of p-FTS to
contacting solution (c), which I have denoted as (E/t)nomal. The SCI micelle radius was
determined using dynamic light scattering (DLS) measurements at 350 C. The CMC of SCI at
350 C was provided by the BASF Company.
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NormalizedType of Aqueous Average Aqueous Normalized Micelle Critical Micelle
Contacting Pore Radius, Porosity-to- Radius, Concentration,
Solution rpore (A) Tortuosity Ratio (A) CMC (mM)
(a) SCI 29±5 2±1 33.5 ±1 1.0
(b) SDS 33±5 7±1 19.5 +1 8.7
(c) PBS Control 20±3 1 N/A N/A
3.4.2. Determination of the SCI Micelle Size Using Dynamic Light Scattering
(DLS)
Using DLS, I determined the size (radius) of the SCI micelles in aqueous solutions, as
shown in Figure 3-4 (for details, see references (11-13)). The SCI micelle radius was determined
by extrapolation to a zero SCI micelle concentration. Using a linear regression analysis, we
found that the SCI micelle radius is 33.5.±l4.
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Figure 3-4. Measured radii of the SCI micelles in aqueous solutions (triangles) plotted versus the
SCI concentration minus the CMC, corresponding to the concentration of the SCI micelles, using
DLS measurements at 35 0C. The SCI micelle radii were determined using a CONTIN analysis.
The error bars represent standard errors based on 6 samples at each SCI concentration.
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3.4.3. Plausible Explanation for the Skin Mildness of SCI
SCI is a mild skin agent that is not known to significantly induce skin barrier perturbation
in vivo. In order to provide a plausible explanation for the observed skin mildness of SCI, it will
be instructive to examine the micelle size and the CMC of SCI, along with the SCI-induced
average skin aqueous pore radius and the porosity-to-tortuosity ratio. As discussed above, the
average aqueous pore radius, rpore , induced by an aqueous SCI contacting solution is 29±5,,
while the radius of the SCI micelle is 33.5f±1• (see Table 3-1). Therefore, the larger SCI micelle
experiences significant steric hindrance in penetrating through aqueous pores that have, on
average, a smaller radius." On the other hand, a SDS micelle having a radius of 19.5flA
experiences no steric hindrance in penetrating through aqueous pores in the SC that have an
average pore radius of 33±5A (see Table 3-1 and reference (13)). In addition, the normalized
porosity-to-tortuosity ratio, (s/T)norma , corresponding to the aqueous SCI contacting solution
2_+1, is less than half that corresponding to the SDS aqueous contacting solution, 7±1.
With the above findings in mind, my explanation for the observed dose independence of
SCI skin penetration and associated skin barrier perturbation is based on a comparison of the
radius of a SCI micelle with the average radius of the skin aqueous pores induced by the aqueous
SCI contacting solutions. Specifically, the SCI micelle radius is larger than the average aqueous
pore radius, and therefore, the SCI micelles are sterically hindered from penetrating into the SC
through these skin aqueous pores.
" In fact, the skin aqueous pores have a distribution of pore radii (13, 41). The average pore radius is the mean of
this distribution of pore radii. In Chapter 6, the size distribution of skin aqueous pores upon exposure to SDS (1
wt%) and to SDS (1 wt%) + Glycerol (10 wt%) have been modeled using single-parameter exponential and
truncated normal distribution functions.
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As a result, SCI in micellar form does not contribute to skin penetration and associated
skin barrier perturbation. 12 Note that in providing this plausible explanation regarding the skin
mildness of SCI, I have implicitly assumed that a surfactant monomer, or a micelle, has to first
penetrate into the skin barrier in order to induce skin barrier perturbation, an assumption which
has been validated by in vivo studies (1-10, 14-16). Because the concentration of the SCI
monomers is approximately constant above the CMC (1 mM) while that of the SCI micelles
increases, a natural manifestation of our explanation of the skin mildness of SCI should be a dose
independence of the SCI skin penetration (see Section 3.4.4), which should reflect primarily the
penetration of SCI in monomeric form, rather than in micellar form, into the skin barrier. I have
determined that the SCI skin penetration is indeed dose independent through a 14C-radiolabeled
SCI skin assay, and discuss this important finding in the Section 3.4.4.
3.4.4. Verification of the Explanation for the Skin Mildness of SCI Using the
SCI Skin Radioactivity Assay
I developed the skin radioactivity assay discussed in Section 3.2.5 to directly quantify the
amount of 14C-SCI that can penetrate into the skin barrier from an SCI aqueous contacting
solution. Use of this assay allows one to directly measure the contribution of the SCI micelles to
SCI skin penetration. The concentrations of SCI in the skin barrier (in wt%) resulting from the
exposure of p-FTS to aqueous contacting solutions of SCI (0.2-200 mM) correspond to the
triangles in Figure 3-5. In Figure 3-5, one can clearly see that the SCI concentration in the skin
12 The CMC of SCI is I mM which is much lower than the CMC of SDS (8.7 mM), which is a well-known harsh
skin agent. Therefore, at a surfactant concentration above the CMC, SCI has a much smaller concentration of
monomers that come in contact with the skin than SDS. Hence, not only does SCI form larger micelles (relative to
SDS) that cannot penetrate into the SC, but it also has a lower concentration of monomers contacting the skin
(relative to SDS) that can penetrate into the SC and induce skin barrier perturbation.
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barrier increases significantly as the SCI concentration in the aqueous contacting solution is
increased from 0.2 mM to about 5 mM, which is close to the CMC of SCI (1 mM).
n
C 50 100 150
Total SCI Concentration in the Aqueous Contacting Solution (mM)
Figure 3-5. Skin penetration of SCI in vitro induced by aqueous contacting solutions of SCI
(triangles). The dotted vertical line at an SCI concentration of 1.0 mM denotes the CMC of SCI.
The error bars represent standard errors based on 6 p-FTS samples.
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However, upon increasing the total SCI concentration in the contacting solution to higher
values, 50-200 mM, the concentration of SCI in the skin barrier does not increase significantly. I
quantified the relative contributions of the SCI monomers and the SCI micelles to SCI skin
penetration by using a multiple linear regression (MLR) analysis of the experimental data
presented in Figure 3-5. The following relation is applicable and forms the basis of the MLR
analysis (please see reference (11) for additional details):
Cskin =a. Cmon +P / .mic (6)
where Cskin is the concentration of SCI in the skin barrier (mmol/g), Cmon,, is the concentration of
the SCI monomers in the aqueous contacting solution, and Cmic is the concentration of the SCI
micelles in the aqueous contacting solution. The value of Cmo,, was set to 1 mM (the CMC of
SCI) while the value of Cmic was obtained using a mass balance (Csci,total - Cmon), where CsctotaI
is the total concentration of SCI in the aqueous contacting solution . The regression coefficients,
a and /, in Eq.(6), which quantify the contributions of a SCI monomer and a SCI micelle,
respectively, to SCI skin penetration, were determined using the MLR analysis. Specifically, I
found that: a= 1.6x10-2+8.4x10 -4 and P3= 6.8x10-s5 9.8x10 -6 (R2=0.93). Since a is more than
two orders-of-magnitude larger than f (a/fl=238), this result clearly demonstrates that a SCI
monomer, when compared to a SCI micelle, is the predominant species contributing to SCI skin
penetration. This, in turn, results in the observed dose independence of SCI skin penetration.
Interestingly, a similar MLR analysis performed by Moore et al. (11) for SDS skin penetration
showed that the value of the SDS monomer-to-micelle contribution ratio, our a/fl, is 3.25, which
is much smaller than the SCI monomer-to-micelle contribution ratio of 238.13 Therefore, this
quantitative comparison indicates that unlike a SDS micelle, a SCI micelle does not penetrate
13 I conduct a similar analysis in Chapter 6 and find that the value of a/fl for SDS skin penetration is 4.163, which is
close to 3.25 determined by Moore et al. (11).
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significantly into the skin, and hence, leads to a dose independent skin penetration in the SCI
case. The amount of SCI that penetrates into the skin barrier in vitro from aqueous contacting
solutions was found to be approximately ten-fold lower than that of SDS (11, 13), which
provides further evidence that the SCI micelles, unlike the SDS micelles (11, 13), do not
contribute significantly to skin penetration.
In summary, the results in Figure 3-5, as well as the MLR analysis, clearly show that SCI
in micellar form does not contribute significantly to SCI skin penetration, which in turn, leads to
the observed dose independence of SCI skin penetration. This observation is consistent with my
explanation of the skin mildness of SCI proposed above. 14 The SCI skin radioactivity results
reported here are also consistent with recent studies (1, 42). For example, Ananthapadmanabhan
et al. found that SCI binds to human SC to a lower extent than SDS, and also that SCI binding,
unlike SDS binding, does not increase above the CMC of SCI (1).
3.5. Conclusions
Using Mannitol transdermal permeability and skin electrical resistivity measurements in
the context of a hindered-transport aqueous porous pathway model of the SC, I determined that
the average aqueous pore radius resulting from skin exposure to an aqueous SCI contacting
solution is 29_±5. Using dynamic light scattering measurements, I found that the SCI micelle
radius is 33±14. These results provide a plausible explanation for the well-documented skin
mildness of SCI. Indeed, since the SCI micelles are larger in size than the average skin aqueous
14 In fact, Moore et al. have shown that micelle kinetics as well as micelle disintegration upon impinging on the SC
and subsequent absorption by the SC do not affect surfactant-skin penetration (11).
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pores, they are sterically hindered from penetrating into the SC through the smaller skin aqueous
pores.
A natural manifestation of my explanation for the skin mildness of SCI is that the SCI
skin penetration should also be dose independent. Using 14C-radiolabeled SCI and in vitro skin
radioactivity measurements, I demonstrated that SCI penetrates into the SC in a dose
independent manner. Furthermore, through in vitro skin electrical current and Mannitol
transdermal permeability measurements, I demonstrated that SCI induces skin barrier
perturbation in a dose independent manner. On the other hand, I have observed in previous
studies that the harsh skin agent SDS, which is also an anionic surfactant like SCI, penetrates
into the SC and induces skin barrier perturbation in a dose dependent manner because the SDS
micelle, being smaller in size than the average skin aqueous pores, can penetrate into the SC
through these pores (11, 13). Furthermore, the amount of SCI that penetrates into the skin barrier
in vitro from an aqueous contacting solution was found to be significantly lower than that of SDS
(11, 13), which may be related to earlier in vitro and in vivo observations that SCI is mild, while
SDS is harsh, to the skin barrier (1, 10-17, 23, 42). Finally, an aqueous SCI contacting solution
results in a 60% lower porosity-to-tortuosity ratio in vitro than an aqueous SDS contacting
solution, which is also consistent with the fact that SCI is known to be mild to the skin barrier
and is also known to induce low skin barrier perturbation in vivo.
In the next chapter, Chapter 4, I develop an in vitro ranking metric capable of ranking
aqueous surfactant/humectant systems based on their perturbation of the skin aqueous pores, and
validate the results through in vivo skin barrier measurements.
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Chapter 4
4. Ranking of Aqueous Surfactant-Humectant
Systems Based on an Analysis of In Vitro and
In Vivo Skin Barrier Perturbation
Measurements
4.1. Introduction
In Chapters 2 and 3, macroscopic in vitro skin barrier measurements, including average
skin electrical resistivity (R) and Mannitol skin (transdermal) permeability (P), were used in the
context of a hindered-transport theory, to calculate the average pore radius (rpore) and the
porosity-to-tortuosity ratio (&/r) of the skin aqueous pores (1-6). Specifically, it was possible to
quantify the extent of in vitro skin barrier perturbation that an aqueous surfactant/humectant
system induces by examining the modifications of rpore and g/r relative to an in vitro PBS
(Phosphate Buffered Saline) control. The harsh surfactant Sodium Dodecyl Sulfate (SDS) was
shown to induce significant skin barrier perturbation in vitro relative to the PBS control, while
the humectant Glycerol was shown to preserve the skin barrier in vitro and to mitigate skin
barrier perturbation (see Chapter 2 and (7-11, 16-19, 25-30)). It is of practical value to be able to
extend these findings to other aqueous surfactant/humectant systems. For example, if a
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correlation is observed between the extent of skin barrier perturbation in vivo and the
modification to the skin aqueous pores that an aqueous surfactant/humectant system induces in
vitro relative to a control, then this would allow one to rank these chemicals based on their
ability to perturb the skin aqueous pores in vitro.
With the above in mind, a ranking metric that combines the characteristics of the skin
aqueous pores will be developed (see Section 4.2.6), which can potentially: (i) reduce, or
eliminate altogether, several costly and time-consuming operations, such as, human and animal
testing and trial-and-error screening, and (ii) simultaneously screen and rank many surfactants
and humectants for use in skin-care formulations, thereby significantly speeding up the effort and
time required to bring new skin-care formulations to the market. In addition, a suitable ranking
metric that uses the skin electrical currents induced in vitro relative to an in vitro PBS control
can be combined with corresponding Mannitol skin permeability measurements, in the context of
a hindered-transport aqueous porous pathway model. Specifically, the hindered-transport model
will allow for the quantification of the modifications of: (i) the average pore radius, and (ii) the
pore number density, induced by aqueous surfactant/humectant systems relative to the in vitro
PBS control, thereby shedding light on the mechanism of in vitro skin barrier perturbation
induced by the aqueous surfactant/humectant system considered (see Section 4.2.6). Knowledge
of the mechanism of in vitro skin barrier perturbation induced by aqueous surfactant/humectant
systems can be valuable in designing skin-care formulations containing these chemicals that are
mild to the skin and that minimize, or eliminate altogether, skin barrier perturbation (17-19, 23,
24, 28, 32).
This chapter is devoted to the development of an in vitro ranking metric, using skin
electrical current measurements relative to an in vitro PBS control, that is capable of ranking
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aqueous surfactant/humectant systems based on their ability to perturb the skin aqueous pores in
vitro. In addition, Mannitol skin permeability measurements were conducted that allowed: (i)
further in vitro validation of the conclusions reached from the ranking metric study, and (ii)
combination, with the skin electrical current measurements conducted as part of the ranking
study, in the context of the hindered-transport aqueous porous pathway model, to determine the
average pore radius and the pore number density values induced by the aqueous
surfactant/humectant systems in vitro. For this purpose, the anionic surfactant SDS and the
nonionic surfactant C12E6 (Dodecyl Hexa (Ethylene Oxide)), and the humectants, Propylene
Glycol (PG) and Glycerol (G), were selected (see Section 4.2). The enhancements in the average
pore radii and pore number densities induced by these two surfactants and two humectants
relative to the in vitro PBS control were analyzed to gain mechanistic insight into their skin
barrier perturbation/mitigation characteristics.
SDS is known to induce skin erythema (8-11, 17), while C12E6 is known to induce skin
dryness when exposed to human skin in vivo (16, 18 19). On the other hand, PG and G are both
humectants which are known to preserve the skin barrier, and to maintain the water content of
the skin when applied to human skin in vivo (27-31). The in vitro ranking of the two surfactants
and the two humectants relative to the in vitro PBS control was compared with various in vivo
skin barrier measurements (see below), and the correlation between the in vitro ranking metric
analysis and the in vivo skin barrier measurements was investigated (see Sections 4.4.2 and
4.4.3).
146
The well-accepted in vivo soap chamber test 15 was utilized to carry out the following
measurements: (1) Transepidermal water loss (TEWL) to determine the moisture vapor flux over
the skin as measured by an evaporimeter, which serves as an excellent quantitative indicator of
skin barrier perturbation in vivo (see Section 4.3.1), (2) Visual skin dryness scores determined by
an expert grader to clinically assess the extent of skin dryness (see Section 4.3.2), and (3) Skin
erythema (redness) determined by the colorimetry scale of a chromameter to assess the extent of
clinical irritation symptom (see Section 4.3.3). The results of these measurements are
summarized, and compared with the in vitro measurements, in Section 4.4.3. In Section 4.4.4, the
results of a comparative study between the in vitro skin barrier mitigation characteristics induced
upon adding 10 wt% Glycerol to SDS aqueous contacting solutions, reported in Chapter 2, and
the in vivo measurements conducted upon adding 10 wt% Glycerol to a 1 wt% SDS aqueous
contacting solution are presented. Finally, the main conclusions of the studies reported in this
chapter are presented Section 4.5.
4.2. In Vitro Skin Barrier Studies
4.2.1. Materials
Sodium Dodecyl Sulfate (SDS) was purchased from Sigma Chemicals (St. Louis, MO).
Analytical-grade Glycerol (G) and Propylene Glycol (PG) were purchased from VWR
Chemicals (Cambridge, MA). 3H-radiolabeled Mannitol was purchased from American
Radiolabeled Chemicals (St. Louis, MO). Dodecyl Hexa (Ethylene Oxide), C12E6, was purchased
from Nikko Chemicals (Tokyo, Japan). All these chemicals were used as received. Water was
15 The in vivo soap chamber test was conducted by CyberDERM Clinical Studies in Broomall, PA, in collaboration
with Neutrogena Corporation, Los Angeles, CA, using a well-accepted and previously published protocol (12, 13,
20-23). See Section 4.3 for additional details.
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filtered using a Millipore Academic water filter (Bedford, MA). Phosphate buffered saline (PBS)
was prepared using PBS tablets from Sigma Chemicals (St. Louis, MO) and Millipore filtered
water, such that a phosphate concentration of 0.01 M along with a NaCl concentration of 0.137
M were obtained at a pH of 7.2.
4.2.2. Preparation of the Solutions
For the in vitro skin barrier studies, the following aqueous solutions were prepared: (i) an
anionic surfactant solution - SDS (1 wt%), (ii) a nonionic surfactant solution - C1 2 E6 (1 wt%),
(iii) a control solution - Phosphate Buffered Saline (PBS), (iv) a humectant solution - Propylene
Glycol (PG) (10 wt%), and (v) a humectant solution - Glycerol (G) (10 wt%).
4.2.3. Preparation of the Skin Samples
Female Yorkshire pigs (40-45kg) were purchased from local farms, and the skin (back)
was harvested within one hour after sacrificing the animal. The subcutaneous fat was trimmed
off using a razor blade, and the full-thickness pig skin was cut into small pieces (2cm x 2cm) and
stored in a -80 'C freezer for up to 2 months. The in vitro experiments involve contacting pig
full-thickness skin (p-FTS) with aqueous surfactant-humectant and PBS control solutions (i)-(v)
(see Section 4.2.2).
4.2.4. Mannitol Transdermal Permeability Measurements
Vertical Franz diffusion cells (Permegear Inc., Riegelsville, PA) were used for the
Mannitol skin permeability measurements (see Chapter 2). All the experiments were performed
at room temperature (25 0 C). The p-FTS samples were mounted in the diffusion cells with the SC
facing the donor compartments. Both the donor and the receiver compartments were filled with
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PBS, and the p-FTS samples were left to hydrate for 1 hour before the beginning of the
experiment to allow the skin initial barrier property to reach steady state (see Chapter 2). At this
point, the skin electrical current across the p-FTS sample was measured, and only p-FTS samples
with an initial skin current < 3 ptA were utilized in the Mannitol skin permeability studies (see
Chapter 2). PBS in the donor compartments was then replaced separately with 1.5 ml of aqueous
contacting solutions (i)-(v) (see Section 4.2.2), and left in contact with the SC of the p-FTS
samples for 5 hours (see Chapter 2). Subsequently, aqueous contacting solutions (i)-(v) were
removed and the donor compartments along with the p-FTS samples were rinsed 4 times with 2
ml of PBS to remove any trace chemical left on the skin surface and in the donor compartments.
Subsequently, the p-FTS samples in the diffusion cells were exposed to aqueous contacting
solutions of 3H-radiolabeled Mannitol in PBS (1-10 gpCi/ml) for 24 hours. For additional
experimental details, including a discussion of the liquid scintillation counting method used to
determine the Mannitol skin permeability, see Chapter 2.
4.2.5. Skin Electrical Current and Resistivity Measurements
During each Mannitol skin permeability experiment, two Ag/AgCl electrodes (E242, In
Vivo Metrics, Healdsburg, CA) were placed in the donor and in the receiver compartments to
measure the electrical current and the electrical resistivity across the p-FTS samples (see Chapter
2). A 100 mV AC voltage (RMS) at 10 Hz was generated by a signal generator (Hewlett-
Packard, Atlanta, GA), and was applied across the two electrodes for 5 s. The electrical current
across the skin was measured using an Ammeter (Hewlett-Packard, Atlanta, GA). The electrical
resistance of the p-FTS sample was then calculated from Ohm's law (see Chapters 2 and 3). The
skin electrical resistivity was obtained by multiplying the actual skin electrical resistance by the
skin area (A=1.77 cm2) (see Chapter 2 for additional details). Skin electrical current and
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resistivity measurements were carried out before and during the permeation experiments at each
predetermined sampling point. For each p-FTS sample, an average skin electrical resistivity was
determined over the same time period for which the steady-state Mannitol skin permeability, P,
was calculated (see Chapter 2).
4.2.6. Development of an In Vitro Test to Rank Aqueous
Surfactant/Humectant Systems
The central objective for developing an in vitro ranking metric is to rank aqueous
surfactant-humectant contacting solutions (i), (ii), (iv), and (v), relative to the in vitro PBS
control (iii), based on the extent of their perturbation to the skin aqueous pores. For this purpose,
I chose skin electrical current induced by aqueous contacting solutions (i)-(v), relative to the in
vitro PBS control (contacting solution iii), as the preferred in vitro ranking test. Specifically, I
adopted the following in vitro ranking metric (RM):
RM = •(1)
I,.
where E denotes the enhancer (that is, aqueous contacting solutions (i), (ii), (iv), and (v)), C
denotes the control (that is, the in vitro PBS control (iii)), IE denotes the skin electrical current
induced by E, and Ic denotes the skin electrical current induced by C. Note that RM in Eq.(1)
corresponds to the enhancement in the skin electrical current.
The in vitro skin electrical current measurements reported in Chapters 2 and 3 show that
these measurements are: (i) extremely sensitive to small changes in the extent of skin barrier
perturbation, (ii) highly reproducible, and (iii) simpler to implement, less time consuming, and
safer than typical skin permeability measurements which make use of radioactive materials and
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involve relatively complex assaying procedures. In addition to benefits (i)-(iii), I will show that
the in vitro skin electrical current measurements correlate well with the in vivo skin barrier
measurements reported in this chapter (see Section 4.4.3).
As shown in Chapter 2, skin electrical current measurements can also be related to
average skin electrical resistivity, R, values, which, in turn, can be combined with Mannitol skin
permeability, P, values, in the context of the hindered-transport aqueous porous pathway model
(1-5). Specifically, by analyzing Log P as a function of Log R, two important characteristics of
the skin aqueous pores can be obtained: (i) the average pore radius, rpore, and (ii) the porosity-to-
tortuosity ratio, e/r. In order to determine if aqueous contacting solutions (i)-(v) induce skin
barrier perturbation by increasing the average pore radius and/or the pore number density
(number of pores/unit area) of the aqueous pores in the SC (see Section 4.1), it is important to
consider the relationship between rpore and e/r. Specifically,
S(N,(r 2) rI(= N, 2 2
__ r ) 7Y.pore = p orP e (2 )S atotal t aotal
where Np is the number of aqueous pores contained within a SC cross-sectional area of atota,,,, and
p is the number of tortuous pores/unit area = (N/a,,,totr) = pore number density. Interestingly,
Eq.(2) shows that e/rincreases linearly with p and quadratically with rpo,e. Because aqueous
contacting solutions (i)-(v) may modify either rpore and/or p, an analysis of the ranking metric to
obtain mechanistic insight on the extent of perturbation of the skin aqueous pores should
incorporate changes in both rpo,e and p. Once rpo,,e and e/z are determined using the theoretical
analysis involving the Log P and Log R values (see Chapter 2), Eq.(2) can be used to obtain p.
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The skin permeability (P) of a hydrophilic permeant, such as Mannitol, can be modeled
by considering transport of the hydrophilic permeant through the skin aqueous pores (see
Chapter 2 and (1-4)). Specifically, this results in the well-known relationship between P and the
aqueous pore characteristics, given by (1-6):
P = H · ,) (3)
where Dp is the permeant (p) infinite-dilution diffusion coefficient, L is the thickness of the SC,
and H(2p) is the hindrance factor experienced by permeant p as it partitions into the SC from the
aqueous contacting solution and diffuses across the SC. The hindrance factor, H(2p), is a
nonlinear function of Ap, where ,p is the ratio of the permeant radius, rp, and the average pore
radius, rpore, that is, Ap = r/rpore (5, 6). By combining Eqs.(2) and (3), it follows that P is a
function of both p and rpore for a specific hydrophilic permeant, such as Mannitol. Specifically,
P = (P~r (10P H(2i,) (4)
Because P is inversely proportional to [RH(A)/H(Ap)], 16 and R is inversely proportional to the
skin electrical current, I, P is directly proportional to [IH(Ap)/H(Ad] (see Chapter 2 and (1-4), as
well as Eq.(5) below). Therefore, the ranking metric adopted here, which corresponds to the
enhancement in the skin electrical current, can also be expressed as an enhancement in the
Mannitol skin permeability, within the context of the hindered-transport aqueous porous pathway
model (1-5). Specifically,
16 Note that analogous to p,, 2, = r/rpore, where i represents the current-carrying ion (1).
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RM = (5)
PH(AP) H Ii
where I have used Eq.(3), and the fact that (DP /L)E = (Dp' /L)c. 17
It is instructive to consider the following characteristics of the in vitro ranking metric,
RM: (1) RM is numerically equal to unity for the in vitro PBS control (iii), and (2) increasing
values of RM indicate an increase in the extent of perturbation to the skin aqueous pores, and
hence, an increase in the extent of skin barrier perturbation. In addition, it is also worth noting
the following implications regarding the ranking metric when analyzed in the context of the
hindered-transport aqueous porous pathway model:1 8 (i) it scales linearly with the skin
permeability (P) of a hydrophilic permeant, 19 (ii) it is a linear function of p and a nonlinear
function of rore, and (iii) because it depends on both p and rpore, it can shed light on the
mechanism of skin barrier perturbation; specifically, one can determine if an aqueous contacting
solution induces a high ranking metric value by increasing rpore, p, or both. The results of the in
vitro ranking metric study are presented in Section 4.4.1, and are compared with in vivo skin
barrier measurements in Section 4.4.3.
17 Because Dp /L does not depend on the nature of the aqueous contacting solution, and depends solely on the
choice of the permeant (Mannitol in the present case) and the skin model used (p-FTS in the present case), it follows
that( D /L)E = (D /L)c.
18 It is important to note that RM, which is defined as the enhancement in the skin electrical current induced by E
relative to C (see Eq.(1)), is independent of the hindered-transport aqueous porous pathway model. However, the
hindered-transport aqueous porous pathway model can be used to further analyze the RM to determine rpore and p.
19 Because the skin electrical resistivity (R) scales linearly with P (see Chapter 2 and (25)) and P scales linearly with
the ranking metric, the ranking metric also scales linearly with R.
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4.3. In Vivo Skin Barrier Studies
The in vivo skin barrier studies were carried out by CyberDERM Clinical Studies in
Broomall, PA, in collaboration with Neutrogena Corporation, Los Angeles, CA. The objective of
this study was to conduct quantitative in vivo skin barrier perturbation measurements upon
contacting volar forearm skin test sites of human volunteers with aqueous solutions (i), (ii), (iv),
and (v) (see Section 4.2.2). The control for these in vivo measurements was a skin test site that
was not occluded and that was not exposed to aqueous contacting solutions (i)-(v), and therefore,
had no in vivo reaction induced by aqueous contacting solutions (i)-(v). This control will be
referred to hereafter as the in vivo control to differentiate it from the in vitro PBS control (iii).
Note that this in vivo control was adopted because studies have shown that natural hydration of
the skin in vivo can be mimicked in vitro by contacting skin with a PBS solution that has a pH =
7-7.4 (the in vitro control, see Section 4.2.2), which is similar to the in vivo pH of the hydrated
SC (8-12). The in vivo skin barrier perturbation studies were carried out using a modified soap
chamber test (7, 12, 13). The modified soap chamber test involved application of patches
containing aqueous contacting solutions (i), (ii), (iv), and (v) to skin test sites on the volar
forearms of 96 female volunteers (4 groups of 24). The volunteers were interviewed to verify
that they had no known allergies to soaps or fragrances, and that they were not using any
medications that could have interfered with the results of the study. In addition, the
transepidermal water loss rate (TEWL), discussed in Section 4.3.1, for these volunteers was less
than 10 g/m 2hr at the beginning of the study. 20 Following the appropriate selection of the
volunteers, the extent of in vivo skin barrier perturbation on a volar forearm skin test site was
20 Note that the equivalent in vitro selection criterion used was a skin current < 3 ýiA at the beginning of the study
(see Section 4.2.5 and Chapter 2).
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evaluated using various in vivo measurements (see Sections 4.3.1-4.3.3) on Day 1 (prior to
treatment). Subsequently, the patch containing one of aqueous contacting solutions (i), (ii), (iv),
and (v) was applied to the skin test site for 5 hours. After approximately 18-20 hours (on Day 2),
the skin test site was re-evaluated, according to the in vivo measurements discussed in Sections
4.3.1-4.3.3. Some of the skin test sites were not exposed to the patches, and were left non-
occluded to serve as the in vivo control. The in vivo measurements will be reported as deviations
from the baseline measurements (see Section 4.4.2), which include initial measurements prior to
exposure of a test site to a contacting test formulation.
4.3.1. Measurement of Transepidermal Water Loss Using an Evaporimeter
Transepidermal water loss (TEWL) measurements provide a noninvasive instrumental
assessment of the skin barrier function in vivo. Specifically, skin barrier perturbation may lead to
a disruption of the intercellular lipid bilayers in the SC, thereby resulting in elevated water loss
rates. Such elevated water loss rates can, in turn, lead to the skin becoming dry and chapped,
thereby enhancing skin dryness (15-19).
The TEWL measurements were made using an evaporimeter (Broomall, PA) with probes
manufactured by Cortex Technology (Hadsund, Denmark) and available in the US through
CyberDERM, Inc. (Broomall, PA). This instrument is based on the vapor pressure gradient
estimation method as designed by Nilsson and initially utilized by the Servo Med Evaporimeter
(20). The probes contain two sensors that measure the temperature and relative humidity at two
fixed points along the axis normal to the skin surface. This arrangement is such that the device
can electronically derive a value that corresponds to evaporative water loss from the skin surface
expressed in g/m 2hr. Additional details on the TEWL measurements using an evaporimeter can
be found in (21 and 22).
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The TEWL measurements were conducted following a 15-30 minute acclimation period
in a controlled environment with the relative humidity maintained at less than 50% and the
temperature maintained at 21+1 0 C. At baseline (that is, with no exposure to a contacting test
formulation), TEWL measurements were conducted for each of the skin test sites. Any
individuals with TEWL values outside the normal range (>10 g/m 2hr) were excluded at this time.
The test formulations were then applied to the test sites under occlusive soap chambers. On Day
2 (approximately 18-20 hours after patch removal), TEWL measurements were conducted for
each of the skin test sites as described above.
4.3.2. Evaluation of Visual Skin Dryness by an Expert Grader
The visual skin dryness on the volar forearm test sites of each candidate were evaluated
by an expert grader using the grading scale described in Table 4-1. Intermediate grades were
allowed so that finer distinctions could be made. To conduct the study in an objective manner
with no biases, the expert grader was not made aware of the contents of the patches containing
aqueous contacting solutions (i), (ii), (iv), and (v). One should note that the range [0-2] contained
all the visual skin dryness scores (see Table 4-1 and Section 4.4.2). Although these scores
correspond to the mild range, the expert grader was nevertheless able to effectively discriminate
between the observed low levels of visual skin dryness.
Table 4-1. Expert grader score system used to determine the visual skin dryness as part of the in
vivo soap chamber skin barrier measurements.
Grade .es-ipia
0 None
2 Slight flaking/uplifting of flakes (patchy and/or powdered appearance)
4 Moderate flaking/uplifting flakes (uniform) and/or slight scaling
6 Severe flaking/scaling, uplifting of scales and/or slight fissuring
8 Severe scaling/uplifting scales; with severe fissuring/cracking
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4.3.3. Measurement of Skin Erythema Using a Chromameter
Skin erythema was measured instrumentally by a Minolta CR-200 Chromameter that is
based on a standardized reflectance technique using a tristimulus system. The tristimulus system
makes use of color reading values on three independent axes: (i) L* axis, reflecting the tone of
lightness/darkness, with positive values indicating lightness and negative values indicating
darkness, (ii) a* red/green axis, reflecting the extent of redness/greenness, with positive values
indicating a reddish tinge and negative values indicating a greenish tinge, and (iii) b*
blue/yellow axis, reflecting the extent of blueness/yellowness, with positive values indicating a
bluish tinge and negative values indicating a yellowish tinge. Specifically, the color reading
values were translated into the L*a*b* coordinates whose spacing correlates closely with color
changes perceived by the human eye. For the evaluation of skin erythema using a chromameter,
only values along the a* red/green axis that can capture the extent of redness (erythema) of the
skin were considered. Sets of three a* readings from each of the volar forearm test sites were
taken on Day 1 (prior to exposure, which served as the baseline), as well as on Day 2
(approximately 18-20 hours after patch removal), and the average a* value was calculated for
each site at each time point. A positive a* value along the red/green axis, relative to the baseline
measurements, indicates that the patch containing the aqueous contacting solution has induced
skin redness (erythema) (13). Additional details can be found in (13 and 14).
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4.4. Results and Discussion
4.4.1. Results of the In Vitro Skin Barrier Measurements in the Context of a
Ranking Metric
The average skin electrical currents induced by aqueous contacting solutions (i)-(v) are
reported in Figure 4-1. It is important to note that the measurement of skin electrical currents in
vivo is different from the measurement of skin electrical currents in vitro. The in vivo skin
electrical current (or conductance) measurement is carried out on dry skin, with a low value
indicating less hydrated skin that displays a greater extent of skin barrier perturbation (15). On
the other hand, the in vitro skin electrical current measurement is performed on skin in contact
with a PBS solution (see Section 4.2.5 and Chapter 2). Consequently, a high skin electrical
current in vitro indicates that the skin barrier has been compromised because ions can traverse
the barrier more freely (see Chapter 2 and (15, 24)).
The skin electrical currents induced by aqueous surfactant solutions (i) (1 wt% SDS) and
(ii) (1 wt% C12E6) are significantly higher than those induced by the in vitro PBS control solution
(iii) and by the aqueous humectant solutions (iv) (10 wt% PG) and (v) (10 wt% G). Clearly, and
perhaps as expected, these results indicate that surfactants induce the greatest extent of
perturbation to the skin aqueous pores through which ions can cross the skin barrier, thereby
resulting in the largest observed skin electrical current values.21 In addition, aqueous contacting
solution (v) (10 wt% G) induces a lower skin electrical current than aqueous contacting solution
21 Note that I wt% SDS induces a larger skin electrical current in vitro, and consequently, a greater extent of
perturbation to the skin aqueous pores in vitro than that induced by 1 wt% C1 2E6 in vitro. This finding is consistent
with SDS inducing a greater extent of erythema than C12E6, although C12E6 does induce skin dryness (see Section
4.4.2 and (16-19)).
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(iv) (10 wt% PG).22 This is consistent with the observation that G is able to diffuse into the SC,
increasing skin hydration and relieving clinical signs of erythema and skin-dryness, more readily
than PG and the in vitro PBS control (iii) (see Chapter 2 and (25-30)).
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Figure 4-1. Skin electrical currents induced by aqueous solutions (i)-(v) upon contacting p-FTS
in vitro in diffusion cells. The error bars represent standard errors based on 6 p-FTS samples.
More specifically, the following effects of Glycerol on the skin barrier have been
reported in the literature: (i) Glycerol affects the crystalline arrangement of the intercellular lipid
22 A student-t test with a significance (p<0.05) indicates that each of the bars in Figure 4-1 is statistically different
from the other bars.
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bilayers, thereby enhancing SC barrier function and decreasing SC water permeability (29), (ii)
Glycerol increases the rate of corneocyte loss from the upper layers of the SC, through a
keratolytical effect on desmosome degradation, thereby reducing scaliness of dry skin and
maintaining SC barrier (28), and (iii) Glycerol can penetrate into the SC, and, due to its high
hygroscopic property, is able to bind water and thus reduce water evaporation (25).
The Mannitol skin permeability values induced by aqueous contacting solutions (i)-(v)
are reported in Figure 4-2. As can be seen, aqueous contacting solution (i) (1 wt% SDS) induces
the largest Mannitol skin permeability in vitro. Because the 1 wt% aqueous SDS contacting
solution (i) induces the largest perturbation to the skin aqueous pores relative to the other
aqueous contacting solutions ((ii)-(v)), the Mannitol skin permeability values are the largest for
SDS. This result is consistent with those of the skin electrical current measurements (see above).
In addition, the 1 wt% C12E6 aqueous contacting solution (ii) induces a significantly larger
Mannitol skin permeability relative to the in vitro control (iii) and also relative to the aqueous
humectant solutions (iv) and (v). This result is consistent with those of the in vivo skin barrier
measurements which show that a 1 wt% C12E6 aqueous contacting solution induces a larger
extent of erythema and skin dryness than a 10 wt% PG and a 10 wt% G aqueous contacting
solution (see Section 4.4.2). It is important to note that aqueous contacting solution (v) (10 wt%
G) induces the smallest extent of perturbation to the skin aqueous pores relative to the other
aqueous contacting solutions (i)-(iv), as reflected in both the in vitro skin electrical current and
the Mannitol skin permeability measurements (see Figures 4-1 and 4-2). This finding is
consistent with the in vivo skin barrier measurements which show that Glycerol is indeed the
mildest to the skin barrier (see Section 4.3).23
23 A student-t test with a significance (p<0.05) indicates that each of the bars in Figure 4-2 is statistically different
from the other bars.
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Figure 4-2. Mannitol skin permeability induced by aqueous solutions (i)-(v) upon contacting p-
FTS in vitro in diffusion cells. The error bars represent standard errors based on 6 p-FTS
samples.
The results of the in vitro ranking metric, RM, corresponding to the enhancement in the
skin electrical current values relative to the in vitro control (iii), are reported in Table 4-2. The
skin electrical current values were converted to skin electrical resistivity values according to the
procedure described in Section 4.2.5, and detailed in Chapter 2. The Mannitol skin permeability
values, P, and the skin electrical resistivity values, R, were then analyzed in the context of the
theoretical model presented in Section 4.2.6 to obtain the average pore radius (rpo,e) and the pore
number density (p), which are reported in Table 4-2.
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Table 4-2. Ranking Metric (RM) values, permeability enhancements, average pore radii, and
pore number density enhancements induced by aqueous solutions (i)-(v) upon contacting p-FTS
in vitro in diffusion cells. Note that the error bars represent standard errors based on 6 p-FTS
samples. Note that 'E' indicates enhancer (aqueous contacting solutions (i), (ii), (iv), and (v)) and
'C' indicates the in vitro PBS control (iii).
Type ofAqueous Ranking Metric Permeability Average Pore Pore Number Density
Contacting Solution RM ( IE I c) Enhancement (= PE /Pc) Radius, r pore (A) Enhancement (= PE /Pc)
(i) 1 wt% SDS 7.6±1.0 9.8±2.0 33±5 2.6±1.0
(ii) I wt% C 12E 6  3.5±1.0 4.7±1.0 38±3 0.7±0.5
(iii) PBS Control 1.0 1.0 20±3 1.0
(iv) 10 wt% PG 0.8±0.2 0.7±0.2 18±2 0.9±0.3
(v) 10 wt% G 0.6±0.1 0.3±0.1 11±4 1.7±0.8
Recall that Eq.(1) indicates that if the RM value corresponding to an aqueous contacting
solution is less than one, then that aqueous contacting solution induces a lower extent of skin
barrier perturbation relative to the in vitro PBS control (iii). Conversely, if the RM value
corresponding to an aqueous contacting solution is greater than one, then that aqueous contacting
solution induces a larger extent of skin barrier perturbation relative to the in vitro PBS control
(iii). An examination of Table 4-2 reveals that aqueous humectant contacting solutions (iv) and
(v) induce a lower extent of skin barrier perturbation because their RM values are both less than
one, while aqueous surfactant contacting solutions (i) and (ii) induce a larger extent of skin
barrier perturbation because their RM values are both greater than one. In addition, Table 4-2
reveals the following order of ranking for aqueous contacting solutions (i)-(v) (from the harshest
to the mildest): (i) (1 wt% SDS) > (ii) (1 wt% C12E6)> (iii) (in vitro PBS control) > (iv) (10 wt%
PG) > (v) (10 wt% G).
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It is important to note that the ranking of the permeability enhancement, PF/Pc (see the
third column in Table 4-2) follows the order of ranking obtained using the in vitro ranking metric
(RM), which corresponds to the skin electrical current enhancement, IElIc. This result indicates a
strong correlation between skin electrical current and Mannitol skin permeability measurements
in vitro.
Table 4-2 also reveals that 1 wt% C12 E6 (aqueous contacting solution (ii)) induces the
largest average pore radius, rpore, value when compared to aqueous contacting solutions (i)-(v).
Nevertheless, 1 wt% C12E6 ranks below 1 wt% SDS in terms of skin barrier perturbation, as
reflected in both the RM and PE/Pc values in Table 4-2. This reflects the fact that 1 wt% SDS
induces a much larger pE/Pc value than that induced by 1 wt% C12E6, which more than offsets
the larger rpore value induced by 1 wt% C12E6. In addition, Table 4-2 reveals that the ranking
metric (RM) value corresponding to 1 wt% C12E6 (aqueous contacting solution (ii)) is
significantly larger than the RM values corresponding to the in vitro PBS control (iii) and to the
aqueous humectant contacting solutions (iv) and (v).
Transmission electron microscopy studies (16, 19) have provided evidence that nonionic
surfactants like C1 2E6 can disorder, and at times, disrupt the ordered intercellular lipid bilayers in
the SC. The disordering of the lipid bilayers of the SC can in turn result in a compromised skin
barrier, and may also result in skin dryness (8-11, 16-20). Another interesting observation from
Table 4-2 is that 10 wt% PG (aqueous contacting solution (iv)) induces a smaller pE/Pc value,
yet a larger RM value compared to 10 wt% G (aqueous contacting solution (v)). This result
reflects the fact that 10 wt% PG induces a significantly larger rpore value relative to 10 wt% G,
which more than offsets the smaller pE/Pc value that it induces relative to 10 wt% G. There is
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evidence provided by the in vivo measurements reported in Section 4.4.2, as well as by other
researchers (25, 27, 28), that G, because of its superior hygroscopic character, can better
modulate water fluxes in the SC relative to PG, and therefore, can preserve the skin barrier more
effectively than PG. It is important to note that the key measure of in vitro skin barrier
perturbation is RM, which ranks aqueous contacting solutions (i)-(v) appropriately. The other,
model dependent variables, such as, rpore and pE Pc, provide additional information, thereby
shedding light on the nature of the aqueous pores induced in the SC upon contacting p-FTS in
vitro with aqueous contacting solutions (i)-(v).
4.4.2. Results of the In Vivo Skin Barrier Measurements
Transepidermal water loss (TEWL) values, determined using an evaporimeter as
described in Section 4.3.1, are reported in Figure 4-3. In this figure, the height of each bar
corresponds to the average TEWL value, which is measured as a deviation from the baseline, as
explained in Section 4.3.1. Recall that TEWL is a measure of how easily water passes through
the skin. Therefore, skin whose barrier has been compromised should exhibit a higher TEWL
value (8, 9).
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Figure 4-3. Transepidermal Water Loss (TEWL) values, with the error bars corresponding to
standard errors, that were measured using an evaporimeter upon contacting human skin in vivo
with aqueous contacting solutions (i), (ii), (iv), (v), and for the in vivo control (iii).
The orange and blue bars in Figure 4-3, which correspond to the two aqueous surfactant
contacting solutions ((i) and (ii)), are significantly higher than those corresponding to the in vivo
control (iii), and to the two aqueous humectant contacting solutions ((iv) and (v)) (student-t test,
p<0.05). These results indicate that aqueous surfactant contacting solutions (i) and (ii) induce a
significantly larger extent of skin barrier perturbation, as determined by TEWL, relative to the in
vivo control (iii), and to the two aqueous humectant contacting solutions (iv) and (v). In addition,
a student t-test conducted at a significance of (p<0.05) indicates: (1) no significant difference
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between the TEWL values corresponding to the two humectant aqueous contacting solutions (iv)
and (v), (2) no significant difference between the TEWL values corresponding to the two
surfactant aqueous contacting solutions (i) and (ii), and (3) a statistically significant difference
between the TEWL values corresponding to the two surfactant aqueous contacting solutions (i)
and (ii) relative to the in vivo control (iii), and between the TEWL values corresponding to the
two humectant aqueous contacting solutions (iv) and (v) relative to the in vivo control (iii).
These results indicate that aqueous humectant contacting solutions (iv) and (v) induce
statistically lower skin barrier perturbation, as quantified by the TEWL values, relative to the in
vivo control (iii). On the other hand, aqueous contacting surfactant solutions (iv) and (v) induce
statistically higher skin barrier perturbation relative to the in vivo control (iii).
Visual skin dryness scores, determined by an expert grader as described in Section 4.3.2,
are reported in Figure 4-4. In this figure, the height of each bar corresponds to the average visual
skin dryness score, which is measured as a deviation from the baseline, as discussed in Section
4.3.2. The orange and blue bars in Figure 4-4, which correspond to the two aqueous surfactant
contacting solutions ((i) and (ii)), are significantly higher than those corresponding to the in vivo
control (iii) 24 and to the two aqueous humectant contacting solutions (iv) and (v).
These results indicate that aqueous surfactant contacting solutions (i) and (ii) induce a
significantly larger extent of skin dryness relative to the in vivo control (iii), and to the two
aqueous humectant contacting solutions (iv) and (v), as determined by an expert grader. A
student-t test did not indicate any significant difference (p>0.05) between the visual skin dryness
24 Note that the control for the in vivo skin barrier measurements is a skin test site exhibiting natural skin hydration,
that is not occluded and is not exposed to aqueous contacting solutions (i), (ii), (iv), and (v), while the control for the
in vitro skin barrier measurements is a p-FTS sample that is exposed to PBS. The reason why the in vitro PBS
control can be compared to the in vivo non-exposed, non-occluded control was discussed in Section 4.3.
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scores corresponding to the in vivo control (iii), and to the two aqueous humectant contacting
solutions (iv) and (v).
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Figure 4-4. Visual skin dryness scores, with the error bars corresponding to standard errors,
which were determined by an expert grader upon contacting human skin in vivo with aqueous
contacting solutions (i), (ii), (iv), (v), and for the in vivo control (iii).
This result indicates that the expert grader could not discriminate skin dryness visually
between the two aqueous humectant solutions (iv) and (v) relative to the in vivo control. In
addition, no significant differences were noted (p>0.05, student-t test) between the visual skin
dryness scores corresponding to the two aqueous surfactant solutions (i) and (ii). One should
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note that in comparing results from the TEWL measurements and the visual skin dryness scores,
the TEWL measurements more closely resemble the in vitro skin barrier perturbation
measurements (skin electrical current and Mannitol skin permeability) (see Figures 4-1, 4-2, 4-3,
and 4-4) (12-15).
In addition, an instrumental measurement like TEWL allows for finer discrimination
between the effects of aqueous humectant solutions (iv) and (v), and the in vivo control, relative
to the visual skin dryness scores determined by an expert grader. Indeed, the expert grader was
unable to discriminate between the effects of aqueous humectant solutions (iv) and (v), and the in
vivo control (iii) (see Figure 4-4). Both the TEWL measurements and the visual skin dryness
scores indicate that the aqueous surfactant solution containing 1 wt% C1 2E6 induces significant
skin dryness relative to the in vivo control and to the aqueous humectant solutions (iv) and (v).
This finding is consistent with in vivo studies that have shown that although nonionic surfactants
like C12E6 do not induce significant erythema (skin redness), relative to SDS, they can be drying
to the skin (16-19). This reflects the fact that nonionic surfactants like C12E6 can interact with the
intercellular lipid bilayers of the SC, disorder them, thereby increasing water loss from the skin,
which in turn, results in skin dryness.
Skin erythema scores, determined using a chromameter as described in Section 4.3.3, are
reported in Figure 4-5. In this figure, the height of each bar corresponds to the average skin
erythema score, which is measured as a deviation from the baseline (see Section 4.3.3). Note that
the orange bar in Figure 4-5, which corresponds to aqueous surfactant contacting solution (i)
containing 1 wt% SDS, is above the chromameter reading of zero, which indicates that SDS is
indeed harsh to the skin and induces skin erythema (redness) relative to the baseline
measurement (8-11, 16-19, 24, 32). On the other hand, the blue bar in Figure 4-5, which
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corresponds to aqueous surfactant contacting solution (ii) containing 1 wt% C12E6, is not
statistically different (p>0.05) from a chromameter reading of zero, which indicates that C12E6, is
indeed mild to the skin and does not induce skin erythema (redness) relative to the baseline
measurement (16-19).25
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Figure 4-5. Skin erythema scores, with the error bars corresponding to standard errors, that were
measured using a Minolta chromameter upon contacting human skin in vivo with aqueous
contacting solutions (i), (ii), (iv), (v), and for the in vivo control (iii).
25 It is important to note that a mild surfactant is defined in the skin-care literature as one which does not induce
erythema (skin redness) (16-19). On the other hand, a harsh surfactant is defined as one which induces erythema (8-
11, 16-19). It is also important to keep in mind that a mild surfactant such as C12E6 induces skin barrier perturbation
because it induces skin dryness by disordering intercellular lipid bilayers in the SC (see the in vivo TEWL
measurements in Figure 4-3 and the visual skin dryness scores in Figure 4-4).
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In fact, a student-t test did indicate a significant difference (p<0.05) between the skin
erythema (redness) chromameter reading corresponding to aqueous contacting solution (i) (1
wAt% SDS) and that corresponding to aqueous contacting solution (ii) (1 wt% C12E6). One should
stress that the TEWL measurements and the visual skin dryness scores determine the extent of
intercellular lipid bilayer perturbation in the SC, while the chromameter measurements of
erythema (skin redness) determine the extent of denaturing of the keratins in the
corneocyte/keratinocyte domains of the SC and the VE (viable epidermis), which leads to an
increase in the cutaneous blood flow and associated skin redness (8-11, 14-17, 19-24, 32).
Therefore, the results in Figure 4-5 indicate that SDS induces a larger extent of erythema (skin
redness) relative to C12E6, because SDS can interact strongly with the keratins of the corneocytes
and the keratinocytes, relative to C12E6. As a result, because SDS can interact with both the
keratins and the intercellular lipid bilayers in the SC, while C1 2E6 can interact only with the
intercellular lipid bilayers in the SC, SDS can induce a larger extent of skin barrier perturbation
relative to C12E6 (8-11, 16-20, 24). The in vitro skin barrier measurements discussed in Section
4.4.1 corroborate this finding.
In Figure 4-5, the bars corresponding to the in vivo control (iii) and to the two aqueous
humectant contacting solutions (iv) and (v) are below the chromameter reading of zero, which
indicates that no skin erythema (redness) was observed in these three cases. In addition, no
statistical difference (p>0.05) was observed between the chromameter reading values induced by
the in vivo control (iii) and aqueous humectant contacting solution (iv) containing 10 wt% PG.
However, a statistically significant difference (p<0.05) was observed between the chromameter
reading values induced by the in vivo control (iii) and aqueous humectant contacting solution (v)
containing 10 wt% G. These results indicate that Glycerol has a stronger beneficial impact on the
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skin barrier relative to Propylene Glycol, which is consistent with the in vitro ranking metric
results discussed in Section 4.4.1 (25-29, 31).
4.4.3. Relationship Between the In Vitro and In Vivo Skin Barrier
Perturbations Induced by Aqueous Surfactant-Humectant Systems
The in vitro ranking metric (RM) analysis and the Mannitol skin permeability
measurements indicate that the two surfactant aqueous contacting solutions ((i) and (ii)) induce a
significantly larger extent of skin barrier perturbation relative to the in vitro PBS control (iii),
and relative to the two humectant aqueous contacting solutions ((iv) and (v)). The in vivo TEWL
measurements, the visual skin dryness scores, and the chromameter measurements of in vivo
skin erythema (redness) are consistent with the in vitro results (see Figures 4-3, 4-4, and 4-5).
The in vitro ranking metric analysis also predicts that aqueous contacting solution (i) containing
1 wt% SDS induces the largest extent of skin barrier perturbation in vitro. Conversely, aqueous
contacting solution (v) containing 10 wt% G was predicted to induce the smallest extent of skin
barrier perturbation in vitro. A similar result was obtained from the chromameter measurements
of in vivo skin erythema (redness) (see Figure 4-5). Note that the TEWL values (see Figure 4-3)
and the visual skin dryness scores (see Figure 4-4) corresponding to aqueous contacting solution
(ii) (1 wt% C12E6) were found not to be statistically different (p>0.05) from those corresponding
to aqueous contacting solution (i) (1 wt% SDS). In addition, the in vitro RM analysis and the
Mannitol skin permeability measurements indicate that aqueous contacting solution (v)
containing 10 wt% G induces a smaller extent of skin barrier perturbation, and therefore better
preserves the skin barrier, relative to aqueous contacting solution (iv) containing 10 wt% PG (see
Section 4.4.1 and Table 4-2). This result is consistent with the chromameter measurements of in
vivo erythema (see Figure 4-5).
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In view of the agreement between the in vitro ranking metric analysis and the in vivo skin
barrier measurements summarized above, the methodology presented in this chapter to rank
aqueous surfactant/humectant systems based on their ability to perturb the skin aqueous pores in
vitro should be useful to a formulator of skin-care products who is interested in understanding
skin barrier perturbation induced by aqueous surfactant/humectant systems in vivo. The in vitro
ranking methodology presented here represents a novel approach to rank surfactants and
humectants used in skin-care formulations, and may potentially reduce the need to conduct costly
and time-consuming in vivo skin barrier measurements (see Section 4.5).
4.4.4. Comparison of the In Vitro and In Vivo Effects of Adding 10 wt%
Glycerol to an Aqueous SDS Contacting Solution
In Chapter 2, I presented an in vitro analysis which makes use of skin electrical current
and Mannitol skin permeability measurements to determine the effect of adding 10 wt% Glycerol
to an aqueous SDS contacting solution. Specifically, skin electrical current and Mannitol skin
permeability values were measured following exposure of p-FTS to an aqueous contacting
solution containing SDS (1 wt%) + G (10 wt%). These values are reported again in Table 4-3 for
completeness. In terms of the ranking metric (RM) analysis presented here (see Section 4.2.6), a
RM value of 4.1+1.0 corresponds to an aqueous contacting solution containing SDS (1 wt%) + G
(10 wt%), a value that is obtained by taking the ratio of the skin electrical current values in Table
4-3 corresponding to the aqueous contacting solution containing SDS (1 wt%)+G (10 wt%)
(49+10 pA) relative to the in vitro PBS control (12+3 ýiA). On the other hand, Table 4-3 also
shows that the RM value corresponding to an aqueous contacting solution containing SDS (1
wt%) is (91+10)/(12+3) = 7.6+1.0, which is significantly higher than the RM value of 4.1+1.0
corresponding to an aqueous contacting solution containing SDS (1 wt%)+G (10 wt%).
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Therefore, as already shown in Chapter 2, adding 10 wt% G to an aqueous contacting solution
containing 1 wt% SDS significantly reduces in vitro skin barrier perturbation. The Mannitol skin
permeability values reported in Table 4-3 also indicate a decrease in skin barrier perturbation
induced by an aqueous contacting solution containing 1 wt% SDS+10 wt% G (P=30±10x10 -5
cm/hr), relative to an aqueous contacting solution containing 1 wt% SDS (P=66+10x 10-5 cm/hr).
The in vivo TEWL results in Table 4-3 indicate that the TEWL value corresponding to an
aqueous contacting solution containing SDS (1 wt%)+G (10 wt%) is statistically lower (p<0.05)
than that corresponding to an aqueous contacting solution containing SDS (1 wt%).26 In
addition, the in vivo visual skin dryness scores in Table 4-3 reveal that an aqueous contacting
solution containing SDS (1 wt%)+G (10 wt%) induces statistically lower (p<0.05) visual skin
dryness than that induced by an aqueous contacting solution containing SDS (1 wt%). Taken
together, the in vivo TEWL and visual skin dryness results reported in Table 4-3 imply that
adding 10 wt% G to an aqueous SDS (1 wt%) contacting solution mitigates the ability of SDS to
perturb the skin barrier. In Chapter 2, using dynamic light scattering measurements to determine
the effective SDS micelle hydrodynamic radii in the presence and in the absence of 10 wt% G, I
showed unambiguously that SDS micelles are too large to penetrate into the skin aqueous pores
in vitro when 10 wt% G is added to the aqueous contacting solution containing SDS (1 wt%). As
a result, SDS in micellar form is not able to contribute to SDS skin penetration and associated
SDS-induced skin barrier perturbation. Therefore, the in vivo TEWL and visual skin dryness
results reported in Table 4-3 support the in vitro results reported in Chapter 2 by clearly showing
26 It is important to note that the TEWL value corresponding to an aqueous contacting solution containing SDS (1
wt%)+G (10 wt0 /o) is statistically not different (p>0.05) from that corresponding to the in vivo control (iii), while it
is statistically lower (p<0.05) than that corresponding to an aqueous contacting solution containing SDS (1 wt%).
This finding provides additional evidence for the ability of Glycerol to mitigate SDS-induced skin barrier
perturbation.
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a smaller extent of skin barrier perturbation in vivo induced by an aqueous contacting solution
containing 1 wt% SDS in the presence of 10 wt% G, relative to that in the absence of 10 wt% G.
Table 4-3. In vitro and in vivo skin barrier measurements for aqueous contacting solutions
containing SDS (1 wt%) and SDS (1 wt%)+Glycerol (10 wt%), including a comparison with the
appropriate in vitro/in vivo controls. The table reports average values and standard errors.
Aqueous Contacting Solutions
Skin Barrier SDS SDS (1 wt%) + Control
Measurements (1 wt%) Glycerol (10 wt%) (In Vitro/In Vivo)*
Skin Electrical Current (pA) 91±10 49±10 12±3
Mannitol Skin Permeability
In Vitro (cm/hr)x10 5  66±10 30±10 7±3
Average Pore Radius, rpore
(A) 33±5 20±5 20±3
Enhancement in p=pE/Pc** 2.6±1 2.9+1 1
TEWL (Barrier Damage) 5.30±0.20 4.00±0.40 3.40±0.30
In Vivo Visual Skin Dryness 0.89±0.11 0.60±0.13 0.15±0.02
Chromameter (Erythema) 0.57±0.11 0.58±0.14 -0.08±0.05***
* The in vitro control corresponds to PBS in water (aqueous contacting solution (iii), see Section 4.2.2), and
the in vivo control corresponds to a no reaction, non-occluded control (see Section 4.3).
** The enhancement in the aqueous pore number density, p, is reported relative to the in vitro control. In
addition, recall that E denotes enhancer (that is, aqueous contacting solutions (i), (ii), (iv), and (v)) and C
denotes the in vitro control (that is, aqueous contacting solution (iii)).
*** Note that the in vivo control showed erythema values close to zero, which is not unexpected (the small
negative mean value of -0.08 results from the fact that some of the volunteers in the control group exhibited
lower skin redness on Day 2, when compared to Day 1).
Although the TEWL and visual skin dryness values repeated in Table 4-3 indicate that
Glycerol can indeed mitigate SDS-induced skin barrier perturbation in vivo, a similar
corroboration was not obtained using the chromameter measurements of skin erythema (redness).
This is because the chromameter scores in Table 4-3 indicate no statistical difference (p>0.05)
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between the erythema (skin redness) scores corresponding to an aqueous contacting solution
containing 1 wt% SDS in the absence of G (0.57±0.11), relative to that in the presence of 10
wt% G (0.58±0.14). It is possible that an aqueous contacting solution containing 1 wt% SDS +
10 wt% G may induce an initial cutaneous reaction that attracts increased blood flow to the
dermis of the affected skin site, thereby leading to skin redness (erythema), even though the skin
barrier may not be significantly perturbed (8-11, 14, 17, 24, 32). Therefore, the skin at the
corresponding site may appear red from an increased blood flow to the dermis, without the skin
barrier being compromised, which would lead to a higher erythema score. Accordingly, the in
vivo erythema response associated with adding 10 wt% Glycerol to an aqueous SDS contacting
solution on the skin barrier needs to be investigated further. For example, in vivo cutaneous
biochemical reaction pathways triggering erythema, which may be triggered by SDS even in the
presence of Glycerol, could be investigated (8, 9, 14, 32-36). It is also possible that: (1) a higher
concentration of SDS than the 1 wt% used in the in vivo soap chamber, (2) a higher
concentration of Glycerol than the 10 wt% used in the in vivo soap chamber, and/or (3) longer
exposure times of the in vivo soap chamber, may be necessary to discriminate between the in
vivo erythema induced by SDS in the presence of Glycerol relative to that induced by SDS in the
absence of Glycerol.
4.5. Conclusions
Macroscopic in vitro skin barrier measurements, which quantify the extent of skin barrier
perturbation induced by aqueous surfactant/humectant contacting solutions commonly
encountered in skin-care formulations, can be effectively used to rank these contacting solutions.
Such a ranking is based on the ability of the solutions to perturb the skin aqueous pores of the
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stratum corneum (SC). An in vitro ranking metric was developed using the enhancement in the
skin electrical current induced by an aqueous surfactant/humectant contacting solution, relative
to an in vitro PBS control aqueous contacting solution, as the metric. In vitro Mannitol skin
permeability measurements, when combined with skin electrical resistivity measurements, in the
context of a hindered-transport aqueous porous pathway model, provided mechanistic insight on
the results of the in vitro ranking metric analysis. Specifically, the pore number density (p) and
the average pore radius (rpore) of the skin aqueous pores induced by aqueous solutions of
surfactants and humectants contacting p-FTS were determined. The in vitro skin electrical
current/resistivity and Mannitol skin permeability measurements were carried out using the
following aqueous solutions: (i) an anionic surfactant solution - SDS (1 wt%), (ii) a nonionic
surfactant solution - C12E6 (1 wt%), (iii) an in vitro control solution - PBS, and (iv) a humectant
solution - Propylene Glycol (PG) (10 wt%), and (v) a humectant solution - Glycerol (G) (10
wt%). Utilizing the in vitro ranking metric introduced in this chapter, I obtained the following
ranking order, from the mildest to the harshest, for the surfactants and the humectants considered
above, based on their ability to perturb the skin aqueous pores: (v) 10 wt% G < (iv) 10 wt% PG <
(iii) PBS < (ii) 1 wt% C1 2E6 < (i) 1 wt% SDS.
To substantiate the findings above, in vivo soap chamber measurements were carried out
on human subjects by CyberDERM Clinical Studies (Broomall, PA), in collaboration with
Neutrogena Corporation (Los Angeles, CA). Specifically, the following in vivo skin barrier
measurements were conducted: (1) Transepidermal water loss (TEWL) determined using an
evaporimeter, (2) Visual skin dryness determined by an expert grader, and (3) Skin erythema
measurements using a chromameter. The overall implications of the in vivo results is that
aqueous surfactant contacting solutions (i) and (ii) induce a larger extent of skin dryness and
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erythema relative to aqueous humectant contacting solutions (iv) and (v). In addition, the in vivo
measurements (1)-(3) above indicate that a 1 wt% aqueous SDS contacting solution induces the
largest extent of skin barrier perturbation, while a 10 wt% aqueous Glycerol contacting solution
induces the smallest extent of skin barrier perturbation. Both of these in vivo findings are
consistent with the results of the in vitro ranking metric analysis. Therefore, determining the in
vitro perturbation to the skin aqueous pores induced by aqueous surfactant/humectant systems
represents a viable practical strategy to predict their in vivo skin barrier perturbation potential.
Because of the correlation established between the in vitro ranking metric analysis and
the in vivo skin barrier measurements, the in vitro ranking methodology formulated in this
chapter, which quantifies the perturbation to the skin aqueous pores, can potentially be used to
screen and rank many surfactants and humectants for use in skin-care formulations, without the
need to conduct costly and time-consuming human and animal testing procedures. Such a
practical strategy could significantly speed up the effort and time required to bring new skin-care
formulations to the market.
In the next chapter, Chapter 5, I report the results of a novel two-photon microscopy
(TPM) visualization study that is conducted to visually determine, as well as quantify, the extent
of perturbation to the skin morphology induced by aqueous surfactant/humectant systems.
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Chapter 5
Visualization and Quantification of Skin
Barrier Perturbation Induced by Surfactant-
Humectant Systems Using Two-Photon
Fluorescence Microscopy
5.1. Introduction and Motivation
In Chapter 1, I presented a brief overview of the application of Two-Photon Fluorescence
Microscopy (TPM) as a novel imaging tool for human skin and pig full-thickness skin (p-FTS).
Specifically, the advantages of using TPM to image skin and to obtain visual and quantitative
morphological information were discussed relative to other available methods, including: (a)
traditional skin tissue biopsy, and (b) skin imaging tools such as electron microscopy and
confocal laser scanning microscopy (1-4). The key advantages that TPM has over methods (a)
and (b) above include: (i) it is a non-invasive technique that does not require tissue excision and
fixation, thereby avoiding loss of important cellular and morphological information, which is a
concern using invasive methods such as (a), and (ii) it can image skin to a depth of several
hundred micrometers with reduced photo-damage, which is not possible with imaging methods
such as (b).
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5.
In the past, studies have demonstrated the viability of using TPM to visualize, as well as
to quantify, human skin morphological characteristics. In particular, Yu et al. developed a TPM
visualization technique to visualize, as well as to quantify, the effect of a chemical enhancer,
Oleic Acid (OA), on human skin (5-8). Specifically, Yu et al. used TPM to visually determine
three-dimensional spatial distributions of the hydrophilic and the hydrophobic fluorescent
probes, Sulforhodamine B (SRB) and Rhodamine B Hexyl Ester (RBHE), respectively, in
excised full-thickness human cadaver skin exposed to phosphate buffered saline (PBS), the
control, and to OA, the chemical enhancer. Both SRB and RBHE were observed to reside
primarily in the intercellular lipid bilayer region surrounding the corneocytes within the stratum
corneum (SC). In addition, from the TPM skin images, Yu et al. calculated the changes in the
concentration gradient and in the vehicle-to-skin partition coefficient of each probe in the skin
samples exposed to OA and to PBS (5). These calculations were subsequently used, along with
theoretically derived mathematical expressions of transdermal transport, to quantitatively
characterize the OA-induced relative changes to the SC transport characteristics, including the
SC diffusion coefficient and the SC diffusion length of the two fluorescent probes (5, 8).
Furthermore, based on the results of these studies, Yu et al. were able to conclude that for the
hydrophobic RBHE probe, the OA-induced enhancement in the skin epithelial barrier
permeability was driven primarily by an increase in the vehicle-to-skin partition coefficient,
leading to an increase in the steepness of the RBHE probe concentration gradient across the skin
(5). The primary OA-induced changes in the transdermal transport properties of the hydrophilic
SRB probe included increases in both the vehicle-to-skin partition coefficient and the skin
diffusion coefficient (5). These findings, utilizing the TPM skin imaging methodology data
analysis and transdermal transport modeling, demonstrate that, in addition to providing visual
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scans that clearly delineate probe distributions in the SC, the subsequent quantification of these
TPM skin images provides additional important insight into the mechanistic changes in
transdermal transport underlying the visualized changes in probe distributions across the SC (5,
8).
In addition to the fluorescence originating from the hydrophobic/hydrophilic fluorescent
probes that have penetrated into the skin, the skin has an inherent florescence, referred to as the
skin autofluorescence, that originates from endogenous fluorophores in the skin, including
reduced pyridine nucleotides, flavoproteins, collagen, and elastin (9, 10). Na et al. (10) showed
that excitation wavelengths ranging from 340 to 380 nm, in the skin autofluorescence emission
spectrum, have two major component bands centered at 450 nm (75% of the spectrum) and 520
nm (25% of the spectrum). Using an appropriate filter set in the TPM apparatus (see Section
5.2.6), these emission wavelengths can be collected by the green channel, while wavelengths of
578 nm and 586 nm which are the emission peaks of the fluorescent probes RBHE and SRB,
respectively, can be collected by the red channel. Since there is minimal wavelength overlap
between the red and the green channels, a quantification of probe spatial distributions relative to
the brick-and-mortar SC structure in the same skin sample, at precisely the same skin spatial
locations, can be achieved by this technique of dual-channel (the green channel and the red
channel) TPM. Hence, the skin inherent structural features, as delineated in the green channel,
can provide a fingerprint relative to the probe spatial distribution, as delineated in the red
channel.
Yu et al. utilized this advanced dual-channel TPM method to determine mechanisms of
OA-induced skin barrier perturbation. By an overlap of the fluorescence intensities of the
red/probe and green/autofluorescence channels, they could deduce that the hydrophobic RBHE
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probe was localized in the intercellular lipid bilayer region of the SC. In addition, they reported that
OA induced the formation of RBHE microdomains within the SC. On the other hand, Yu et al.
observed that OA induced the hydrophilic SRB probe to preferentially partition across the
corneocyte envelopes and diffuse into the corneocytes within the SC. Hence, the dual-channel
TPM skin images that were obtained by Yu et al. upon exposing human skin to OA and to SRB
for 24 hours provided evidence for the existence of intra-comeocyte diffusion in addition to the
commonly accepted lipid bilayer transdermal pathway (6).27 Therefore, the OA enhancer
mechanism was clearly shown to be a function of the fluorescent probe physicochemical
properties.
Because the permeability and morphological characteristics of pig full-thickness skin (p-
FTS) are similar to those of human skin, pig skin is an excellent model for human skin for both
in vitro and in vivo skin permeability and imaging studies (12, 13). With this in mind, I have
utilized TPM imaging of p-FTS samples to obtain visual and quantitative insight on the effect of
aqueous surfactant-humectant systems on the skin barrier (see Section 5.2 for additional details).
Through past research in the surfactant-induced skin barrier perturbation area, it is now well
accepted that surfactants (both as monomers and as micelles) have to first penetrate into the SC
in order to induce skin barrier perturbation (14-22). However, once surfactants have penetrated
into the SC, it is not known whether they are located in the keratins in the corneocytes or in the
intercellular lipids in the lamellar bilayers comprising the SC. Several researchers have
hypothesized that surfactants interact with the corneocyte keratins (12, 19, 22) and also with the
lamellar lipid bilayers (18, 23). An imaging method that can visualize the location of a
27 Recently, Kushner et al. have also carried out dual-channel TPM visualization studies of human skin exposed to
ultrasound and to the harsh surfactant, Sodium Dodecyl Sulfate (SDS) (11). These studies also provided evidence
for intra-corneocyte probe diffusion induced by ultrasound and SDS (1 1).
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fluorescent probe in the SC that has been exposed to an aqueous surfactant solution may help
shed light on this issue. For example, if the surfactant penetrates into the corneocytes and
denatures the corneocyte keratins, then this will result in increased corneocyte permeability to
the fluorescent probe. Therefore, the fluorescent probe will be located in the corneocyte domains
of the SC, and accordingly, will be detected in the TPM skin images. Alternatively, if the
surfactant penetrates into the intercellular lipid bilayers of the SC and disorders the lipid bilayer
domains of the SC, then the fluorescent probe will also penetrate into the lipid bilayers and can
be detected in the TPM skin images. By contacting skin with surfactant solutions in the presence
and in the absence of humectants, in the context of these TPM skin visualizations studies, one
can obtain fundamental insight into the modification of the skin barrier morphology induced by
surfactants in the presence of humectants. Specifically, one may be able to determine
conclusively if a specific surfactant interacts strongly with the keratins in the comeocytes and/or
with the intercellular lipids. Furthermore, one may also determine conclusively how such
surfactant-skin interactions are modified by a humectant like Glycerol when it is added to the
aqueous surfactant solution contacting the skin.
The remainder of this chapter summarizes the results of an in vitro TPM visualization
study of physical SC perturbations induced by aqueous contacting solutions of surfactants and
humectants relative to an aqueous control solution (PBS). For this purpose, I have carried out
TPM imaging studies of p-FTS exposed to aqueous contacting solutions containing: (i) SDS (an
anionic surfactant which is a harsh skin agent, see Chapters 2 and 4), (ii) SDS+Glycerol (a
surfactant/humectant mixture, see Chapters 2 and 4), (iii) SCI (an anionic surfactant which is a
mild skin agent, see Chapter 3), (iv) PBS (the control), and (v) Glycerol (a humectant which is a
skin beneficial agent, see Chapters 2 and 4). The TPM visualization studies were carried out
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using the hydrophilic fluorescent probe, Sulforhodamine B (SRB), which penetrates into the skin
through aqueous pores in the SC, and hence, can shed light on the modification of these aqueous
pores induced by surfactants in the presence of humectants (5-8, 11, 29, 30, 33, 34). Specifically,
SRB emits a fluorescent signal in the red channel, has an emission peak wavelength of 586 nm,
an absorbance peak wavelength of 565 nm, and has a molecular weight of 559 Da (37). The p-
FTS samples were exposed to aqueous contacting solutions (i)-(v) separately, and subsequently,
were contacted with aqueous SRB solutions (see Section 5.2.2). Following these SRB exposures,
the p-FTS samples were dried and visualized using the TPM apparatus (see Section 5.2.5). Using
a filter set in the TPM apparatus, the emission wavelengths resulting from the presence of SRB
in the skin (probe fluorescence) were collected by the red channel, while the emission
wavelengths resulting from the inherent fluorophores present in the skin (skin autofluorescence)
were collected by the green channel, thereby enabling dual-channel TPM skin imaging of p-FTS
samples exposed to solutions (i)-(v) (see Section 5.2.6). The results of the TPM visualization
study are presented in Section 5.4. Finally, Section 5.5 summarizes the main conclusions of this
chapter.
5.2. Experimental
5.2.1. Materials
Sodium Dodecyl Sulfate (SDS) was purchased from Sigma Chemicals (St. Louis, MO).
Analytical-grade Glycerol was purchased from VWR Chemicals (Cambridge, MA).
Sulforhodamine B (SRB), a hydrophilic fluorescent probe, was obtained from Molecular Probes
(Eugene, OR). Sodium Cocoyl Isethionate (SCI) from BASF was provided to us by UNILEVER
(Edgewater, NJ). Water was filtered using a Millipore Academic water filter (Bedford, MA).
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Phosphate Buffered Saline (PBS) was prepared using PBS tablets from Sigma Chemicals (St.
Louis, MO) and Millipore filtered water, such that a phosphate concentration of 0.01M along
with a NaCl concentration of 0.137M were obtained at a pH of 7.2. All these chemicals were
used as received.
5.2.2. Preparation of the Solutions
For the visualization of SRB in p-FTS, a solution of 0.05 mg/ml of SRB in PBS was
prepared. The following aqueous solutions of surfactants, a humectant, and surfactant+humectant
that contacted p-FTS were prepared: (i) a harsh surfactant solution - SDS (1 wt%), (ii) a harsh
surfactant+humectant solution - SDS (1 wt%) + Glycerol (10 wt%), (iii) a mild surfactant
solution - SCI (1 wt%), 28 (iv) a control solution - PBS, and (v) a humectant solution - Glycerol
(10 wt%). Aqueous solutions (i)-(v) were used to be consistent with the in vitro studies carried
out in Chapters 2 and 3. Note that a mild surfactant+humectant solution - SCI (1 wt%)+Glycerol
(10 wt%) , did not induce skin morphological modifications different from those induced by
solutions (iv) and (v), and therefore, was not considered here.
5.2.3. Preparation of the Skin Samples
Female Yorkshire pigs (40-45kg) were purchased from local farms, and the skin (back)
was harvested within one hour after sacrificing the animal. The subcutaneous fat was trimmed
off using a razor blade, and the full-thickness pig skin was cut into small pieces (2cm x 2cm) and
stored in a -80 'C freezer for up to 2 months. The TPM skin visualization experiments were
performed using p-FTS.
28 Note that p-FTS samples were contacted with aqueous SCI solutions at 350 C. This is because SCI (1 wt%) is
soluble in water at 35'C, and not at room temperature (25'C) (see Chapter 3).
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5.2.4. In Vitro Diffusion Cell Skin Exposure to Surfactant-Humectant Systems
Followed by Exposure to SRB
Prior to use in the TPM skin visualization experiments, the p-FTS sample was thawed for
half an hour. The p-FTS sample was then mounted in a vertical Franz diffusion cell obtained
from Permegear (Bethlehem, PA) with the SC facing the donor compartment. Both the donor and
the receiver compartments were filled with PBS, and the p-FTS sample was left to hydrate for 1
hour to allow the skin initial barrier property to reach steady state. At this point, the skin
electrical current across the p-FTS sample was measured, and only p-FTS samples with an initial
skin current < 3 pA were utilized in the permeation studies (see Chapter 2 for additional details).
The PBS in the donor compartment of the diffusion cell was then replaced with 1.5 ml of
aqueous contacting solution (i), (ii), (iii), or (v). The aqueous solution in each donor
compartment was then allowed to contact the p-FTS sample for 5 hours. Following this skin
treatment with each aqueous contacting solution, the aqueous contacting solution was removed
and the donor compartment along with the p-FTS sample were rinsed 4 times with 2 ml of PBS
to remove any trace chemical left on the skin surface and in the donor compartment.
Subsequently, each p-FTS sample was exposed to an aqueous SRB fluorescent probe solution in
the diffusion cell for an additional 24 hours.
Each p-FTS sample was then removed from the diffusion cell, rinsed 4 times with 2 ml of
PBS as before, and blotted with a Kimwipe (Kimberly Clark, Roswell, GA) to ensure the
removal of any excess SRB present on the skin surface. The circular area of the skin exposed to
SRB was cut out with a surgical carbon steel razor blade (VWR Scientific, Media, PA), and
subsequently sealed in a 2.5 mm imaging chamber (Coverwell, Grace Bio-Laboratories, Bend,
OR) with a coverslip (VWR Scientific, Media, PA) that contacted the SC side of the p-FTS
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Discriminator. The number of photons collected at each pixel, for the red and green channel
images, is counted and recorded digitally by the computer (9, 25).
Aqueous contacting solutions (i)-(v) (see Section 5.2.2) were exposed separately to 7 p-
FTS samples, and six 100 ptm x 100 pm skin sites were imaged for each p-FTS sample. Each p-
FTS sample was imaged to a depth of 40 ptm. Specifically, for each skin site imaged, forty one
100 p.m x 100 p.m images were obtained, the first one at the skin surface (z=0) and the last one
40 p.m below the skin surface (z=40), each separated by a depth of 1 p.m from the other.
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Figure 5-1. Schematic illustration of the apparatus used for the Two-Photon Fluorescence
microscopy (TPM) skin imaging experiments (5, 25).
It was observed that most of the SRB probe was present in the p-FTS samples within a
depth of 20 gpm below the skin surface. Consequently, the TPM skin images obtained within the
first 20 gpm below the skin surface were analyzed (5-8, 11), and images obtained at layers
corresponding to z=3 (3 pm below the skin surface) and z=20 (20 gpm below the skin surface) are
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Discriminator. The number of photons collected at each pixel, for the red and green channel
images, is counted and recorded digitally by the computer (9, 25).
Aqueous contacting solutions (i)-(v) (see Section 5.2.2) were exposed separately to 7 p-
FTS samples, and six 100 ýpm x 100 pým skin sites were imaged for each p-FTS sample. Each p-
FTS sample was imaged to a depth of 40 ýpm. Specifically, for each skin site imaged, forty one
100 ýpm x 100 pm images were obtained, the first one at the skin surface (z=0) and the last one
40 ýpm below the skin surface (z=40), each separated by a depth of 1 ýpm from the other.
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Figure 5-1. Schematic illustration of the apparatus used for the Two-Photon Fluorescence
microscopy (TPM) skin imaging experiments (5, 25).
It was observed that most of the SRB probe was present in the p-FTS samples within a
depth of 20 pým below the skin surface. Consequently, the TPM skin images obtained within the
first 20 pm below the skin surface were analyzed (5-8, 11), and images obtained at layers
corresponding to z=3 (3 ýpm below the skin surface) and z=20 (20 ptm below the skin surface) are
192
presented in Section 5.4. One should note that 3pm below the skin surface is within the SC,
while 20 ýpm below the skin surface is within the viable epidermis (VE) (see Chapter 1).
Therefore, the effects of aqueous contacting solutions (i)-(v) were visualized on the structure of
both the SC and the VE (see Section 5.4.1).
5.2.6. Determination of SC Morphological Changes Induced by Surfactant-
Humectant Systems Using a Deconstruction Analysis of the Dual-Channel
TPM Images
The investigation of the effect of aqueous SDS and aqueous SDS+Glycerol contacting
solutions presented in Chapter 2 indicates that the addition of 10 wt% Glycerol to an SDS
aqueous solution contacting the skin reduces the ability of the SDS micelles to penetrate into the
epidermis, thereby significantly reducing the amount of SDS in the epidermis. Presumably, this
reduction in the amount of SDS that can penetrate into the epidermis should also reduce SDS
interactions with the keratins in the epidermis. Specifically, this should result in a reduction in
the ability of SDS to rupture the corneocyte envelopes, and expose and disrupt secondary and
tertiary structures of keratin in the corneocytes in the SC. On the other hand, mild surfactants
such as SCI are known to perturb the ordered intercellular lipid bilayers in the SC, thereby
inducing skin dryness. In fact, researchers have hypothesized that the skin barrier perturbation
response may be modulated by both of these two distinct mechanisms, that are: (i) the direct
interaction of a penetrating skin agent with the keratins in the corneocytes in the SC, and (ii)
bilayer disruption and delipidization of the SC lipid bilayers. Furthermore, either or both of
these mechanisms can potentially trigger cytokine production, thereby triggering biochemical
signals and promoting skin inflammation. Therefore, in order to mitigate skin barrier
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perturbation induced by surfactant-humectant systems, it is important to be able to minimize the
deleterious effects of mechanisms (i) and (ii) above on the skin barrier. Clearly, the first step in
this direction involves being able to identify if mechanism (i), or (ii), or both, induce significant
skin barrier perturbation. The dual-channel TPM skin images obtained following exposure of the
skin to surfactant-humectant systems, when analyzed using the image deconstruction analysis
described below, can identify the relative roles of mechanisms (i) and (ii) in inducing skin barrier
perturbation.
To elucidate the effect of aqueous contacting solutions (i)-(v) (see Section 5.2.2) on the
corneocyte keratins and on the intercellular lipid bilayers of the SC, a two-dimensional slice, 5
pixels (width) [y=l to 5] x 256 pixels (length) [x =1 to 256], 29 of the red channel (SRB) and the
green channel (skin auto-fluorescence) TPM skin images was selected for analysis of the
location of SRB relative to the inherent skin barrier morphology. Note that the arbitrarily
selected line width of 5 pixels accounts for intensity variations along the width of the slice, while
limiting the inclusion of intensities that may result from different SC morphological features in
the average value (6). The slice of 5 pixels (width) x 256 pixels (length) was deconstructed into
its pixel intensity values to determine the intercellular region width, defined by the fluorescence
intensity peak widths. At each position along the length of this slice, the intensities of the
corresponding 5 pixels along the width were averaged and then normalized. Because the skin
autofluorescence and the SRB fluorescence signals span two different intensity ranges, the
fluorescence intensity normalization enables a comparison of the relative changes in the spatial
intensity distributions between these two fluorescence intensity signals in the context of the same
29 Note that in the TPM skin images, 256 pixels corresponds to 100 jim in dimension; therefore, a 100 gm x 100 gm
image is actually a collection of 256 x256 = 65536 pixels.
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normalized scale, where values of zero reflect the absence of a fluorescence intensity signal and
values of 1 reflect maximum fluorescence intensity signals (6).
The green channel skin autofluorescence intensity spectrum, plotted as a function of the
length of the slice (in pixels, 1-256), reveals: (i) the peak-to-peak separation which indicates the
width of the corneocytes in the SC, and (ii) the peak width which indicates the intercellular
spacing that is essentially comprised of the intercellular lipid bilayers and the corneocyte
envelopes (see Chapter 1 and (5-8, 11)). The corresponding plot of the SRB fluorescence
intensity spectrum for the red channel describes the SRB distribution relative to the inherent skin
morphology, as defined by the green channel skin autofluorescence intensity spectrum. The peak
widths and peak heights in the normalized average SRB intensity profile in p-FTS samples
exposed to aqueous contacting solutions (i), (ii), (iii), and (v) were compared to the peak width
and peak height of SRB in the p-FTS sample exposed to the aqueous PBS control contacting
solution (iv). Through this comparison, it was possible to determine an enhancement, or a
reduction, in the SRB penetration into the corneocytes induced by solutions (i), (ii), (iii), and (v)
relative to the PBS control solution (iv). Specifically, an increase in the peak height and a
decrease in the peak width indicate less SRB penetration into the corneocytes relative to the
intercellular lipid bilayers. This serves as a qualitative indicator of mechanism (ii) above, that is,
intercellular lipid bilayer disruption, because a disordering of the lipid bilayers induced by the
surfactant-humectant system should result in an increase in the defects or voids in the bilayers,
which in turn, should increase the size/number of aqueous pores (see Chapter 1 and (26-28))
through which SRB may penetrate into the lipid bilayers of the SC. Conversely, as the peak
height decreases and the peak width increases, there is more SRB present inside the corneocytes
relative to the intercellular lipid bilayers. This serves as a qualitative indicator of mechanism (i),
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that is, keratin denaturation in the corneocytes, because a disruption of the comeocyte envelope
and subsequent keratin denaturation induced by the surfactant-humectant system should result in
an increase in SRB penetration into the corneocytes in the SC.
5.3. Theoretical
5.3.1. Determination of Enhancements in Aqueous Pore Characteristics
Induced by Surfactant-Humectant Systems Using the SRB Intensity Profiles
in the SC
The four intrinsic aqueous pore characteristics of the SC include: (1) the porosity,
, (2) the tortuosity, ;, (3) the pore radius, rpore,30 and (4) the SC thickness (AX) (see Chapter 1
and (29-33, 36)). The goal of the analysis presented here is to obtain quantitative values of the
enhancements in the aqueous pore radius, rpore, and in the porosity-to-tortuosity ratio, e/r,
induced by aqueous contacting solutions (i), (ii), (iii), and (v) - denoted hereafter as the chemical
enhancer (E), relative to the aqueous PBS contacting solution (iv) - denoted hereafter as the
control (C). In addition to the visual insights that can be obtained from the TPM skin
visualization studies (see Sections 5.2.5, 5.4.1, and 5.4.2), the analysis presented below can
provide quantitative insight on the modification of the skin barrier induced by the enhancer
relative to the control.
30 Note that rpo,, is, in fact, an average aqueous pore radius (see Section 5.4.3 and Table 5-1). In the case of a size
distribution of aqueous pore radii, rpore can be considered to be the expectation value of this distribution (see Chapter
6).
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Based on the four characteristics of the skin barrier (1)-(4) (see above), one can express
the permeability, Pi , of permeant i (where i corresponds to SRB in the TPM skin visualization
studies presented here) across the SC through the skin aqueous pores as follows (29, 30, 33):
eDpore
Pi = r (1)
tAX
where DP"'r is the diffusion coefficient of permeant i in the aqueous pore. Note that Dfore can be
related to the infinite-dilution diffusion coefficient of permeant i in the bulk aqueous solution,
Di", using the following relation (29-31):
Dpore = DiH(/i) (2)
where H(A;) is the hindrance factor accounting for the hindered diffusion of permeant i, modeled
as a hard sphere of radius, r,, through the aqueous cylindrical pore, and A2 is the ratio of the
permeant i radius to the aqueous pore radius, that is, 2; = ri/rpo,,re.
Anderson and Quinn have defined H(2i) for a spherical permeant i in a cylindrical pore as
follows (32):
H(k,) )= (1- 2.1044 i + 2.089W - 0.948X) ,for ki<0.4 (3)
where 4i is the partition coefficient of permeant i, defined as CP / Ci", where CPre is the
concentration of permeant i in the pore, and Cj" is the concentration of permeant i in the bulk
solution. Note that Eq.(3) considers only steric, hard-sphere permeant i-pore wall interactions,
and does not account for long-range electrostatic or van der Waals interactions (31, 32).
Using Eq.(2) in Eq.(1), one can express the permeability, Pi, as follows:
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Pi = (4)AX
Upon exposing skin to a chemical enhancer, E, relative to a control, C, in the context of Eq.(4),
the following relation between the enhancement in the permeability of permeant i, (E)p, and the
SC aqueous pore radii values corresponding to E and C, rpore,E and rpo,e,c , reflected in H(A)E and
H(Adc, respectively, is obtained:
P_ ___ i2 DE H(A,) XE A(E(,),, - (5)
The permeability of permeant i, Pi, across the SC membrane can also be defined in terms
of the flux of permeant i across the membrane (in the z direction) as follows (5, 34, 35):
- Dpore dC,
J i ( dz (6)
ac, c, -c (6)AC, Cd _ Cr
where the trans-membrane flux, Ji, is predicted by Fick's First Law of Diffusion, and AC,
denotes the concentration difference between the donor and the receiver chambers of the
diffusion cell. Assuming an infinite donor-infinite receiver condition (see Chapter 2), that is,
Cd (t)- C,' (t)Z C (t)M C, (0)- Cd , one can simplify Eq.(6) as follows:
- D po dC,Sdz(7)
P,= (7)c
id
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Next, considering the same probe donor concentration, Ctd , for the enhancer and the
control, one can write the permeability enhancement, (E)p, using Eq.(7) as follows:
Dore (dCo /dz) E
DPore (dCi /dz)(
(8)
where DPor is the probe (or permeant) i pore permeability in the chemical enhancer case, and
D por is the probe (or permeant) i pore permeability in the control case. One can then utilize
Eq.(2) and express DPor and Dpor in terms of H(A)E and H(2dc to obtain the following
relation:
D porei,E
D porefDfwm
H(~, )E
- H(2,)(. (9)
where the infinite dilution diffusion coefficients of probe i were cancelled out because they are
equal in the enhancer and in the control solutions, that is, D', = D',".
Next, noting that: (i)D = D"  , and (ii)AX E AXC (the SC intrinsic thickness is
constant), one can rewrite Eq.(5) as follows:
(E,) (DO)E; H( )E AXE ()E H(E)EII,( ={H( )IAXJ C)I (10)
Because the concentration of SRB (probe i) inside the skin, C1, is proportional to its
fluorescence intensity, Ii, (5-8, 11), the SRB concentration gradient in the skin is proportional to
the SRB intensity gradient in the skin, which can be determined through the TPM skin
visualization measurements (see Section 5.4.3 and 5, 11, 34). Therefore, one can now determine
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(E,), (~ = - -
= -DH
Di,(. H(Ai), ),
the enhancement in the SRB concentration gradient inside the skin induced by a chemical
enhancer, E, relative to a control, C, through the following relationship:
(dC, /dz)E (dI, /dz),.
(dC, /dz),. - (dI, /dz)(,. (11)
Furthermore, using Eq.(9) in Eq.(8) along with Eq.(11), one can express the permeability
enhancement of probe i, (Ed), as follows:
(E, ) , H( (12)
t dz ) .
Comparing Eq.(12) with Eq.(10), one finds that the enhancement in the porosity-to-
tortuosity ratio, E/r, is equal to the enhancement in the SRB probe intensity gradient in the skin.
Specifically,
CE dQz (13)
( dIjl( dz J.
The partition coefficient, ;, of permeant i partitioning into a skin aqueous pore from a
bulk solution contacting the skin can be evaluated as follows (31, 32):
c pore (14)
S= --- cr = 2 e[-E(r)/kT']rdr (14)
Equation (14) indicates that in the case of weak electrostatic and van der Waals interactions, that
is, when E(r) 0 , the permeant-pore partition coefficient, 0 , is equal to (1-AJ2, which accounts
solely for steric, hard-sphere interactions (31). Therefore, when steric interactions dominate, it
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follows that the overall partition coefficient, cDi, of permeant i partitioning into all the available
aqueous pores on the surface of the SC from a bulk solution contacting the skin is given by (31,
32):
O, = -E, = E(1-0A) 2  (15)
Note that the overall partition coefficient, Oi, of permeant i, is equal to the ratio of the
concentration of permeant i at the SC surface, Ci(z=O), and the bulk concentration of permeant i
in the donor solution, C , that is, Ii = C,(z=O)/C . The enhancement in the partition coefficient
(for steric, hard-sphere SRB probe-aqueous pore wall interactions, see Eq.(15)) can then be
related to the ratio of the SRB probe skin surface intensity, for the chemical enhancer (E) and for
the control (C), as follows:
C,( (z 
= 0)
:E 
i E(1-c /(z = 0)(E ) ( - • I(z=O)E (16)
16 (' -2, )C' C (z= 0) Ii (z = 0)
where we have made the following assumptions: (i) a similar probe i (in our case, SRB) donor
concentration, Cd', for the chemical enhancer and for the control cases (5-8, 11), and (ii) the ratio
of the SC surface concentration of probe i for the chemical enhancer and for the control cases is
identical to the ratio of the corresponding skin surface (z=0) intensities of probe i (5-8, 11).
Joe Kushner, in his PhD thesis (11), showed that the effective diffusion path length for
SRB does not change significantly relative to untreated skin, when skin samples are exposed to
aqueous SDS contacting solutions. Given that: (a) aqueous contacting solution (i) which contains
I wt% SDS is expected to have the strongest effect on the skin barrier relative to the other
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aqueous contacting solutions (ii)-(v), and (b) aqueous contacting solution (i) does not
significantly modify the SRB diffusion path length,3 1 it is reasonable to assume that TE = c.
Therefore, using that TE = rc in Eq.(13), one obtains:
e ,. dz )h
--= (17)
> dz IC
where the ratio of the SRB intensity gradients in the skin induced by E and C,
[(dI/dz)E/(dI/dz)c], can be determined experimentally using TPM (see above). Next, using
Eq.(17) for EE/&C in Eq.(16), one obtains:
I, (z = 0),
l,) I- A(Z - (18)
- At )Y (dI, / dz ),
(dI, /dz)J.
where I4(z=O)E and Ii(z=O)c are also obtained using TPM. Therefore, the quantity A in Eq.(18) is
uniquely determined using the TPM skin visualization measurements. In addition, recalling that
Ai,E = ri/rpore,E and Ai,c = ri/rpore,c, Eq.(18) shows that:
rpore,' = A (19)1lrr
rpore,(C
31 The SRB diffusion path length through the SC (11, 38) is equal to the product of the tortuosity of the aqueous
pores (c) x SC thickness (AX), because being hydrophilic, SRB traverses the SC through the aqueous pores and not
through lipoidal pathways (5-8, 11, 26, 29). Since both the diffusion path length and the SC thickness are assumed to
be constant, it follows that T should be constant as well.
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Since A can be determined uniquely using the TPM skin visualization measurements, and
ri , the SRB hydrodynamic radius, can be determined to be 5.6A using the Stokes-Einstein
equation (see Chapters 2 and 3), by solving Eq.(19), it becomes possible to obtain rpore,E , and
thereby, the enhancement in the pore radius induced by E relative to C, Er.0 = rpore,E / rpore,C (see
Section 5.4) ifrpore,c can be determined. In Chapters 2 and 3, I used a previously published, well-
accepted aqueous porous pathway model that is based on the hindered-transport of a hydrophilic
permeant (Mannitol) and ions through aqueous pores in the SC (29-33, 36), and showed that
rpore,,, = 20±3A. Using this value of rpore,c = 20+3A, along with the value of A determined using
TPM, in Eq.(19) it is then possible to determine rpore,E as well as the enhancement in the pore
radius, Erp~,re
5.4. Results and Discussion
5.4.1. Comparison of the TPM Skin Images Close to the SC Surface (z = 3ýtm)
with the TPM Skin Images Below the SC (z = 20ýpm)
In Figures 5-2 and 5-3, I show representative TPM skin images (100 ýLm x 100 ptm) of
SRB in p-FTS samples that were exposed to aqueous contacting solutions (i)-(v) (see Section
5.2.2) and visualized at a depth of z = 3 jtm below the skin surface, and at a depth of z = 20 jam
below the skin surface. The corneocytes are denoted by C (see Figures 5-2(a), (c), and (e) and
Figures 5-3(a) and (c)), and the nuclei of the keratinocytes are denoted by N (see Figures 5-2(b),
(d), and (f) and Figures 5-3(b) and (d)). One can clearly see that the TPM skin images
corresponding to aqueous contacting solution (i) (1 wt% SDS), see Figures 5-2 (a) and (b), are
the brightest among all the reported TPM skin images (see Figures 5-2 and 5-3 along with their
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associated color scale bars). This is because the TPM skin images shown in Figures 5-2 (a) and
(b) correspond to a p-FTS sample exhibiting a larger extent of skin barrier perturbation, and
consequently, show a larger amount of the SRB fluorescent probe that has penetrated into the
skin (both at z = 3 ýpm and at z = 20 gpm), than all the other TPM skin images shown in Figures
5-2 and 5-3.
In Chapter 2, I have already shown that the addition of 10 wt% Glycerol to a SDS
contacting solution above the CMC significantly inhibits SDS skin penetration by reducing the
porosity-to-tortuosity ratio, &/r, and the average pore radius, rpore, of the aqueous pores in the SC,
such that the SDS micelles cannot penetrate into the skin barrier. Therefore, one would expect
less SDS skin penetration and associated smaller extent of skin barrier perturbation, and
consequently, lower amounts of SRB in the skin, due to the presence of Glycerol in the aqueous
SDS contacting solution. The TPM skin images in Figures 5-2(c) and (d), when compared to
those in Figures 5-2 (a) and (b), show that, indeed, a smaller extent of skin barrier perturbation
due to the presence of Glycerol in an aqueous SDS contacting solution results in a smaller extent
of SRB skin penetration. A smaller amount of SRB in the skin barrier, in turn, generates a
weaker fluorescence signal. Consequently, the TPM skin images obtained upon exposing p-FTS
samples to solution (ii) (1 wt% SDS+10 wt% Glycerol) (see Figures 5-2 (c) and (d) with their
associated color scale bars) exhibit a dark red color, as opposed to the bright red color seen in
the TPM skin images of p-FTS samples exposed to contacting solution (i) (1 wt% SDS), which
reflects a larger amount of SRB in the skin barrier (see Figures 5-2 (a) and (b) with their
associated color scale bars).
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The corneocytes in the TPM skin image shown in Figure 5-2 (a) exhibit a color gradient
which is not exhibited by the corneocytes in the TPM skin image shown in Figure 5-2 (c),
indicating that the presence of 10 wt% Glycerol in the SDS contacting solution minimizes SRB
penetration into the corneocytes. This is because Glycerol minimizes SDS skin penetration,
thereby minimizing the ability of SDS to interact with the keratins as well as with the lipids
comprising the corneocyte envelopes which surround the corneocytes in the stratum corneum
(SC). Consequently, the corneocyte envelopes, which would otherwise be damaged by SDS (12,
19, 22), are not compromised, and prevent SRB from penetrating into the comeocytes.
A related observation is the formation of LTRs (localized transport regions) in the TPM
skin image shown in Figure 5-2 (a), and the absence of LTRs in the TPM skin image shown in
Figure 5-2 (c). The LTRs are localized regions within the skin barrier characterized by a larger
extent of skin barrier perturbation. Consequently, a permeant diffusing across the skin barrier
would exhibit a high LTR permeability relative to the non-LTR permeability and to the overall
skin barrier permeability (37, 38). Kushner et al. (37) and Pliquet et al. (38) have observed LTRs
in the SC upon exposing skin to ultra sound+SDS and to high voltage electric pulses,
respectively. It is noteworthy that the diameters of the LTRs reported by Pliquet et al. (38) are in
the range of 40-80 Gtm, similar to the diameters of the LTRs observed in Figure 5-2 (a). The
LTRs observed by Kushner et al. (37) are larger in diameter (10-40 mm), because
ultrasound+SDS acts as a more effective enhancer than the ones considered in this study or by
Pliquet et al. (38).
It is also important to note that the LTRs are not sweat ducts or hair follicles, as observed
in this study, by Kushner et al. (37), and by Pliquet et al. (38). Glycerol may minimize the
formation of LTRs by minimizing SDS skin penetration and associated damage to the comeocyte
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envelopes and to the corneocytes. Such LTRs do not form in the skin barrier exposed to aqueous
contacting solution (iii) (1 wt% SCI), as shown in Figures 5-2 (e) and (f). This is because SDS,
being a harsher skin agent than SCI (see Chapters 2 and 3, and (19)), interacts strongly with the
skin barrier. Because of the inherent heterogeneity of the skin barrier, the SDS-skin barrier
interaction is heterogeneous in nature. One of the manifestations of this heterogeneous
interaction is the formation of heterogeneous LTRs in the skin barrier. The milder surfactant,
SCI, exhibits a weaker skin barrier interaction relative to SDS, particularly with the corneocyte
envelopes and the corneocyte keratins (see Chapter 3 and (19)). Therefore, SCI does not induce
the formation of LTRs in the skin barrier.
At z = 20 ptm, the TPM skin image of the p-FTS sample exposed to solution (i) shows
more SRB relative to the TPM skin images of the p-FTS samples exposed to solutions (ii)-(v)
(see Figure 5-2 (b) with its associated color scale bar and compare it to Figures 5-2 (d) and f9,
and to Figures 5-3 (b) and (d), with their associated color scale bars). Therefore, not only does
SDS (1 wt%) induce a greater extent of skin barrier perturbation, but in addition, this
perturbation extends deeper into the skin barrier relative to the skin barrier perturbation induced
by aqueous contacting solutions (ii)-(v).
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Figure 5-2. TPM images of SRB in p-FTS samples that were exposed to aqueous contacting
solutions (i) (1 wt% SDS), (ii) (1 wt% SDS+10 wt% Glycerol), and (iii) (1 wt% SCI), and
visualized at a depth of: (i) 3 pim below the skin surface (z=3), shown in (a), (c), and (e),
respectively, and (ii) 20 tm below the skin surface (z=20), shown in (b), (d), and (f),
respectively. The color scale bars indicate an increase in SRB concentration as the color
progresses from a low value close to zero (black) to a high value (red). Key: C - corneocyte, N -
nucleus of a keratinocyte, LTR - localized transport region, and yellow line in (a) - 25 ptm.
207
(a) z =3
LTR
C
O UU IU LUUVV ZOU
OU IUU IOU ZU U ZOU
z=3 .. Z=ZU
I-' fri
140
120
100
80
60
40
20
bU 1Th UU uu
(Ch (dh1-11
140
5(
120
100 10(
80
15(
60
40 20(
20
25C
50 100 150 200 250
Figure 5-3. TPM images of SRB in p-FTS samples that were exposed to aqueous contacting
solutions (iv) (PBS Control) and (v) (10 wt% Glycerol), and visualized at a depth of: (i) 3 /am
below the skin surface (z=3), shown in (a) and (c), respectively, and (ii) 20 rm below the skin
surface (z=20), shown in (b) and (d), respectively. The color scale bars indicate an increase in
SRB concentration as the color progresses from a low value close to zero (black) to a high value
(red). Key: C - comeocyte, N - nucleus of a keratinocyte, and yellow line in (a) - 25 gm.
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5.4.2. Analysis of the Dual-Channel TPM Skin Images Close to the SC Surface
(z = 31Im)
The dual-channel TPM skin images of p-FTS samples exposed to aqueous contacting
solutions (i)-(v), at z = 3 tm, are shown in Figures 5-4, 5-5, and 5- 6. In all these figures: (a) the
SRB probe fluorescence (red channel) images are shown in the top panels (Figures 5-4 (a) and
(d), Figures 5-5 (a) and (d), and Figure 5-6 (a)), (b) the skin autofluorescence (green channel)
images are shown in the bottom panels (Figures 5-4 (c) and (f), Figures 5-5 (c) and (f), and
Figure 5-6 (c)), and (c) the overlay of the normalized SRB probe fluorescence (the red line) and
the skin autofluorescence (the green line) spectra are shown in the middle panels (Figures 5-4 (b)
and (e), Figures 5-5 (b) and (e), and Figure 5-6 (b)).
Yu et al. have shown that the skin autofluorescence spatial intensity distribution is
independent of the specific SRB skin penetration pathways (6). As a result, the SRB skin spatial
distributions can be characterized relative to the green channel skin autofluorescence maps of the
intrinsic skin morphology (6). In the green channel TPM skin images in Figures 5-4, 5-5, and 5-
6, the comeocytes correspond to the dark polyhedral regions surrounded by the green
autofluorescence of the SC intercellular lipid bilayers. The SRB skin spatial distributions shown
in these figures provide evidence that aqueous contacting solutions (ii)-(v) primarily interact with
the intercellular lipid bilayers of the SC and induce SRB to be localized within the bilayer
domains of the SC. On the other hand, aqueous contacting solution (i), containing 1 wt% SDS,
interacts strongly with the lipid bilayers as well as with the corneocytes of the SC, thereby
inducing SRB penetration into the corneocytes as well as into the lipid bilayers of the SC
(compare Figures 5-4 (a) and (c)).
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A quantification of the observations made above about the dual-channel TPM skin
images is presented below. For this purpose, a linear image deconstruction analysis was used
(see Section 5.2.6). The normalized red and green channel fluorescence intensities within a linear
deconstruction path of 256 x 5 pixel skin area (see the yellow rectangles in the top and bottom
panels in Figures 5-4, 5-5, and 5-6) were examined to quantify the SC morphological
modifications induced by aqueous contacting solutions (i)-(v). As mentioned above, these plots
are shown in the middle panels in Figures 5-4, 5-5, and 5-6. In Figure 5-4 (b), the
autofluorescence spectrum (green line) of the p-FTS sample exposed to solution (i) (1 wt% SDS)
exhibits one major peak at x = 102 pixels, and three minor peaks at x = 10 pixels, x = 163 pixels,
and x = 225 pixels. These four peaks correspond to the positions of the intercellular lipid bilayer
regions shown in the yellow box marking the linear path evaluated in the corresponding green
channel TPM skin image (see Figure 5-4 (c)). 32 The red channel TPM skin image shown in
Figure 5-4 (a) also has these 4 peaks as observed in the green channel TPM skin image (see
Figure 5-4 (c)). The SRB probe intensity spectrum peak widths (see the red line in Figure 5-4
(b)) are larger than those corresponding to the skin autofluorescence peaks (see the green line in
Figure 5-4 (b)). This difference between the SRB probe fluorescence and the skin
autofluorescence intensity peak widths provides unambiguous evidence of SDS-induced SRB
penetration into the corneocytes of the SC (see Section 5.2.5 and (5-8, 11, 34)). In addition, the
minor peak heights corresponding to the red channel spectrum are larger than the minor peak
heights corresponding to the green channel spectrum (see the red and green lines in Figure 5-4
(b)). This provides evidence that SDS promotes SRB penetration into the lipid bilayers, in
addition to promoting penetration into the corneocytes. These results indicate that not only does
32 Note that the distance between each of these peaks corresponds approximately to the length of a corneocyte (20-
40 iam), thereby implying that the positions of these peaks denote the locations of the intercellular bilayer regions in
the SC (5-8, 11).
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SDS rupture the corneocyte envelopes and denatures the corneocyte keratins, but that it also
disrupts the intercellular lipid bilayers, thereby inducing SRB penetration into the comeocytes
(the bricks) and into the lipid bilayers (the mortar) in the SC.
In Figure 5-4 (e), the autofluorescence spectrum (green line) of the p-FTS sample
exposed to solution (ii) (1 wt% SDS+10 wt% Glycerol) exhibits two major peaks, at x = 50
pixels and x = 145 pixels, and three minor peaks at x = 1 pixels, x = 73 pixels, and x = 254
pixels. These five peaks again correspond to the positions of the intercellular lipid bilayer
regions (see above). The SRB probe intensity spectrum peak heights (see the red line in Figure
5-4 (e)) are almost identical to those corresponding to the skin autofluorescence peaks (see the
green line in Figure 5-4 (e)). This indicates that contacting solution (ii) does not induce any
significant SRB penetration into the lipid bilayers of the SC. The peak widths corresponding to
the peaks at x = 1 pixels and x = 145 pixels are larger for the SRB probe fluorescence intensity
spectrum (the red line in Figure 5-4 (e)) relative to the skin autofluorescence intensity spectrum
(the green line in Figure 5-4 (e)). This indicates penetration of the SRB probe into these regions,
which are, in fact, the comeocyte regions of the SC. Therefore, these TPM results indicate that
adding 10 wt% Glycerol to an aqueous 1 wt% SDS contacting solution mitigates SDS-induced
intercellular lipid bilayer disruption, but does not eliminate SDS-induced SRB penetration into
the corneocyte regions of the SC.
In Figure 5-5 (b), the autofluorescence spectrum (green line) of the p-FTS sample
exposed to solution (iii) (1 wt% SCI) exhibits two major peaks, at x = 1 pixels and x = 107
pixels, and three minor peaks at x = 57 pixels, x = 158 pixels, and x = 210 pixels. These five
peaks again correspond to the positions of the intercellular lipid bilayer regions (see above). The
SRB probe intensity spectrum peak heights (see the red line in Figure 5-5 (b)) are higher than
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those corresponding to the skin autofluorescence peaks (see the green line in Figure 5-5 (b)).
This indicates that contacting solution (iii) promotes SRB penetration into the intercellular lipid
bilayers of the SC. However, upon comparing Figures 5-5 (a), (b), (c) with Figures 5-4 (a), (b),
(c), which correspond to 1 wt% SDS, it is clear that 1 wt% SCI induces a lower SRB penetration
into the intercellular lipid bilayers relative to 1 wt% SDS. 33 This finding is consistent with
transmission electron micrography (TEM) studies on the effect of SCI on the skin barrier
reported by Ananthapadmanabhan et al. (19, 39). Specifically, these authors found that SCI does
not induce skin-dryness relative to SDS, because SCI disorders the intercellular lipid bilayer
structure in the SC to a lower extent than SDS (see Chapter 3, and (19, 39)). The SRB probe
intensity spectrum peak widths (see the red line in Figure 5-5 (b)) are slightly larger than the
skin autofluorescence intensity spectrum peak widths (see the green line in Figure 5-5 (b)). This
difference between the SRB probe fluorescence and the skin autofluorescence intensity peak
widths provides evidence of SCI-induced SRB penetration into the corneocytes, albeit to a lower
extent than that induced by SDS (see above).34
In Figure 5-5 (e), the peaks corresponding to the skin autofluorescence intensity
spectrum are lower in height than those corresponding to the SRB probe fluorescence intensity
spectrum. This indicates that when p-FTS samples are exposed to the PBS control solution
(contacting solution (iv)) followed by exposure to the SRB probe solution, SRB is located within
the intercellular lipid bilayers. The peak widths corresponding to the red and green channels in
33 Comparing Figures 5-4 (d), (e), () with Figures 5-5 (a), (b), (c), one can observe that contacting solution (iii)
containing 1 wt% SCI promotes a lower extent of SRB penetration into the intercellular lipid bilayers relative to
contacting solution (ii) containing 1 wt% SDS+1 0 wt% Glycerol.
34 Indeed, SDS induces a larger difference in the SRB fluorescence and skin autofluorescence peak widths than SCI
(compare Figures 5-4 (b) and 5-5 (b)). This is because SDS, being a harsh surfactant, interacts more strongly with
the corneocyte envelopes and corneocyte keratins than SCI, which is a mild surfactant (see Chapters 2 and 3, and
(19, 39)).
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Figure 5-5 (e) are very similar, thereby showing that very little SRB probe is present in the
comeocyte regions of the SC.
In Figure 5-6 (b), the intensity spectrum peaks corresponding to the skin
autofluorescence is almost identical to that corresponding to the SRB probe fluorescence
intensity spectrum, including the peak positions, widths, and heights. This indicates that very
little SRB probe is present in the intercellular lipid bilayer region of the SC. In addition, the
widths of the peaks corresponding to the red channel (SRB probe fluorescence) intensity are
similar to those corresponding to the green channel (skin autofluorescence) intensity. Therefore,
very little SRB probe is present in the corneocyte region of the SC. Indeed, when p-FTS samples
are exposed to solution (v) (10 wt% Glycerol), Glycerol reduces the average pore radii and the
porosity-to-tortuosity ratio of the aqueous pores in the SC (see Chapter 2) through which
hydrophilic permeants like SRB penetrate into the SC. As a result, p-FTS samples that were
exposed to solution (v) containing 10 wt% Glycerol, and subsequently exposed to the SRB
contacting solution, show very little SRB penetration into the SC. Therefore, SRB is not present
in any significant amount either in the intercellular lipid bilayer region or in the corneocyte
region of the SC.
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Figure 5-4. Dual-channel TPM skin images of p-FTS samples at z=3 pm that were exposed to
solution (i, 1 wt% SDS): (a) - SRB fluorescence (red channel), (c) - skin autofluorescence
(green channel), with the linear fluorescence intensity deconstruction regions marked by the
yellow rectangles. The red and the green lines in (b) represent the normalized SRB fluorescence
and skin autofluorescence spectra, respectively. Figures (d), (f), and (e) are the analogous figures
for p-FTS samples that were exposed to solution (ii, 1 wt% SDS+10 wt% Glycerol). The color
scale bars indicate an increase in SRB intensity for the red channel images (a) and (d), and an
increase in skin autofluorescence intensity for the green channel images (c) and (f), as the color
progresses from a low value close to zero (black) to a high value (red/green). Key: C -
corneocyte, white line in (a) - 25 ýtm.
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Figure 5-5. Dual-channel TPM skin images of p-FTS at z=3 pm that were exposed to solution
(iii, 1 wt% SCI): (a) - SRB fluorescence (red channel), (c) - skin autofluorescence (green
channel), with the linear fluorescence intensity deconstruction regions marked by the yellow
rectangles. The red and the green lines in (b) represent the normalized SRB fluorescence and.
skin autofluorescence spectra, respectively. Figures (d), (f), and (e) are the analogous figures for
p-FTS samples exposed to solution (iv, PBS Control). The color scale bars indicate an increase:
in SRB intensity for the red channel images (a) and (d), and an increase in skin autofluorescence
intensity for the green channel images (c) and (f), as the color progresses from a low value close
to zero (black) to a high value (red/green). Key: C - corneocyte, white line in (a) - 25 ýlm.
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Figure 5-6. Dual-channel TPM skin images of p-FTS samples at z=3[tm that were exposed to
solution (v, 10 wt% Glycerol): (a) - SRB fluorescence (red channel), (c) - skin autofluorescence
(green channel), with the linear fluorescence intensity deconstruction regions are marked by the
yellow rectangles. The red and the green lines in (b) represent normalized SRB fluorescence and
skin autofluorescence spectra, respectively. The color scale bars indicate an increase in SRB
intensity for the red channel image (a), and an increase in skin autofluorescence intensity for the
green channel image (c), as the color progresses from a low value close to zero (black) to a high
value (red/green). Key: C - corneocyte, white line in (a) - 25 pm.
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5.4.3. Analysis of the Aqueous Pore Pathway Characteristics Using SRB
Intensity Profiles as a Function of SC Depth in the Context of a Hindered-
Transport Model
The five SRB fluorescence intensity profiles corresponding to solutions (i)-(v) are plotted
as a function of the skin barrier depth (z) in Figure 5-7. One can clearly see that the SRB
fluorescence intensity count induced at the SC surface (z=0) by aqueous contacting solutions (i)-
(v) follows the order (from the highest to the lowest): (i) > (ii) > (iii) > (iv) > (v). Specifically,
for all these five contacting solutions, the aqueous contacting solution with 1 wt% SDS induces
the highest SRB-skin partition coefficient. 35 Interestingly, the SRB-skin partition coefficient
induced by the 1 wt% SDS aqueous contacting solution is significantly reduced, by more than
three times, when 10 wt% Glycerol is added to the solution (see Figure 5-7 and Table 5-1). This
provides additional evidence that Glycerol mitigates the ability of SDS to interact strongly with
the SC surface, thereby reducing skin permeability. In addition, the 1 wt% SDS aqueous
contacting solution induces significantly deeper penetration of SRB into the skin relative to
aqueous contacting solutions (ii)-(v) (see Figure 5-7). Note that a similar observation was made
in Section 5.4.1 when comparing the color scale bars associated with Figure 5-2 (b) to those
associated with Figures 5-2 (d) and (), and with Figures 5-3 (b) and (d).
35 Note that the SRB-skin partition coefficient between the donor contacting solution and the skin, <, is proportional
to the SRB fluorescence intensity count induced at the SC surface (z=0) (see Section 5.3.1).
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Figure 5-7. Quantification of the SRB probe intensity in units of pixel count as a function of the
skin barrier depth (z) from the skin surface (z = 0) for p-FTS samples exposed to aqueous
contacting solutions (i)-(v). The error bars represent standard errors based on 6 skin imaging
sites on 7 p-FTS samples. Key: 0 - SDS (1 wt%), o - SDS (1 wt%)+Glycerol (10 wt%), * - SCI
(1 wt%), x - PBS Control, and o - Glycerol (10 wt%).
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Therefore, adding 10 wt% Glycerol to a 1 wt% aqueous SDS contacting solution not only
reduces the SRB-skin partition coefficient, but it also reduces the depth to which SDS can drive
SRB into the skin. Both of these findings provide evidence of the ability of the humectant,
Glycerol, to mitigate SDS-induced skin barrier perturbation. Aqueous contacting solutions (iii)-
(v) lead to significantly smaller values of SRB-skin partition coefficients and SRB-skin
penetration depths, relative to contacting solution (i) containing 1 wt% SDS.
The enhancements in the intercepts and in the slopes of the SRB fluorescence intensity
profiles induced by aqueous contacting solutions (i)-(v) were evaluated relative to the PBS
control, that is, relative to aqueous contacting solution (iv). 36 These results are reported in Table
5-1. Using an average aqueous pore radius corresponding to the PBS control (rpore,c) of 20±3A
(see Table 5-1 and Chapter 2) in the context of the theoretical model presented in Section 5.3.1,
rpore,E values (denoted as rpore in Table 5-1) induced by aqueous contacting solutions (i), (ii), (iii),
and (v) were determined, and are reported in Table 5-1. These rpore values are in excellent
agreement with the rpore values reported in Chapters 2, 3, and 4.
36 Note that the enhancement in the intercept induced by aqueous contacting solutions (i)-(v) relative to the control
(aqueous contacting solution (iv)) is equal to the enhancement in the overall SRB partition coefficient, (Ed)0 (see
Section 5.3.1). In addition, note that the (Ed pvalues were used to determine rpore,E values by inputting rpore,c =
20±3A (see Section 5.3.1).
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Table 5-1. Enhancements in the slopes and intercepts of the SRB fluorescence intensity profiles
as a function of skin barrier depth, and the corresponding theoretically computed aqueous pore
characteristics (the porosity-to-tortuosity ratio, e/r, and the average pore radius, rpore) induced by
aqueous contacting solutions (i), (ii), (iii), and (v) relative to aqueous contacting solution (iv, the
control).
Aqueous Contacting Solution E(Slope) E(Intercept) E(c/r)* rpore
(i) 1 wt% SDS 6.5±1.5 9.3±0.9 6.5±1.5 34±5
(ii) 1 wt% SDS+10 wt% Glycerol 3.1±1.2 2.8±0.7 3.1±1.2 19+6
(iii) 1 wt% SCI 2.5±1.3 2.4±0.6 2.5±1.3 28±5
(iv) PBS Control 1 1 1 20±3**
(v) 10 wt% Glycerol 0.5±0.2 0.3±0.2 0.5±0.2 13+5
* Note that E(Slope) = E(e/r), as discussed in Section 5.3.1.
** This rpore value, induced by aqueous contacting solution (iv), was determined previously using
Log P-Log R measurements in the context of a hindered-transport aqueous porous pathway
model (see Chapter 2), and has been utilized as an input to the model described in Section 5.3.1
to determine the rpore values induced by aqueous contacting solutions (i), (ii), (iii), and (v).
The findings reported here indicate that: (a) an aqueous contacting solution of 1 wt%
SDS (a harsh surfactant) induces the largest E/r value relative to the other four aqueous
contacting solutions considered, (b) an aqueous contacting solution of 1 wt% SCI (a mild
surfactant) induces a rpore value that is closer to that induced by an aqueous contacting solution of
1 wt% SDS, while inducing a significantly smaller /r value, (c) adding 10 wt% Glycerol to the
1 wt% SDS aqueous contacting solution significantly reduces the rpore and //r values, and (d) an
aqueous contacting solution of 10 wt% Glycerol induces significantly smaller rpore and c/r values
than does the PBS control.
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5.5. Conclusions
The TPM skin visualization studies reported in this chapter revealed that SDS induces
corneocyte damage by rupturing corneocyte envelopes and denaturing keratins. This may further
induce the creation of intra-corneocyte penetration pathways once SDS "opens-up" the cross-
linked keratin structure of the comeocytes. Therefore, a group of such damaged adjacent
corneocytes, taken together, may exhibit a large number of intra-comeocyte penetration
pathways that may result in a localized transport region (LTR). A simultaneous quantitative
analysis of the red and the green channel TPM skin images showed that an aqueous contacting
solution of 1 wt% SDS+10 wt% Glycerol does not significantly induce corneocyte damage or
LTR formation. Therefore, taken together with the results presented in Chapter 2, these dual-
channel TPM images provide additional evidence that adding 10 wt% Glycerol to a 1 wt% SDS
aqueous contacting solution significantly mitigates the ability of SDS to penetrate into the SC
and interact with the keratins of the comeocytes and induce comeocyte damage. The dual-
channel TPM images of p-FTS exposed to an aqueous 1 wt% SCI contacting solution showed a
lower extent of SRB penetration into the comeocytes and into the intercellular lipid bilayers
relative to the aqueous contacting solution of 1 wt% SDS. The PBS control solution induced
localization of the SRB probe within the intercellular lipid bilayers surrounding the comeocytes
of the SC. In addition, aqueous contacting solutions containing 10 wt% Glycerol showed the
least extent of lipid bilayer perturbation, and no effect on the comeocytes of the SC, relative to
the other surfactant/humectant aqueous contacting solutions considered here. This important
finding is consistent with the results of the studies reported in Chapters 2 and 4, where I showed
that an aqueous contacting solution of 10 wt% Glycerol reduces the porosity-to-tortuosity ratio
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and the average radius of the aqueous pores through which the hydrophilic SRB probe molecules
can penetrate into the SC.
For the five aqueous contacting solutions considered in this chapter, most of the SRB
probe that penetrates into the skin barrier is present in the SC, and the probe intensity decays
significantly as one visualizes the layers in the epidermis below the SC. I have quantified the
amount of SRB that penetrated into the SC as a function of the SC depth upon contacting p-FTS
separately with the five aqueous contacting solutions (i)-(v). This TPM analysis revealed that
SDS enhances the probe partition coefficient the most, and that the extent of skin barrier
perturbation induced by aqueous contacting solutions follows the order (from the highest to the
lowest): (i) > (ii) > (iii) > (iv) > (v), which is consistent with the results of the in vitro ranking
metric reported in Chapter 4.
In the next chapter, Chapter 6, I will investigate the effects of adding 10 wt% Glycerol to
SDS aqueous contacting solutions on the skin aqueous pores by developing a theoretical pore
size distribution model.
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Chapter 6
6. Aqueous Pore Size Distribution Induced by an
Aqueous Surfactant Solution in the Absence
and in the Presence of a Humectant
6.1. Introduction and Motivation
In Chapter 1, Section 1.4.2, I examined the existence and the nature of an aqueous pore
pathway in the stratum corneum (SC). The aqueous pore pathway results from aqueous pores in
the SC that align vertically and horizontally to form tortuous, cylindrical channels accessible to
polar permeants, thereby making it possible for hydrophilic, polar permeants to penetrate into the
SC and traverse the continuous hydrophobic, lipoidal domains within the SC. The following
mechanisms were advanced in the literature to provide a physical basis for the existence of the
aqueous pore pathway: (i) discrete lacunar domains between two layers of lipid headgroups in a
lipid bilayer that may fill up with water upon skin hydration (1), and (ii) imperfections in the
lipid bilayers, including fault dislocations or missing lipids, separation of grain boundaries, and
lattice vacancies (2, 3). One, or more, of these mechanisms may act in tandem to lead to the
229
formation of the aqueous pores in the SC (1-4, 8, 9). Because of the inherent skin heterogeneity,
the number of lacunae and defects at different SC sites is expected to be different (4-7). As a
result, this variation in the number of lacunae and defects can potentially lead to a size
distribution of the aqueous pores that align to form the aqueous pore pathway in the SC (8, 9).
Evidence for the existence of a size distribution of aqueous pores in the SC was provided
indirectly by conducting skin permeability studies which revealed that permeants of similar
charges and hydrophobicities/hydrophilicities, but of different molecular sizes (radii), exhibit
different rates of skin permeability (8-10). In particular, Tezel et al. measured different skin
permeability values for hydrophilic permeants having different molecular radii, such as, Urea
and Mannitol, which have hydrodynamic radii smaller than 5A, and Dextran, which has a
hydrodynamic radius larger than 20A (8). Specifically, Tezel et al. observed an inverse
correlation between the permeant hydrodynamic radius (size) and the permeant transdermal
permeability, a finding that provides indirect evidence for the existence of a size distribution of
aqueous pores in the SC. Indeed, the larger the molecular radius of a permeant, the fewer the
number of aqueous pores that it can access in order to penetrate into and traverse the SC, and
therefore, the smaller its transdermal permeability. Because there is a size distribution of aqueous
pores in the SC, smaller hydrophilic permeants can access a larger number of these aqueous
pores, and therefore, can exhibit higher permeabilities when compared to larger hydrophilic
permeants (8-10).
In Chapter 2, we reported that SDS aqueous contacting solutions induced an average
aqueous pore radius of 33+5A, while when 10 wt% Glycerol was added to these contacting
solutions, the aqueous pore radius was decreased to 20±5A. As a result, an SDS micelle in an
SDS aqueous contacting solution, having an effective hydrodynamic radius of 19.5±1A was able
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to penetrate into the SC, and induce skin barrier perturbation, by accessing aqueous pores whose
average radius was significantly larger (33±5A). On the other hand, an SDS micelle in an SDS
aqueous contacting solution with 10 wt% added Glycerol, having an effective hydrodynamic
radius of 18.5+1A, was sterically hindered from penetrating into the SC because it was not able
to access, to the same extent, the aqueous pores having an average radius of 20±5A.
In this chapter, in order to gain additional mechanistic insight on the radii (sizes) of the
aqueous pores induced by aqueous contacting solutions containing: (i) SDS (1-200 mM), and (ii)
SDS (1-200 mM) +10 wt% added Glycerol, I developed a theoretical methodology to
characterize the size distribution of aqueous pores induced by aqueous contacting solutions (i)
and (ii) above. Because there is an inherent size distribution of aqueous pores in the SC, being
able to characterize it in the presence of aqueous surfactant/humectant systems can lead to an
accurate prediction of the contribution of surfactant in micellar form, relative to that of surfactant
in monomeric form, to surfactant skin penetration, and thereby, to surfactant-induced skin barrier
perturbation in the presence of humectants (see Section 6.3). For example, consider the
theoretical analysis reported in Chapter 2 on the role of SDS micelles on skin barrier
perturbation, in the presence and in the absence of 10 wt% added Glycerol. Although the
analysis in Chapter 2 revealed that the SDS micelles did not play a significant role in SDS skin
penetration in the presence of 10 wt% Glycerol, it was unable to specifically quantify the relative
contributions of SDS in monomeric and in micellar forms to SDS skin penetration. Indeed,
because there is a size distribution of aqueous pores induced by an SDS+10 wt% Glycerol
aqueous contacting solution, there are still some aqueous pores which are sufficiently large to
allow penetration of SDS micelles into the SC, even though, on average, the SDS micelles are
sterically hindered from penetrating into the SC through the aqueous pores (see Chapter 2).
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Therefore, unless one is able to characterize the size distribution of the aqueous pores induced
upon exposure of the skin to the aqueous contacting solutions containing SDS+10wt% added
Glycerol, one cannot accurately quantify the contribution of the SDS micelles, relative to that of
the SDS monomers, to SDS skin penetration and associated skin barrier perturbation.
In determining the size distribution of the aqueous pores upon exposing skin to: (i)
aqueous SDS contacting solutions, and (ii) aqueous SDS+10 wt% Glycerol contacting solutions,
I have: (a) considered the SDS monomers and the SDS micelles as the two penetrating entities,
and (ii) used appropriate steric pore-partition coefficients for the SDS monomers and the SDS
micelles (see Section 6.2). Furthermore, in determining the aqueous pore size distribution, I have
used the measured SDS skin penetration data reported in Chapter 2, instead of using the
measured skin permeability data for commonly used hydrophilic permeants, such as Mannitol
and ions.37 Indeed, using the measured SDS skin penetration data to determine the size
distribution of the aqueous pores has two key advantages: (i) the SDS skin penetration
measurements provide a direct way to probe the aqueous pore size distribution, as opposed to the
Mannitol skin permeability and skin electrical current measurements which provide an indirect
way to do so, and (ii) the SDS skin penetration measurements enable the development of a model
to quantify surfactant penetration into the skin, as opposed to determining only enhancements in
the transdermal delivery of hydrophilic permeants, such as Mannitol and ions, upon exposing
skin to surfactants. In order to develop mechanistic insight on the skin barrier perturbation
induced by aqueous surfactant/humectant systems, it is essential to understand the process of
surfactant skin penetration in the presence of humectants, rather than the transdermal delivery of
37 The skin permeability of ions, in this case, of Na4 and Cl-, is primarily responsible for inducing an electrical
current across the skin, and can therefore be determined experimentally using skin electrical current measurements
(see Chapter 2).
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surfactants in the presence of humectants. This follows because: (1) the skin barrier is not
saturated with surfactants, and therefore, it may continue to absorb surfactants before these
chemicals can actually cross the skin barrier and enter into the blood stream (11-15), (2) the in
vivo erythema (skin redness) response has been shown to result from the ability of surfactants to
penetrate into, and subsequently damage, the skin barrier, and not so much from their ability to
diffuse into the blood stream (13-15), (3) researchers have observed that the skin penetration of
surfactants is relatively large compared to their diffusion across the skin barrier and into the
blood stream (15-17), and (4) I have observed that a humectant, such as Glycerol, significantly
inhibits the skin penetration of surfactants, such as SDS, which in turn, minimizes the in vivo
erythema response (see Chapter 2). Clearly, for our purposes here, being able to model the
penetration of surfactants into the skin, which is directly responsible for surfactant-induced skin
barrier perturbation, is more important than being able to model the systemic uptake of
surfactants by the body, or than being able to model the skin permeation enhancement induced
by surfactants.
6.2. Development of the Aqueous Pore Size Distribution Model
Using Single-Parameter Exponential and Truncated Normal
Distribution Functions
I investigated the size distribution of the aqueous pores in the SC induced by aqueous
contacting solutions of SDS (1-200 mM) and SDS (1-200 mM) + 10 wt% added Glycerol using
the SDS skin penetration data reported in Chapter 2. The SDS monomers and the SDS micelles
were considered as the two skin penetrating entities having different sizes (effective
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hydrodynamic radii).38 Due to simplicity and model tractability, single-parameter distributions,
specifically: (i) an exponential distribution function, and (ii) a truncated normal distribution
function, were used to represent the size distribution of the aqueous pores in the SC. Below, I
present the various steps involved in formulating the two aqueous pore size distribution models,
including evaluating the corresponding pore size distribution parameters.
Step 1: Use single-parameter distribution functions to model the aqueous pore size
distribution in the SC (8, 9, 18).
Using an exponential distribution function to model the size distribution of aqueous pores
in the SC results in the following expression:
y(r) = A exp(-Ar) (1)
where r is the aqueous pore radius, y(r) is the exponential distribution function, and A is the pore
size distribution parameter characterizing the exponential distribution function. In addition, using
Eq.(1), one can obtain an analytical expression for the average aqueous pore radius, rpXpr,
corresponding to the aqueous pore size distribution in Eq.(1). Specifically (30),
rexp = ryrdr = (2)
pore A.,
Note that the average pore radius, calculated using Eq.(2) is, in effect, an estimate of the
expected pore radius that one would find, on average, upon randomly sampling a pore radius
using the expected distribution of pore radii given in Eq.(1).
Similarly, using a truncated normal distribution function to model the size distribution of
aqueous pores in the SC results in the following expression:
38 The effective hydrodynamic radius of an SDS monomer was determined using the Stokes-Einstein equation. The
effective hydrodynamic radius of an SDS micelle was determined using Dynamic Light Scattering (DLS)
measurements, as reported in Chapter 2.
234
1 2 r2S(r) = - exp(- 2) (3)
where r is the aqueous pore radius, 8(r) is the truncated normal distribution function, and a is the
pore size distribution parameter characterizing the truncated normal distribution function.39 In
addition, one can obtain an analytical expression for the average aqueous pore radius, ,ormoa
corresponding to the aqueous pore size distribution in Eq.(3) (30). Specifically,
roaI =f r6(r)dr = (4)
In addition, note that the aqueous pore size distributions in Eqs. (1) and (3) satisfy the following
physical constraints:
fy(r)dr=l,r-oo=> y(r)-•O (5a)
and
S6(rdr = 1l,r - oo = (r)- 0 (5b)
Because: (1) a hydrophilic permeant can access aqueous pores whose radii are larger than the
permeant radius, and (2) Eqs.(5a) and (5b) imply that, for infinitely large hydrophilic permeants,
the probability of obtaining a very large pore is infinitesimally small, it follows that none of the
aqueous pores are available for penetration of such permeants into the SC. Equations (1)-(4)
were used to model the size distribution and the average radius of the aqueous pores in the SC
induced by aqueous contacting solutions containing: (i) SDS (1-200 mM) and (ii) SDS (1-200
39 Note that the distribution function, 8(r), in Eq.(3) was obtained by truncating the normal distribution function
using the restriction that the aqueous pore radii are not negative (r_0). As a result, the pre-exponential constant in
8(r) differs from the pre-exponential constant in the conventional normal distribution function (R) (18).
Furthermore, note that this pre-exponential constant factor in Eq.(3) satisfies the physical constraints imposed in
Eqs.(5a) and (5b) (18).
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mM)+10 wt% added Glycerol (see Chapter 2 for a discussion of the effects of contacting
solutions (i) and (ii) on the aqueous pores in the SC).
Step 2: Derive mathematical expressions for the pore size distribution parameters,
A and •, in Eqs. (1) and (3), respectively, using experimental values for the SDS monomer / SDS
micelle pore penetration ratio, Rmon/mic, in the presence and in the absence of 10 wt% Glycerol.
In Chapter 2, a multiple linear regression (MLR) analysis of the amount of 14 C
radiolabeled SDS that can penetrate into the epidermis from aqueous contacting solution (i)
containing SDS (1-200 mM) (see above) was used to determine Rmo/mic. 40 Specifically (see
Chapter 2 and (11, 31, 32)):
aCC C + pC C R = ""m (6)
skin mo n  mic mon/mic
Cmic
where Cskin is the concentration of 14C radiolabeled SDS in the epidermis, Cmon and Cmic are the
concentrations of the SDS monomers and the SDS micelles, respectively, in the aqueous
contacting solutions, a is the linear regression coefficient that quantifies the contribution of the
SDS monomers to SDS skin penetration per unit monomer concentration in the aqueous
contacting solution, and 8 is the linear regression coefficient that quantifies the contribution of
the SDS micelles to SDS skin penetration per unit micelle concentration in the aqueous
contacting solution.
40 Note that Rmon mic, which I have defined as the SDS monomer/SDS micelle pore penetration ratio, can also be
interpreted as the contribution of the SDS monomer/SDS micelle ratio to SDS skin penetration. Because SDS binds
strongly to the epidermis, and does not diffuse significantly across the epidermis, the penetration of SDS into the
aqueous pores, rather than the transdermal diffusion of SDS through the aqueous pores, is the primary driving force
that controls the amount of SDS that can penetrate into the skin from an aqueous contacting solution (see Chapter 2
and Section 6.1).
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The SDS monomer / SDS micelle pore penetration ratio, Rmonmic , can also be related to:
(i) the average SDS monomer-aqueous pore partition coefficient, i.mon , (ii) the average SDS
micelle-aqueous pore partition coefficient, (mic , and (iii) the SDS monomer and SDS micelle
skin porosities, Emo. and Emic , 41 respectively, using well-accepted principles of hindered-
transport theory (8, 11, 18-25). Specifically,
Rmon/mic om Cmion Cmon (7)
miccmic mic
Equation (7) describes the penetration of the SDS monomers relative to that of the SDS micelles
through the aqueous pores of the SC. An SDS monomer can access an aqueous pore whose
radius, r, is larger than the radius of the SDS monomer, rmon. Similarly, an SDS micelle can
access an aqueous pore whose radius, r, is larger than the radius of the SDS micelle, rmic. Next,
the SDS monomer and the SDS micelle can partition into the these aqueous pores with an
average SDS monomer-aqueous pore partition coefficient, 0mon , and an average SDS micelle-
aqueous pore partition coefficient, ,mic , respectively. In addition, note that the quantities, 6mon
and vmi,, appear in Eq.(7) because the SC is a porous membrane where only the area occupied by
the aqueous pores is available for penetration of an SDS monomer and an SDS micelle. The ratio
Cmon /Cmic appears in Eq.(7) because the concentrations of the SDS monomers and the SDS
micelles contacting the skin should be directly proportional to the extents to which they penetrate
into the skin (see assumption (vi) below).
It is instructive to summarize and explain the validity of the key assumptions made in the
derivation of Eq.(7): (i) steric interactions are the dominant interactions between the permeants
41 The skin porosity is defined as the fraction of the skin cross-sectional area available for penetration of permeants
that is occupied by the aqueous pores.
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and the aqueous pore walls, (ii) the permeants do not 'clog' the aqueous pore entries and exits,
(iii) the SDS monomer and SDS micelle-pore wall partition coefficients dominate the SDS
monomer and SDS micelle pore diffusion coefficients in determining the total amount of SDS
skin penetration, (iv) the concentration of the permeant in the donor compartment is high, and
does not deplete with time, (v) the concentration of the permeant in the donor compartment is
always much higher than that in the receiver compartment, and (vi) the SDS monomer to micelle
pore penetration ratio is directly proportional to the ratio of the SDS monomer concentration to
the SDS micelle concentration in the aqueous contacting solution. Moore et al. (11, 31, 32) have
shown that assumption (vi) is valid. Assumptions (iv) and (v) are valid because an insignificant
amount of the permeant present in the donor compartment was observed to permeate across the
p-FTS samples used in the appropriate experiments (see Chapter 2). Assumption (iii) is also
valid for the SDS skin penetration assays used because less than 1% of SDS present in the donor
compartment permeated across the p-FTS samples into the receiver compartment, while a
significantly larger amount of SDS present in the donor compartment penetrated into the p-FTS
samples (see Section 6.1 and Chapter 2). Assumption (ii) is a well-accepted one in the hindered-
transport literature aimed at modeling penetration and diffusion of permeants across the skin
barrier (8, 9, 18-26). In addition, Tang et al. have shown that steric interactions between
permeants and the aqueous pore walls are usually more significant than electrostatic and van der
Waals interactions for the types of systems examined here (25).
By combining Eqs.(6) with (7), one can obtain a relationship between: (i) the linear
regression coefficients, a and 8, (ii) the SDS monomer and SDS micelle average aqueous-pore
partition coefficients, #mon and nmic , and (iii) the SDS monomer and SDS micelle skin porosities,
,,,on and ~mic. Specifically,
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a monmon (8)- -.(8)
Because only steric interactions are assumed to operate between the walls of the aqueous
pores and the SDS monomers and the SDS micelles (see assumption (i) above), one can relate
Omon and )mic to rmon and rmic, respectively, and to the single-parameter exponential pore size
distribution, y(r), as follows (8, 9, 18-25):
2
mon= 7r 1 rmon dr (9a)
and
emic = (r - rmic dr (9b)
M" r
In addition, expressions for the skin porosities associated with the SDS monomers and the SDS
micelles, mon, and cmic, respectively, can be derived by assuming that only aqueous pores having
a radius r which is larger than the effective hydrodynamic radius of a SDS monomer (rmo,n) will
contribute to Emon , and that only aqueous pores having a radius r which is larger than the
effective hydrodynamic radius of a SDS micelle (rmic) will contribute to mic (8, 9). Specifically,
N
Emon = 17 (r) rr2dr (10a)A
and
•.c = 17 y(r) .rr2dr (10b)A
where (NA/A) is the pore number density, that is, the number of aqueous pores (Np) per unit skin
area (A).
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By multiplying Eqs.(9a) and (10a), dividing by the product of Eqs.(9b) and (10b), and
using this result in Eq.(8), an explicit expression is obtained which relates the aqueous pore size
distribution, y(r), to the experimentally determined linear regression coefficients, a and P.
Specifically,
a r7(r) 1 - r n r2 j Y(r) N2 2 dr (11)2 N 2[ (r) 1- rmc 2dr v(r)(P )nr2dr
where all the variables were defined above.
Using the truncated normal distribution function to model the size distribution of the
aqueous pores in the SC, one can obtain a similar expression for a/Jl, with K(r) replaced by 6(r)
in Eq.(11). Note that Eqs.(6)-( 11) were derived to determine the aqueous pore size distribution in
p-FTS samples that were contacted with aqueous solutions containing SDS (1-200 mM)
(contacting solution (i)). A similar analysis was carried out to determine the aqueous pore size
distribution in p-FTS samples that were contacted with aqueous solutions containing SDS (1-200
mM)+10 wt% added Glycerol (contacting solution (ii)). Below, I describe how to compute 2 and
a to uniquely determine y(r) and 8(r), in Eqs.(1) and (3), respectively.
Step 3: Evaluate the aqueous pore size distribution parameters, A and ao including the
average aqueous pore radii induced by aqueous contacting solutions containing SDS (1-200
mM) and SDS (1-200 mM) +10 wt% added Glycerol.
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The integrals in the numerator and the denominator of Eq.(1 1) were evaluated
numerically for a specific value of 2 (see Eq.(1)), and subsequently, Eq.(11) was solved using a
trial-and-error procedure.42 The lower limits of the integrals in Eq.(11), rmon and rmic, correspond
to the SDS monomer and the SDS micelle radii, respectively, which were assumed to be equal to
the effective hydrodynamic radii values. In Chapter 2, the SDS micelle effective hydrodynamic
radius in an aqueous SDS solution was determined using Dynamic Light Scattering (DLS)
measurements to be 19.5+1A, while in an aqueous SDS solution with 10wt% added Glycerol, it
was determined to be 18.5±1A. With this in mind, for the purpose of the calculations reported
here, I have used rmic = 19.5A in the absence of Glycerol, and rmic = 18.5A in the presence of 10
wt% added Glycerol. The effective hydrodynamic radius of a SDS monomer, rmon, was
determined to be 5A, using the Stokes-Einstein equation (see Chapter 2 and (27)), which
corresponds to the lower limit of the integral in the numerator of Eq.(11). Using the trial-and-
error solution procedure discussed above, I obtained appropriate A values characterizing the
exponential aqueous pore size distributions in the absence and in the presence of 10 wt% added
Glycerol. Specifically, I obtained: (i) ASDSs, for p-FTS that was exposed to aqueous SDS (1-200
mM) contacting solutions, and (ii) 2 SDS+G , for p-FTS that was exposed to aqueous SDS (1-200
mM)+10 wt% added Glycerol contacting solutions.
In addition, using the truncated normal distribution function to model the size distribution
of the aqueous pores in the SC, I obtained an equation similar to Eq.(l 11), with y(r) replaced by
8(r). Subsequently, I used the trial-and-error solution procedure discussed above to obtain
42 Given this value of 2, the ratio of the integrals was compared to the ratio, a/f, and the error was computed. If this
error was within a pre-specified error tolerance level (10-6), then this value of A was identified as the solution to
Eq.( 11). However, if the error was not within the pre-specified error tolerance level, a new value of 2 was specified,
and the recursive solution procedure was continued until the error was within the pre-specified error tolerance level.
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appropriate a values characterizing the truncated normal aqueous pore size distributions in the
absence and in the presence of 10 wt% added Glycerol. Specifically, I obtained: (i) SDS , for p-
FTS that was exposed to aqueous SDS (1-200 mM) contacting solutions, and (ii) uSDS+G, for p-
FTS that was exposed to aqueous SDS (1-200 mM) +10 wt% added Glycerol contacting
solutions.
The average aqueous pore radii corresponding to the exponential pore size distributions,
induced by aqueous contacting solutions (i) and (ii), rPss and rPesJs+; , were then calculated
using the ASDS and ASDS+G values determined above, respectively, in Eq.(2). In addition, the
average aqueous pore radii corresponding to the truncated normal pore size distributions,
induced by aqueous contacting solutions (i) and (ii), ro"a and or"""mal were calculated
rpore,SDiS  rpore,Si)S+(; Werec
using the YSDS and cUSDS+G values determined above, respectively, in Eq.(4).
Step 4: Evaluate the changes in the skin porosity and pore partition coefficient associated
with the SDS micelles induced upon adding 10 wt% Glycerol to aqueous contacting solutions
containing SDS (1-200 mM).
In Chapter 2, I observed that upon adding 10 wt% Glycerol to aqueous solutions
containing SDS (1-200 mM), the SDS-induced normalized porosity-to-tortuosity ratio, e/r, of the
aqueous pores in the SC decreased from 7±1 to 3±1, which is a decrease of more than 57%.
Furthermore, the decrease in the normalized c/r ratio was attributed to a reduction in the SDS-
induced porosity, E, upon adding 10 wt% Glycerol to aqueous SDS contacting solutions (see
Chapter 2 and (8, 9, 11, 25, 31)). Therefore, it is reasonable to anticipate a decrease in the skin
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porosity to SDS micelles upon adding 10 wt% Glycerol to an aqueous SDS contacting solution. 43
Using the exponential distribution function to model the size distribution of the aqueous pores,
one can now determine the ratio of the skin porosity associated with the SDS micelles induced
by aqueous contacting solution (i), relative to aqueous contacting solution (ii), denoted as E,"p.
Specifically, in terms of the single-parameter exponential aqueous pore size distribution (see
Eq.(10 b)),
7x pA s ss 2dr
exp m.scs AEexp mic,SDS S(12)exp N
mic,SDS+G p N + 2drexp , cS rSDS+G .s r dr
ic.SDS+G A
where •,XP is the skin porosity associated with the SDS micelles induced by aqueous
contacting solution (i), EPSDS+G is the skin porosity associated with the SDS micelles induced
by aqueous contacting solution (ii), ric,SDS is the SDS micelle radius in aqueous contacting
solution (i), rmic.SDS+G is the SDS micelle radius in aqueous contacting solution (ii), K(r)sos is the
exponential pore size distribution induced by aqueous contacting solution (i), and i(r)SDS+G is the
exponential pore size distribution induced by aqueous contacting solution (ii). In addition,
(N1/A)sos is the number of pores per unit skin area (A) induced by aqueous contacting solution
(i), and (Np/A)SDS+G is the number of pores per unit skin area (A) induced by aqueous contacting
solution (ii). Note that because (N/A)SDs # (Np/A)SDs, one cannot directly evaluate Ejxp by
computing the definite integrals in the numerator and denominator of Eq.(12).
43 A similar analysis carried out for the SDS monomers in Chapter 2 indicates that the addition of 10 wt% Glycerol
to the aqueous contacting solutions containing SDS (1-200 mM) does not prevent SDS monomers from contributing
to SDS skin penetration. Indeed, in Table 6-1, one can observe that the values of asDs and xSDS+G are similar (see
Eq.(6)).
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In order to calculate ELX, I have obtained explicit relationships relating: (a) changes in
the skin porosity, E p, and the pore partition coefficient, E xP, to (b) linear regression
coefficients that quantify the contribution of the SDS micelles to SDS skin penetration per unit
SDS micelle concentration in the aqueous contacting solutions (i) and (ii), 8SDS+G and /SDS+G,
respectively (see Eq.(6)). Specifically, upon comparing the contribution of the SDS micelles to
SDS skin penetration in aqueous contacting solution (i) relative to that in aqueous contacting
solution (ii), I obtain:
s snti• m mic,S)S CI -= S - (Exp xE; x p ) (13)
CSS+G DS+G exp Lexp C SDS+(G e
-SS+G mic Smic,SIS+G micSDS+G ( ic ) SDS+(
where P ,s,,, is the average SDS micelle-aqueous pore partition coefficient induced by aqueous
contacting solution (i), I,sx +(; is the average SDS micelle-aqueous pore partition coefficient
induced by aqueous contacting solution (ii), C s is the concentration of SDS micelles in
aqueous contacting solution (i), and C'SY' +( is the concentration of SDS micelles in aqueous
contacting solution (ii), and Exp xp S. Therefore, if one can determine Exp, then
one can determine E xp using Eq.(13) (recall that 8SDS I/ 3 SDS+G in Eq.(13) can be determined
experimentally using an MLR analysis of the '4C radiolabeled SDS skin penetration data upon
contacting p-FTS to aqueous contacting solutions (i) and (ii)).
Using Eq.(9b) to express ,a and 0 esxp  in terms of y(r)sDs and Y(r)SDS+G ,
respectively, it follows that:
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SexpS mcSic,SDS dr
E exp _ SD (14)0 oexp - 2
icSDS+G SDS+G r mic, SDS +G  dr
ic.SDS+G r
Therefore, upon determining y(r)sos, y(r)SDS+G, rmic,SDS, and rmic,SDS+G (see above), Eq.(14) can be
used to determine Exp. Once E•P is determined in this manner, Eq.(13) can then be used to
determine Eexp . In addition, equations similar to Eqs.(13) and (14) can be derived in the case of
the truncated normal distribution function (see Eq.(3)) to determine the ratio of the skin porosity
associated with the SDS micelles induced by aqueous contacting solution (i) relative to the skin
porosity associated with the SDS micelles induced by aqueous contacting solution (ii), denoted
as E2o rmal. To derive this equation, one only needs to replace y(r)sDS by S(r)sDs and K(r)SDS+G by
6(r)SDS+G in Eqs.(13) and (14). 44 These results are discussed next in Section 6.3.
6.3. Evaluation of the Aqueous Pore Size Distributions Induced by
SDS in the Absence and in the Presence of 10 wt% Added
Glycerol
Using multiple linear regression (MLR), I determined values of a and f upon exposing p-
FTS to aqueous contacting solutions containing: (i) SDS (1-200 mM), that is, aSDS and 8SDS, and
(ii) SDS (1-200 mM) + Glycerol (10 wt%), that is, aSDS+G and fSDS+G, as discussed in Section
6.2 (see also Table 6-1 below). The ratio a/fl which quantifies the contribution of the SDS
44Note that y(r)DS appears in the term exp _exp
44 NOte that r)s appears in the term ic,SDS mc,SDS ], and Sr)DSG appears in the term
[exp in Eq.(13).
mic,SDS+G mic,SDS+G]inEq.(13).
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monomers relative to that of the SDS micelles to SDS skin penetration (see Section 6.2)
increases by more than six times when 10 wt% Glycerol is added to the SDS aqueous contacting
solution (see Table 6-1). Clearly, the addition of 10 wt% Glycerol significantly reduces the
contribution of the SDS micelles to SDS skin penetration, which is consistent with my finding in
Chapter 2.45
Table 6-1. Multiple Linear Regression (MLR) analysis of 14C radiolabeled SDS skin penetration
data from aqueous contacting solutions containing SDS (1-200 mM) (i) and SDS (1-200
mM)+Glycerol (10 wt%) (ii).
Aqueous Contacting Solutions
(i) SDS (1-200 mM) (ii)SDS (1-200 mM)+Glycerol (10 wt%)
a 5.228x 10-3  4.477x 103
p 1.256x 10-3  1.699x 10-4
a/p 4.163 26.360
R2  9.641 x 10' 9.707x 10'
Using the a//f values for aqueous contacting solutions containing SDS (1-200 mM) and
SDS (1-200 mM) + 10 wt% added Glycerol, in the context of the trial-and-error solution
procedure discussed in Section 6.2, I determined the following values for the exponential pore
size distribution parameter, A (see Table 6-2): (a) 2AsD = 0. 04 for aqueous contacting solution (i),
and (b) ASDS+G = 0. 10 for aqueous contacting solution (ii).
45 In Chapter 2, the addition of 10 wt% Glycerol to SDS aqueous contacting solutions did not result in a statistically
significant reduction in the contribution of the SDS monomers to SDS skin penetration, while the contribution of the
SDS micelles was significantly reduced. Therefore, it follows that the ratio of the contribution of the SDS monomers
to the contribution of the SDS micelles to SDS skin penetration is significantly increased in the presence of 10 wt%
Glycerol in the SDS aqueous contacting solutions.
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In addition, the following values were determined for the truncated normal pore size
distribution parameter, o-: (a) oSDS = 34 for aqueous contacting solution (i), and (b) SDS+G = 18
for aqueous contacting solution (ii). The resulting aqueous pore size distributions, y(r) and 6(r),
are plotted in Figures 6-1 and 6-2, respectively. Clearly, as shown in both figures, the addition
of 10 wt% Glycerol to an aqueous SDS contacting solution induces a shift in the size distribution
of aqueous pores induced by the aqueous SDS contacting solution - from larger to smaller pores,
a finding that is consistent with the conclusions reached in Chapter 2 on the effect of 10 wt%
added Glycerol on SDS-induced skin barrier perturbation. Indeed, because the addition of 10
wt% Glycerol to an aqueous SDS contacting solution results in smaller aqueous pores, relative to
those found in an aqueous SDS contacting solution with no added Glycerol, the SDS micelles are
sterically hindered from penetrating into the skin through the smaller aqueous pores, and as a
result, cannot effectively contribute to SDS-induced skin barrier perturbation. Nevertheless, as
Figures 6-1 and 6-2 show, because of the existence of a size distribution of aqueous pores, some
of the aqueous pores are sufficiently large to allow SDS micelle skin penetration, even when 10
wt% Glycerol is added to an aqueous SDS contacting solution. In order for our findings here to
be consistent with those in Chapter 2, the number of such aqueous pores should be significantly
reduced in the presence of 10 wt% Glycerol, such that the contribution of the SDS micelles to
SDS skin penetration is also significantly reduced. To verify this claim, using the exponential
pore distribution function, y(r), in Figure 6-1, I computed the percentage of aqueous pores that
are larger in size than the size of an SDS micelle, and hence, allow penetration of SDS micelles
into the skin.
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Figure 6-1. Size distribution of aqueous pores using the exponential pore distribution function
induced in p-FTS exposed to the SDS (1-200 mM) (solid line) and the SDS (1-200
mM)+Glycerol (10 wt%) (dashed line) aqueous contacting solutions.
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Figure 6-2. Size distribution of aqueous pores using the truncated normal pore distribution
function induced in p-FTS exposed to the SDS (1-200 mM) (solid line) and the SDS (1-200
mM)+Glycerol (10 wt%) (dotted line) aqueous contacting solutions.
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Specifically, using the values of ASDS and /SDS+G obtained earlier (see above), the area
under the curves for (rmic,SDS<r<oo) corresponding to aqueous contacting solutions (i), and for
(rmic,SDS+G(<r<oo) corresponding to aqueous contacting solutions (ii), were computed numerically
(see Eq.(15) below).
IS = miAs%  , exp(-AS.sr)dr = exp(-Assrmi,,sIs) = 4 6 %
mc,SDS (15)
exp  ss+c; exp(-AsDs+ r)dr = exp(-ASDS+ ric,ss+c; ) = 16%
mDc.SDS+G
where "P@ is the percentage of aqueous pores induced by SDS (1-200 mM) that are larger in
size than the size of an SDS micelle in an aqueous SDS solution, and xP+G is the percentage of
aqueous pores induced by SDS (1-200 mM)+10 wt% added Glycerol that are larger in size than
the size of an SDS micelle in an aqueous SDS solution containing 10 wt% added Glycerol. In
addition, a similar analysis conducted using the truncated normal pore size distribution yields
normal = 57% and qnOsMa = 30% (see Table 6-2). Therefore, the addition of 10 wt% Glycerol to
an aqueous SDS contacting solution reduces the fraction of aqueous pores available for SDS
micelle penetration by: (i) 65% (- ,1+G /exp ) for aqueous pores in the SC that are modeled
using an exponential pore size distribution function, and (ii) 47% (=1- ns'rna /rm nsomaal) for
aqueous pores in the SC that are modeled using a truncated normal pore size distribution
function.
Using Eq.(2), along with Asos = 0.04 and ASDS+G = 0.10 (see above), the average aqueous
pore radii corresponding to the exponential pore distribution functions are: (i) r 1eoxss = 254 for
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SDS (1-200 mM), and (ii) rx epO,ssc; = 10A for SDS (1-200 mM)+10 wt% added Glycerol (see
Table 6-2). Similarly, using Eq.(4), along with qSDS = 34 and CSDS+G = 18 (see above), the
average aqueous pore radii using the truncated normal pore distribution functions are: (i) r norma
rpore ,SDS
= 27A for SDS (1-200 mM), and (ii) r normal = 144 for SDS (1-200 mM)+10 wt% added
Glycerol (see Table 6-2). These results clearly indicate that the addition of 10 wt% Glycerol to
an SDS aqueous contacting solution results, on average, in aqueous pores having a smaller
radius. Furthermore, these results also indicate that the aqueous pores induced by SDS (1-200
mM), on average, have radii larger than the size of an SDS micelle. However, when 10 wt%
Glycerol is added to the SDS (1-200 mM) aqueous solution, the aqueous pores, on average, have
radii which are smaller than the size of an SDS micelle, a key finding that supports the
hypothesis put forward in Chapter 2 on how Glycerol may minimize SDS-induced skin barrier
perturbation - specifically, Glycerol reduces the size of the aqueous pores induced by aqueous
SDS contacting solutions such that SDS micelles, on average, are sterically hindered from
penetrating into the SC through the aqueous pores, and thereby, from inducing skin barrier
perturbation.
Using the values of A2os and ASDS+-G reported above, along with 6sos = 1.256x10-3 and
/SDS+G = 1.699x10-4 (see Table 6-1), in Eqs.(13) and (14), I obtained: (i) E2xp = 1.2, and (ii)
Eexp= 6.16. These results show that the addition of 10 wt% Glycerol to an aqueous SDS
contacting solution reduces the skin porosity associated with the SDS micelles by 17% (=1-
1/E2xp) and the SDS micelle-aqueous pore partition coefficient by 84% (=1-1/E'xp).
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A similar calculation carried out using the truncated normal pore distribution function
yielded the following results: (i) E""rm"O =1.9, and (ii) Enorma =3.89. 46 Therefore, these results
indicate that the addition of 10 wt% Glycerol to an aqueous SDS contacting solution reduces the
skin porosity associated with the SDS micelles by 47% (=I-1/Enormat) and the SDS micelle-
aqueous pore partition coefficient by 74% (=1-1/E;norma). Taken together, the exponential and
truncated normal distribution functions, which were used to model the size distribution of
aqueous pores in the SC, indicate that upon adding 10 wt% Glycerol to an aqueous contacting
solution containing 1-200 mM SDS, the SDS micelles are sterically-hindered from partitioning
into the aqueous pores, and that the low SDS micelle-aqueous pore partition coefficient is
primarily responsible for the low SDS micelle skin penetration and associated skin barrier
perturbation.
Table 6-2. Summary of the aqueous pore size distribution characteristics induced by aqueous
contacting solutions containing SDS (1-200 mM) (i) and SDS (1-200 mM)+Glycerol (10 wt%)
(ii).
Aqueous Contacting Solutions
(i) SDS (1-200 mM) (ii)SDS (1-200 mM)+ Glycerol (10 wt%)
X 0.04 0.10
a 34 18
exp 25 10
nor.al 27 14
1exp 0.46 0.16pom
normal 0.57 0.30
46 Note that E ep xE xp =1.2x6.16=7.39=[8sDY/3dso(;s, and E"ormal xE norma =19x 3 89=7.39=DsD S G.
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6.4. Testing the Validity of the Aqueous Pore Size Distribution
Functions
In this section, I have conducted tests to determine the validity of using the single-
parameter, exponential and truncated normal distribution functions to model the size distribution
of aqueous pores in the SC. For this purpose, I computed the product of the Mannitol skin
permeability, P, and the average electrical skin resistivity, R, using these distribution functions in
the context of an appropriately modified hindered-transport aqueous porous pathway model. This
type of analysis can prove unambiguously that if the exponential and the truncated normal
distribution functions can accurately predict the experimentally determined PxR quantity (see
Chapter 2), then, these distribution functions can also appropriately model the size distribution of
the aqueous pores in the SC.
To carry out the analysis outlined above, I have modified the theoretical model developed
by Tang et al. (25) by utilizing the single-parameter, exponential pore size distribution function,
as described in Eqs.(l) and (2), instead of an average aqueous pore radius. Tang et al. have used
average values for: (1) the diffusional hindrance parameters that can describe the transport of the
permeant, and the ion, respectively, and (2) the porosity of the skin aqueous pores (25). In
Eq.(16) below, average values for (1) and (2) have been replaced by their expected values using
the single-parameter, exponential pore size distribution function. In addition, the following
assumptions were made: (i) the ions and the hydrophilic permeant access similar aqueous pores
based on their sizes in traversing the SC (8, 9, 23-26), and (ii) the tortuosities experienced by the
ion and the permeant in traversing the aqueous pores are similar (23-25). This yields:
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(16)
where P is the Mannitol skin permeability, R is the average skin electrical resisitivity, D' =
0.672x 10-5 cm 2/s is the infinite-dilution diffusion coefficient of Mannitol at 250 C, rpe,=4.44A is
the hydrodynamic radius of Mannitol, D, =1.33x10-5 cm2/s is the infinite-dilution diffusion
coefficient of the Na÷ ions in the PBS electrolyte at 250 C, and rion,,=2.2A is the hydrodynamic
radius of the Na+ ion. Note that all these constants were reported previously by Tang et al. (25).
In addition, kB=1.38x 10-23 J/K is the Boltzmann constant, T=298 K, F=9.6485x 104 C/mol is the
Faraday constant, z = 1 (in the PBS electrolyte solution, since NaCl is the dominant electrolyte),
Cion = 0.137 M is the concentration of the Na+ ions in the PBS electrolyte, eo =1.6x10-19 C,
-=-rper/io,/r, and H(K)per and H(K)ion are the diffusional hindrance parameters associated with the
transport of the permeant and the ion through the aqueous pores in the SC, respectively. Note
that Deen et al. (19) have provided expressions for H(i)pe, and H(K)jon (see Chapter 2). In
addition, note that Eq.(16) can be further simplified as follows:
R y(r)H(K)perdr (1 +(l+rr p )2 exp(- r)(17)
C y(r)H(K),ondr 1+(l+r on )2 exp(-2r,on)
where C = rD• kT , 2 exp(-r)dr = exp(- 'r) [+ (1+ r,)2] (30), and A is the
D 2 )Lz 2 Fceo0
exponential pore size distribution parameter (see Eq.(1)).
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PR=
In addition, by replacing y(r) by 8(r) in Eq.(16), an expression can be obtained relating
PR/C to t(r). The definite integrals in the expression involving 6(r) were evaluated numerically
using aSDS = 34 and for oSDS+G = 18 (see Table 6.2), which represent the truncated normal pore
size distribution functions for (i) SDS (1-200 mM) aqueous contacting solutions, and (ii) SDS(1-
200 mM)+10 wt% added Glycerol aqueous contacting solutions (see Section 6.3). The
expressions involving y(r) in Eq.(17) were evaluated numerically using XSDS = 0.04 and for
•SDS+G = 0.10 (see Table 6-2), which characterize the exponential pore size distribution functions
in p-FTS contacted with aqueous solutions (i) and (ii), respectively (see Section 6.3). Carrying
out these analyses, it was possible to obtain estimates for PR/C (see Table 6-3). A close
agreement between the experimentally determined and the theoretically predicted PR/C values
will serve as validation of the single-parameter exponential and truncated normal pore size
distributions, K(r) and 6(r), that were assumed in Eqs.(l) and (3) in Section 6.2.
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Table 6-3. Comparison of the theoretically predicted PR/C values, using the single-parameter
exponential and truncated normal distribution functions to model the size distribution of aqueous
pores in the SC, with the experimentally determined PR/C values.
Aqueous Contacting SDS SDS (1-200 mM)
Solutions (1-200 mM) + Glycerol (10 wt%)
y(r) (Exponential) ,r in A 0.04exp(-0.04r) 0.1 exp(-0. lr)
8(r) (Truncated Normal) , r in A 0.02exp(-r 2/2312) 0.04exp(-r 2/648)
PR/C [experimental] 0.73+0.11 0.55+0.09
PR/C [predicted by y (r)] 0.64 0.44
Error [ y(r) prediction ]* 12.3% 18.2%
PR/C [ predicted by 8(r) ] 0.66 0.5
Error [ 8 (r) prediction ] ** 9.6% 9.1%
* Note that the error in the y(r) prediction was calculated using the following relation: Error [y (r)
prediction ] = abs[ (PR/C)expt - (PRC)exp] / (PR/C)expt
** Note that the error in the 8(r) prediction was calculated using the following relation: Error [8(r)
prediction] = abs[ (PR/C)expt - (PR/Cnormal] / (PR/C)expt
The results in Table 6-3 show that: (i) the errors in predicting the PR/C values using both
pore size distribution functions are less than 20% (8, 18, 19, 23, 25, 26), which lends validity to
the modeling of the size distribution of aqueous pores in the SC using the single-parameter,
exponential and truncated normal distribution functions, and (ii) the errors in predicting the PR/C
values for (i) aqueous contacting solutions containing SDS (1-200 mM) and (ii) aqueous
contacting solutions containing SDS(1-200 mM)+10wt% added Glycerol are lower for the
truncated normal distribution function than for the exponential distribution function. Therefore,
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this result indicates that the truncated normal distribution function, 6(r), models more accurately
the size distribution of aqueous pores in the SC of p-FTS contacted with aqueous solutions (i)
and (ii) than does the exponential distribution function, (r).
6.5. Comparison of the Aqueous Pore Size Distribution Models with
an Average Aqueous Pore Radius Model
It is instructive to compare the single-parameter, exponential and truncated normal
aqueous pore size distribution models with an average aqueous pore radius model that uses an
average pore radius, ravg and the skin porosity, e, as the two parameters in describing the 14C
radiolabeled SDS skin penetration data from aqueous contacting solutions containing SDS (1-
200 mM) and SDS(1-200 mM)+10 wt% added Glycerol. Note that the average aqueous pore
radius model does not allow for the use of separate skin porosities associated with the SDS
monomers and the SDS micelles (see Chapter 2). 4 7 Because: (1) the ratio of the contribution of
the SDS monomers to SDS skin penetration per unit SDS monomer concentration to the
contribution of the SDS micelles to SDS skin penetration per unit SDS micelle concentration is
equal to the ratio of the SDS monomer-aqueous pore partition coefficient to the SDS micelle-
aqueous pore partition coefficient (see Section 6.2), and (2) the SDS monomer-aqueous pore
2
r avg
pore,SlDS
47 This reflects the fact that the skin porosity associated with the SDS monomers is assumed to be the same as that
associated with the SDS micelles (see Chapter 2).
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coefficient is equal to 1 -
2
rmic,SDS which account for steric interactions between the SDSSavg
pore,SDS
monomer / SDS micelle and the aqueous pore wall (8, 18-26), the key equations corresponding
to the average aqueous pore radius model are given by:
2
1 mon,SDS
avg I
pore,SDS
-2
rmic,SDS
avvgpore,SDS
2
1- on,SDS+G
avgpore,SDS+G
______
/
rmic,SDS+G
r avg
pore,SD)S+G
where rPass is the average aqueous pore radius induced by aqueous SDS (1-200 mM)
contacting solutions, resas is the average aqueous pore radius induced by aqueous SDS (1-
200 mM)+10 wt% added Glycerol contacting solutions, and all the other variables were defined
previously. In addition, because the skin porosity induced by aqueous SDS (1-200 mM)
contacting solutions, cSDS, is not equal to the skin porosity induced by aqueous SDS (1-200
mM)+10 wt% added Glycerol contacting solutions £SDS+G (that is, es s  eS,, ), ASDS /ISDS+G
has an explicit dependence on 6SDS/ ESDS+G. Specifically,
(' /JSDS )L
sDs+G ) 1-
2
r1icSDS
pore,SDS
2
- C SDJS+G
rpore,SDS+G
where all the variables were defined previously.
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WSDS (18)
(19)
2
SDS +
I I
Using the values of aSDS, asDS+G, 8SDS, and /JSDS+G listed in Table 6-1, along with Eqs.(18)
and (19), the average aqueous pore radii and the enhancements in the skin porosity were
i avg - 32A, (i) avg =
calculated and are given by: (i) re, = 32A, (ii) r,S)+ = 22A, (iii) E" = CSDSI SDS+G
1.23, and (iv) E"ag = OSDSOSDS+G = 6.03. Therefore, these results indicate that adding 10 wt%
Glycerol to aqueous SDS (1-200 mM) contacting solutions leads to: (i) a significant reduction in
the average aqueous pore radius, and (ii) a more significant reduction in the SDS micelle-
aqueous pore partition coefficient in comparison to the reduction in the skin porosity associated
with the SDS micelles. 48 In addition, the average aqueous pore radii estimates using the average
pore radius model are very close to the aqueous pore radii estimates of 33±5A in SDS (1-200
mM) aqueous contacting solutions and 20±5A in SDS (1-200 mM)+10 wt% added Glycerol
aqueous contacting solutions, calculated using Mannitol skin permeability and average skin
electrical resistivity values in the context of a hindered-transport aqueous porous pathway model,
as reported in Chapter 2. The average aqueous pore radii estimates obtained using the average
pore radius model are also in reasonable agreement (see Table 6.2) with the average aqueous
pore radii estimates obtained using the single-parameter, exponential and truncated normal pore
size distribution functions for p-FTS exposed to SDS (1-200 mM) and to SDS(1-200 mM)+10
wt% added Glycerol.
Next, using rOreg s, rpog S)S+G, and E~,v the average PR/C value, (PR/C)avg was
predicted, and then compared to the experimentally determined PR/C value (see Section 6.4).
Specifically,
48 One can observe that the reduction in the SDS micelle-aqueous pore partition coefficient upon adding 10 wt%
Glycerol is equal to (1-1/ E0a ) = 0.834, and the reduction in the skin porosity associated with the SDS micelles
upon adding 10 wt% Glycerol is equal to (I-I/E a vg) = 0.187.
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R = E av H()s (20)
C avg H(K)SDS+G
where all the quantities were defined previously. Note that Eq.(20) is based on similar
assumptions as those leading to Eq.(16). Using Eq.(20), the (PR/C)av,,g values predicted by the
average aqueous pore size model are: (i) 0.71 for SDS (1-200 mM) aqueous contacting solutions,
which deviates by 2.8% from the experimental value of 0.73±0.11, and (ii) 0.59 for SDS (1-200
mM)+10 wt% added Glycerol aqueous contacting solutions, which deviates by 7.3% from the
experimental value of 0.55±0.09 (see Table 6-3). Therefore, from Table 6-3 and Eq.(20), the
following order of accuracy in predicting the experimentally determined PR/C value is obtained
(from the most accurate to the least accurate):
(PR/C) avg> (PR/C)normal> (PR/C) exp
It is interesting to note that the average pore radius model turns out to be more accurate than the
single-parameter exponential and truncated normal pore size distribution models in predicting
PR/C. This probably reflects the fact that the size distribution of aqueous pores in the SC can be
better described using several permeants exhibiting a range of permeant radii, rather than using
only the two skin permeants considered here - an SDS monomer and an SDS micelle (see
Section 6.6).
6.6. Conclusions
14C radiolabeled SDS skin penetration data were analyzed in the context of: (a) a single-
parameter, exponential distribution function, and (b) a single-parameter, truncated normal
distribution function, to model the size distribution of aqueous pores in the SC of p-FTS exposed
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to aqueous contacting solutions containing SDS (1-200 mM) and SDS (1-200 mM)+10 wt%
added Glycerol. The analysis using both (a) and (b) above showed that the addition of 10 wt%
Glycerol to an aqueous SDS contacting solution significantly shifts the pore size distribution -
from larger to smaller pores, resulting in reduced average aqueous pore radii, from 25A to 10A
for (a), and from 27A to 14A for (b). The results of this analysis corroborate the findings
reported in Chapter 2 - that Glycerol reduces aqueous pore sizes, which in turn, sterically
hinders SDS micelles from penetrating into the SC through these aqueous pores. As a result, the
SDS micelle contribution to SDS skin penetration is significantly reduced, which is responsible
for mitigating SDS-induced skin barrier perturbation in the presence of 10 wt% added Glycerol.
The pore size distribution models considered in this chapter also show that Glycerol has a
stronger effect on the SDS micelle-aqueous pore partition coefficient than on the skin porosity
associated with the SDS micelles.
The aqueous pore size distribution models (a) and (b) above were also used to
independently predict the experimentally measured PR/C values, where P is the Mannitol skin
permeability, R is the average skin electrical resistivity, and C is a constant that depends on the
transport characteristics of the permeants (in the present case, the hydrophilic permeant Mannitol
and the ions). Both models were found to satisfactorily predict the experimentally determined
PR/C values (errors < 20%). However, the single-parameter, truncated normal distribution
functions [S(r) =0.02exp(-r2/2312) for SDS (1-200 mM) aqueous contacting solutions and
S(r)=0.04exp(-r2/648) for SDS (1-200 mM)+1O wt% added Glycerol aqueous contacting
solutions] performed better in comparison to the exponential distribution functions
[y(r) =0.04exp(-0.04r) for SDS (1-200 mM) aqueous contacting solutions and K(r)= 0.1exp(-0.1r)
for SDS (1-200 mM)+10 wt% added Glycerol aqueous contacting solutions]. This finding
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indicates that a single-parameter, truncated normal distribution function more closely
approximates the actual size distribution of aqueous pores in the SC of p-FTS exposed to
aqueous contacting solutions of SDS (1-200 mM) and of SDS (1-200 mM)+10 wt% added
Glycerol. Finally, an average aqueous pore radius model was developed using similar
assumptions involved in developing models (a) and (b), the critical difference being the absence
of a size distribution of aqueous pores. The average aqueous pore radius model could predict the
experimentally determined PR/C value more accurately than either model (a) or (b). This
analysis shows that an average aqueous pore radius model can satisfactorily describe the
transport of small hydrophilic permeants (Mannitol and ions) through the SC of p-FTS exposed
to aqueous contacting solutions (i) and (ii), relative to the single-parameter, exponential and
truncated normal aqueous pore size distribution models. Therefore, in order to obtain a more
accurate description of the size distribution of the aqueous pores in the SC, a two-parameter
distribution function may be considered, with the additional requirement of conducting numerous
transdermal permeability studies with a large number of hydrophilic permeants whose molecular
radii should span a wide range, for example 2A to 100 A. These hydrophilic permeants, whose
molecular radii are significantly different from each other, can span a greater window of the size
distribution of aqueous pores in the SC than was possible using solely the SDS monomers and
the SDS micelles, which have molecular radii of 5A and 19.5A, respectively, in an aqueous
solution.
In the final chapter, Chapter 7, I summarize the main conclusions of the studies
conducted in this thesis, and also discuss future research directions in the area of skin barrier
perturbation induced by aqueous surfactant/humectant systems.
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Chapter 7
7. Conclusions and Future Research Directions
The primary objective of this thesis was to develop a mechanistic understanding,
including quantification, of: (i) how aqueous surfactant solutions, once in contact with the skin,
can induce skin barrier perturbation, and (ii) how the phenomenon of surfactant-induced skin
barrier perturbation can be effectively mitigated through the addition of humectants to the
aqueous surfactant solutions contacting the skin. This objective was accomplished using an
integrated analysis involving the following studies: (a) use of diffusion cell bioengineering
assays to determine the transdermal fluxes of: (i) ions (through skin electrical current/resistivity
measurements), (ii) a hydrophilic model permeant (through Mannitol skin permeability
measurements), and (iii) radiolabeled surfactants (through skin radioactivity measurements) upon
contact of the skin with surfactant/humectant systems, (b) use of two-photon fluorescence
microscopy (TPM) imaging to visualize and quantify the skin morphological modifications that
result from contact of the skin with surfactant/humectant systems, and (c) use of theoretical
models to determine the nature and the extent of skin barrier perturbation induced by
surfactant/humectant systems contacting the skin. The fundamental understanding gained from
studies (a)-(c) above on the effects of surfactant/humectant systems on the skin barrier can, in
turn, be utilized to design surfactant-based skin care formulations that do not induce an
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appreciable extent of skin barrier perturbation. Based on the fundamental understanding gained, I
developed an in vitro ranking metric of the effect of surfactant/humectant systems on the skin
barrier. This ranking metric was then validated using in vivo patch tests that are capable of
quantifying the extent of clinical erythema (skin redness) and skin dryness induced by these
surfactant/humectant systems.
In this Chapter, Section 7.1 summarizes the main results and conclusions of the thesis.
Section 7.2 discusses potential future research directions in the field of skin barrier perturbation
induced by surfactant/humectant systems. Finally, Section 7.3 discusses the potential
fundamental and practical impact of this thesis.
7.1. Thesis Summary
Humectants, such as Glycerol, have been shown to mitigate surfactant-induced skin
barrier perturbation in vivo. In Chapter 2, a mechanistic investigation of the effect of anionic
surfactant (Sodium Dodecyl Sulfate, SDS) micelles contacting the skin from an aqueous solution
containing Glycerol (a well-known humectant) on the skin barrier was carried out. When the skin
was contacted with an aqueous SDS solution, SDS penetrated into the skin and disrupted this
barrier. It is well-established, both in vitro and in vivo, that the SDS skin penetration is dose-
dependent, and that it increases with an increase in the total SDS concentration above the Critical
Micelle Concentration (CMC) of SDS. However, when Glycerol was added at a concentration of
10 wt% to the aqueous SDS contacting solution, I observed, through in vitro quantitative skin
radioactivity assays using 14C radiolabeled SDS, that the dose-dependence in SDS-skin
penetration was almost completely eliminated. To rationalize this observation, which may be
related to the ability of Glycerol to mitigate SDS-induced skin barrier perturbation in vivo, I
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hypothesized that the addition of 10 wt% Glycerol may hinder the ability of the SDS micelles to
penetrate into the skin barrier through aqueous pores that exist in the stratum corneum (SC).
To test this hypothesis, I conducted in vitro Mannitol skin permeability and average skin
electrical resistivity measurements upon exposure of the skin to: (i) an aqueous SDS contacting
solution, and (ii) an aqueous SDS+10 wt% Glycerol contacting solution, both in the context of a
hindered-transport aqueous porous pathway model of the SC. My in vitro studies demonstrated
that the addition of 10 wt% Glycerol: (1) reduces the average aqueous pore radius resulting from
exposure of the skin to the aqueous SDS contacting solution from 33±5A to 20±5A, such that a
SDS micelle of radius 18.5±lA (as determined using dynamic light scattering measurements)
experiences significant steric hindrance and cannot penetrate into the SC, and (2) reduces the
porosity-to-tortuosity ratio in the SC by more than 50%, thereby further reducing the ability of
the SDS micelles to penetrate into the SC and perturb the skin barrier.
Certain anionic surfactants like Sodium Cocoyl Isethionate (SCI) are clinically mild to
the skin barrier, and do not induce erythema or skin dryness. In Chapter 3, I investigated the
effect of SCI, which is an important surfactant ingredient in mild, syndet (synthetic detergent)
cleansing bars, on the skin barrier. In vitro and in vivo studies have demonstrated that SCI is
mild and less damaging to the skin barrier than soaps and surfactants such as SDS. As we saw in
Chapter 2, SDS forms small micelles in aqueous solutions contacting the skin relative to the
aqueous pores in the SC, and as a result, the SDS micelles can contribute to SDS skin penetration
and induce skin barrier perturbation. In Chapter 3, I investigated the well-known skin mildness
of SCI by examining the size of the SCI micelles relative to that of the skin aqueous pores.
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For this purpose, I conducted in vitro Mannitol skin permeability and average skin
electrical resistivity measurements upon exposure of the skin to an aqueous SCI contacting
solution in the context of a hindered-transport aqueous porous pathway model of the SC. These
in vitro studies demonstrated that a SCI micelle of radius 33.5f±1 (as determined using dynamic
light scattering measurements) experiences significant steric hindrance and cannot penetrate into
the SC through aqueous pores that have an average radius of 29f5A. This inability of the SCI
micelles to contribute to SCI skin penetration and associated skin barrier perturbation is
responsible for the observed skin mildness of SCI. Through in vitro quantitative skin
radioactivity assays using 14C radiolabeled SCI and pig full-thickness skin (p-FTS), I showed
conclusively that SCI skin penetration is dose independent, an important finding which provides
additional evidence that the larger SCI micelles cannot penetrate into the SC through the smaller
aqueous pores that exist in the SC, and therefore, cannot induce skin barrier perturbation.
Macroscopic measurements, such as average skin electrical resistivity (R) and Mannitol
skin permeability (P), in the context of a hindered-transport theory, can be effectively used to
rank certain chemicals, such as surfactants and humectants commonly encountered in skin-care
formulations, based on their ability to perturb the aqueous porous pathways in the SC. The
development of this methodology can potentially: (i) reduce, or eliminate altogether, several
costly and time consuming testing operations, such as, human and animal testing and trial-and-
error screening, and (ii) simultaneously screen and rank many surfactants and humectants for use
in skin-care formulations, thereby significantly speeding up the effort and time required to bring
new skin-care formulations to the market. In Chapter 4, I developed such an in vitro ranking
metric using enhancements in the skin electrical current induced by aqueous
surfactant/humectant contacting solution - the enhancer, relative to an in vitro PBS aqueous
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contacting solution - the control. The results of the in vitro ranking metric was then analyzed
using P and R measurements, in the context of a hindered-transport aqueous porous pathway
model, to shed light on the enhancements in average pore radius and the pore number density.
For this study, I considered aqueous solutions of the following chemicals: (1) humectants -
Glycerol and Propylene Glycol, (2) surfactants - SDS (anionic) and C12E6 (nonionic), and (3) a
control - PBS (Phosphate Buffered Saline). Utilizing the in vitro ranking metric, I obtained the
following ranking order, from the mildest to the harshest, for the surfactants and the humectants
considered above, based on their ability to perturb the aqueous pores in the SC: Glycerol <
Propylene Glycol < PBS < C12E6 < SDS.
To substantiate the findings above and to establish the validity of the ranking metric, in
vivo soap chamber measurements were carried out using aqueous solutions of the surfactants
and the humectants described above.49 Specifically, a patch containing an appropriate treatment
solution was applied to the volar forearm of a human volunteer for five hours. Subsequently, the
patches were removed and the test site rinsed with water and dried with a towel. Finally, a
clinical assessment of erythema (skin redness) was conducted using a chromameter, visual skin
dryness was assessed by an expert grader, and transepidermal water loss (TEWL) measurements
were conducted using an evaporimeter. These measurements were performed at baseline (no
exposure to test formulations), and then again, after the application of the patches, and deviations
from the baseline measurements were reported. These in vivo soap chamber measurements
showed excellent agreement with the ranking results obtained using the in vitro ranking metric
for the aqueous surfactant and humectant contacting solutions considered. In addition, in vivo
soap chamber measurements were also carried out for SDS+Glycerol aqueous contacting
49 The in vivo soap chamber patch studies were conducted by the research group of Dr. Gary Grove of CyberDERM
Clinical Studies, in collaboration with Dr. Sidney Hornby of Neutrogena/J&J (see Chapter 4).
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solutions. These in vivo measurements indicated that adding Glycerol to a SDS aqueous
contacting solution significantly minimizes SDS-induced in vivo skin barrier perturbation, a
result which is consistent with the results that I reported in Chapter 2. Specifically, Glycerol
reduced the size of the aqueous pores in the SC relative to that of the SDS micelles, such that
SDS in micellar form was not able to contribute to SDS skin penetration, which in turn,
minimized SDS-induced skin barrier perturbation.
Chapter 5 described the results of an in vitro visualization study of physical SC
perturbations induced by aqueous contacting solutions of surfactants and humectants relative to
an aqueous control solution (PBS). For this purpose, I carried out two-photon fluorescence
microscopy (TPM) imaging studies of p-FTS exposed to aqueous contacting solutions
containing: (i) SDS (an anionic surfactant which is a harsh skin agent), (ii) SCI (an anionic
surfactant which is a mild skin agent), (iii) Glycerol (a humectant which is a skin beneficial
agent), (iv) SDS+Glycerol (a surfactant/humectant mixture), and (v) PBS (the control). TPM is a
non-invasive, three-dimensional imaging technique based on two-photon induced nonlinear
excitations of fluorophores. TPM has the capability for deep-tissue imaging (up to several
hundred micrometers) and reduced photo-damage, which are extremely desirable characteristics
for the imaging of opaque and highly scattering tissues, such as, skin (1).
The TPM visualization studies were carried out using Sulforhodamine B (SRB), which is
a hydrophilic fluorescent probe that emits a fluorescent signal in the red spectrum. The p-FTS
samples were exposed to aqueous contacting solutions (i)-(v) separately, and subsequently, were
contacted with aqueous SRB solutions. Following these SRB exposures, the p-FTS samples were
dried and visualized using the TPM apparatus. Using a filter set in the TPM apparatus, the
emission wavelengths resulting from the presence of SRB in the skin (probe fluorescence) were
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collected by the red channel, while the emission wavelengths resulting from the inherent
fluorophores present in the skin (skin autofluorescence) were collected by the green channel.
Since there is minimal wavelength overlap between the red and the green channels, a
quantification of the SRB spatial distribution relative to the SC morphology in the same skin
sample, at precisely the same skin spatial locations, was achieved using this technique of dual-
channel (the green channel and the red channel) TPM. Hence, the skin inherent structural
features, as delineated in the green channel, provided a fingerprint relative to the probe spatial
distribution, as delineated in the red channel.
The results of this TPM visualization study revealed that SDS induces corneocyte
damage (which is expected because SDS has the potential to denature keratins). Intra-corneocyte
penetration pathways may be created once SDS "opens-up" the cross-linked keratin structure of
the corneocytes through keratin denaturation. Therefore, a group of such damaged adjacent
corneocytes, taken together, may exhibit a large number of intra-corneocyte penetration
pathways that may result in a localized transport region, LTR. A simultaneous quantitative
analysis of the red and the green channel TPM images showed that solution (iii) did not
significantly induce corneocyte damage. Therefore, taken together with the results presented in
Chapter 2, these dual-channel TPM images provide additional evidence that adding Glycerol to a
SDS aqueous contacting solution significantly minimizes the ability of SDS in micellar form to
penetrate into the SC and interact with the keratins of the corneocytes and induce corneocyte
damage. The dual-channel TPM images of p-FTS exposed to aqueous contacting solutions (ii),
(iii), and (v) showed: (a) low SRB penetration into the comeocytes, and consequently, low extent
of corneocyte damage, and (b) localization of the SRB probe within the lipid bilayers
surrounding the corneocytes of the SC. Of all the five aqueous contacting solutions (i)-(v)
272
considered in this study, p-FTS exposed to aqueous contacting solution (iii), that is, Glycerol,
showed the least extent of SRB probe penetration. This important finding is consistent with the
results of the studies reported in Chapters 2 and 4, where I showed that an aqueous contacting
solution of Glycerol reduces the porosity-to-tortuosity ratio and the average radius of the
aqueous pores through which the hydrophilic SRB probe molecules can penetrate into the SC.
For the five aqueous contacting solutions considered above, most of the SRB probe that
penetrates into the skin barrier is present in the SC, and the probe intensity decays significantly
as one visualizes the layers in the epidermis below the SC. I have quantified the amount of probe
that penetrated into the SC as a function of the SC depth upon contacting p-FTS separately with
the five aqueous contacting solutions. This TPM analysis revealed that SDS enhances the probe
partition coefficient the most, and that the extent of skin barrier perturbation induced by these
chemicals follows the order: (iii) < (v) < (ii) < (iv) < (i), which is consistent with the results of
the in vitro ranking metric reported in Chapter 4.
In Chapter 6, I focused my efforts on a quantitative determination and prediction of how
surfactants may penetrate into the skin barrier, both in the absence and in the presence of
humectants, thereby damaging this barrier. There is evidence that the aqueous pores present in
the SC have a size distribution, which may determine how surfactants such as SDS may
penetrate into the SC. Recently, Mitragotri et al. attempted to characterize the skin aqueous pore
size distribution, in the presence of strong enhancers such as ultrasound, using hydrophilic
transdermal permeants of different hydrodynamic radii, such as, Urea and Mannitol, which have
hydrodynamic radii which are less than 5A, as well as Dextran which has a hydrodynamic radius
which is larger than 20A (2). I investigated the size distribution of the aqueous pores in the SC
induced by aqueous contacting solutions of SDS and of SDS+10 wt% Glycerol. For this purpose,
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I utilized the skin penetration data of SDS in the presence and in the absence of Glycerol, as
reported in Chapter 2. The SDS monomers and the SDS micelles were considered as the two skin
penetrating species having different effective hydrodynamic radii. The effective hydrodynamic
radius of the SDS monomers was determined using the Stokes-Einstein theory. The effective
hydrodynamic radius of the SDS micelles was determined in Chapter 2. Due to simplicity and
model tractability, a (i) single-parameter exponential distribution function and a (ii) single-
parameter truncated normal distribution function (12) were used to represent the pore size
distribution of the aqueous pores in the SC induced by SDS and by SDS+ 10 wt% Glycerol
aqueous contacting solutions. The pore size distribution parameter for each of these distributions
was obtained through a numerical, non-linear integral solution for the SDS monomer-skin
partition coefficient and for the SDS micelle-skin partition coefficient, which were, in turn,
deduced using a multiple linear regression analysis of the SDS skin penetration data in the
presence and in the absence of 10 wt% Glycerol (see Chapter 6). The average pore radii induced
by these aqueous contacting solutions were computed as the means of the pore size distributions.
The next part of the analysis involved establishing the validity of these distributions. For this
purpose, I computed the product of the Mannitol skin permeability, P, and the average electrical
skin resistivity, R, using these distributions in the context of an appropriately modified hindered-
transport aqueous porous pathway model. This analysis proved unambiguously that the pore size
distributions derived from the SDS skin penetration data, both in the absence and in the presence
of 10 wt% Glycerol, could correctly predict the experimentally determined PxR quantity,
thereby establishing the validity of these single-parameter distribution functions used in this
analysis. In addition, the aqueous pore size distribution analysis, as applied to the SDS skin
penetration data in the absence and in the presence of 10 wt% Glycerol, was found to be superior
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when compared to an equivalent analysis using average aqueous pore radii values (see Chapter 6
for additional details).
The pore size distributions induced by SDS and by SDS+10 wt% Glycerol aqueous
contacting solutions, which were obtained using the analysis outlined above, were significantly
different from each other. Adding 10 wt% Glycerol to the SDS aqueous contacting solution
induced a shift in these single-parameter pore size distributions - from larger to smaller pores. In
fact, upon adding 10 wt% Glycerol to a SDS aqueous contacting solution: (i) the mean pore
radius calculated using the single-parameter exponential distribution function decreased from
25A to 10A, a reduction of 60%, and (ii) the mean pore radius calculated using the single-
parameter truncated normal distribution function decreased from 27A to 14A, a reduction of
47%. Using an average pore radius analysis based on the hindered-transport aqueous porous
pathway model (see Chapter 2), I had previously shown that the average pore radii values
induced by SDS and by SDS+10 wt% Glycerol are equal to 33A and 20A, respectively. The
observed difference in the average versus the mean (expected) pore radii values clearly shows
that one needs to use the pore size distribution analysis developed here to gain deeper insight into
the sizes of the aqueous pores induced by SDS and by SDS+10 wt% Glycerol aqueous
contacting solutions. For example, the pore size distribution analysis conducted using the single-
parameter exponential distribution function suggests that less than 10% of the SDS micelles can
penetrate into p-FTS that was exposed to a SDS+10 wt% Glycerol aqueous contacting solution
through the aqueous pores. This is because less than 10% of the aqueous pores have pore radii
which are larger than the average SDS micelle hydrodynamic radius in p-FTS exposed to this
contacting solution. On the other hand, more than 45% of the SDS micelles can penetrate into p-
FTS that was exposed to a SDS aqueous contacting solution, because more than 45% of these
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aqueous pores have pore radii which are larger than the effective SDS micelle hydrodynamic
radius.
7.2. Future Research Directions
In this section, I discuss potential future research directions aimed at gaining additional
insight on the effect of surfactants and humectants on the skin barrier. Some of the proposed
research directions involve generalizations of the experimental and the theoretical studies
pursued as part of this thesis, while others involve exploring exciting new avenues.
7.2.1. Location of Surfactants in the Skin Barrier
Although we can currently measure the total amount of surfactant, for example, of 14C
radiolabeled SDS, that penetrates into the SC, we still do not know the specific location of the
surfactant within the SC. Using two-photon fluorescence microscopy, along with the image
analysis procedure developed in Chapter 5, I have indirectly visualized the effect of surfactants,
such as SDS and C12E6, on the lipid bilayers and on the corneocytes of the SC by determining
the location of the fluorescent probe (SRB) in the SC that was previously exposed to the aqueous
SDS and C12E6 contacting solutions. Furthermore, I have also visualized the effect of the
aqueous SDS contacting solution on the SC in the presence of 10 wt% Glycerol.
Using a fluorescent surfactant, one could study directly the location of the fluorescent
surfactant in the SC, as opposed to indirectly visualizing the effect of a surfactant on the SC by
studying the location of the fluorescent probe in the SC. However, identifying such a fluorescent
surfactant is not without challenges. For example, some of the common Rhodamine-based
fluorescent dyes that could be attached to a surfactant molecule may be too large to enable the
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surfactant to remain surface active. Additional research should be directed at synthesizing
fluorescent surfactant heads or tails, using smaller fluorescent dyes, for example, benzene.
Preliminary studies should be conducted to ensure that the fluorescent surfactant does indeed
remain surface active, and retains its ability to form micelles at concentrations above the CMC.
The next phase of these studies should focus on determining the wavelength at which the
surfactant shows fluorescent characteristics. Once known, the appropriate filter may be used in
the TPM apparatus to determine the fluorescent surfactant intensity, and thereby, its
concentration within the SC (see Chapter 5 for additional details).
The benefits of conducting the study proposed above are clear. One can determine
directly how the surfactant partitions, and thereby modifies the structure of the SC, once it has
penetrated into the SC, by directly visualizing its location in the SC. Furthermore, such a study
may also shed light on how surfactants affect the transport pathways in the SC (lipoidal versus
aqueous pore). One may also be able to visualize if a harsh fluorescent surfactant can rupture the
corneocyte envelopes and expose keratins within the corneocytes that may then be denatured,
thereby eliciting skin barrier perturbation and possibly erythema (see Chapter 4). If the presence
of humectants such as Glycerol does not alter the surfactant fluorescent properties, then, one may
also be able to directly visualize the ability of Glycerol to mitigate the surfactant-induced rupture
of the corneocyte envelopes, as was shown indirectly through the TPM studies reported in
Chapter 5.
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7.2.2. Penetration of Surfactants into the Skin Barrier as a Function of the
Humectant Concentration in the Contacting Solution
In Chapter 2, I studied the effect of increasing the concentration of SDS in an aqueous
contacting solution containing 10 wt% Glycerol. It was observed that at a concentration of 10
wt%, Glycerol does not significantly alter the micellization characteristics of SDS or the micellar
solution properties, such as the viscosity. Therefore, at 10 wt%, the ability of Glycerol to
mitigate SDS-induced skin barrier perturbation is due to its effect on the SC, specifically by
reducing the average pore radius and the porosity-to-tortuosity ratio of the aqueous pores in the
SC. However, certain skin-care formulations contain Glycerol at high concentrations, such as 40
wt% (3). At these high concentrations, not only will Glycerol directly impact the skin barrier, but
it may also significantly increase the viscosity of the contacting micellar solution, which should
further mitigate the extent of surfactant-induced skin barrier perturbation by decreasing the
ability of the surfactant to penetrate into the SC from a highly viscous contacting solution. Future
research should focus on conducting in vitro and in vivo surfactant-skin penetration studies that
can determine the amount of SDS in the epidermis as a function of the concentration of Glycerol
(in the range 1 to 40 wt%) in the contacting solution. In addition, these studies can be extended
to include other humectants of interest in cosmetic science, such as, Propylene Glycol and
Sorbitol.
7.2.3. Penetration of Humectants into the Skin Barrier
Humectant-skin penetration studies by Okamoto et al. have shown that an increase in the
amount of Glycerol absorbed by the SC correlates with an increase in the extent of skin
moisturization as determined using an evaluation of the skin surface electrical conductance
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measured with a high-frequency impedance meter (4). Future research should focus on a
systematic investigation of the beneficial impact of humectants on the skin barrier as a function
of their concentration in the epidermis. In vitro studies, similar to those discussed in Chapter 4,
can be conducted by exposing skin to contacting solutions of radiolabeled humectants such as
Glycerol and Propylene Glycol at different concentrations, and subsequently, by assaying for the
skin radioactivity to determine the amount of radiolabeled humectant that has penetrated into the
epidermis. In addition, in order to determine the amount of humectant that has penetrated into the
epidermis in vivo, repeated tape-strippings can be carried out on skin exposed to these contacting
solutions of non-radiolabeled humectants. The weight of the collected epidermis can be
estimated from a measurement of the weight of a sheet of adhesive tape before and after tape-
stripping (4). The humectant can then be extracted from the epidermis on the tape using
methanol, and subsequently analyzed using gas chromatography (4).
The studies proposed in this section can reveal if there is a critical concentration of
humectant in the epidermis which is required for the humectant to beneficially impact the skin
barrier, as well as if this critical humectant concentration is different for different humectants.
7.2.4. Effect of Other Additives on Surfactant-Skin Penetration
In Chapter 2, I examined how humectants such as Glycerol affect the extent of SDS-skin
penetration. Moore et al. have shown that: (i) a nonionic polymer such as PEO (5), and (ii) a
nonionic surfactant such as C12E6 (6), can reduce the amount of SDS that can penetrate into the
epidermis by increasing the size of the SDS micelles relative to that of the skin aqueous pores, as
well as by reducing the SDS monomer concentration in the micellar solution contacting the skin.
Other additives, for example, cationic polymers such as Poly Vinyl Pyrrolidone (PVP), can be
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expected to dramatically reduce the monomer concentration of an anionic surfactant like SDS, as
well as to form polymer-surfactant complexes that are too large to penetrate into the epidermis,
thereby minimizing the amount of SDS that can penetrate into the epidermis (11). However, one
of the main challenges associated with mixing a positively-charged (cationic) polymer like PVP
with a negatively-charged (anionic) surfactant like SDS in aqueous solution is the precipitation
of the polymer-surfactant complexes that form due to charge neutralization (see below).
Preliminary studies that I have conducted with proteins, such as zein which: (i) has positively-
charged sites that bind to negatively-charged surfactants like SDS at pH=7-7.4, and (ii) exhibits
cooperative binding with the SDS micelles to form protein-surfactant complexes that are soluble
in water (22), have shown that there is a dramatic reduction in the penetration of SDS into the
skin. In addition to polymers and proteins, other additives of interest are oils, which have been
shown to improve the mildness characteristics of surfactant-based skin care formulations (7). It is
not clear how the addition of oils mitigates surfactant-induced skin barrier perturbation, although
possible mechanisms may include: (i) swelling of surfactant micelles by incorporation of the oil
in the hydrophobic micelle cores, thereby preventing penetration of surfactant in micellar form
into the skin, and/or (ii) forming an occlusive oil coating on the surface of the SC, thereby
minimizing surfactant-skin interactions (7, 11).
As discussed above, one of the main challenges in designing oppositely-charged
polymer/protein-surfactant systems is preventing the precipitation of the resulting complexes in
aqueous solution. This may be achieved by tuning the solution properties, including the
temperature, the viscosity, and the charge density of the complexes. Once a suitable non-
precipitating surfactant-additive system is identified, in vitro surfactant skin penetration studies
can be conducted, similar to those reported in Chapter 2. Furthermore, (i) in vitro studies that use
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the penetration of radiolabeled surfactants into the skin (see Chapter 2), and (ii) in vivo studies
that use tape-strippings followed by surfactant extraction with methanol (see Section 7.2.3), can
be utilized to determine the amount of surfactant that has penetrated into the skin from
contacting solutions containing the appropriate surfactant-additive systems (4).
7.2.5. Penetration of Charged Surfactant Micelles into the Skin Barrier in the
Presence of Humectants
The hindered-transport aqueous porous pathway model presented in Chapter 2, and the
pore size distribution model presented in Chapter 6, did not account for electrostatic repulsions
between the negatively-charged SDS micelles and the skin aqueous pore walls, which are also
negatively charged (8-10). Indeed, in this case, it was sufficient to consider the Debye-Hiickel
screening length 50 which was much smaller than the average skin aqueous pore radius (see
Chapter 2), which indicated that steric effects should dominate any potential electrostatic effects.
However, positively-charged skin permeants, for example, micelles consisting of the cationic
surfactant Cetyl Trimethyl Ammonium Bromide (CTAB), may experience an electrostatic
attraction with the negatively-charged skin aqueous pore walls at salt concentrations where the
Debye-Htickel screening length may become comparable to the average skin aqueous pore
radius. 5 1 Moore et al. have observed that tuning the ionic strength of the surfactant solution and
the charge density of the surfactant micelles may lead to electrostatic interactions of the
surfactant micelles with the skin aqueous pore walls, which can in turn play a significant role in
controlling the penetration of charged surfactants into the skin (11). The role of humectants like
50 The Debye-Htickel screening length is the length scale associated with the screening of electrostatic interactions
between the ions (or between the charged permeants) and the negatively-charged skin aqueous pore walls.
5' In fact, the negatively-charged SDS micelles may experience an electrostatic repulsion with the negatively-
charged skin aqueous pore walls at salt concentrations where the Debye-Hiickel screening length may become
comparable to the average skin aqueous pore radius.
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Glycerol, which may affect surfactant solution properties, for example, the solution dielectric
constant,52 at high Glycerol concentrations of 40 wt%, may result in less effective screening, and
consequently, in stronger electrostatic interactions between the surfactant micelles and the
negatively-charged skin aqueous pore walls.
Future research should focus on conducting experiments that can determine the skin
penetration ability of an anionic surfactant like SDS and of a cationic surfactant like CTAB
under a systematic variation of the ionic strength of the contacting solution, in the presence and
in the absence of Glycerol. This will allow determining the effect of the contacting solution ionic
strength on the skin penetration ability of these surfactants. Through Dynamic Light Scattering
(DLS) measurements, one can determine the effective hydrodynamic radius of the surfactant
micelles in the presence and in the absence of Glycerol (see Chapter 2), and analyze the skin
penetration results using an electrostatic hindered-transport theory (13-15; see also Section
7.2.7). Such a study may indicate how factors other than the steric size of the surfactant micelles,
for example, the micellar charge density, control the ability of charged micelles to access and
traverse the skin barrier through the aqueous pores that exist in the skin. Furthermore, the study
proposed above can also determine the effect that humectants like Glycerol may exhibit on the
ability of charged surfactant micelles to penetrate into the epidermis and induce skin barrier
perturbation.
52 At 25 0C, the dielectric constant of water is 78.3, and that of Glycerol is 42.5. Therefore, the higher the
concentration of Glycerol in the aqueous contacting solution, the lower is the solution dielectric constant (29). This,
in turn, should lead to an increase of the electrostatic interactions, since they are inversely proportional to the
magnitude of the dielectric constant (18).
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7.2.6. Effect of the Solution pH on Surfactant-Induced Skin Barrier
Perturbation in the Presence of Humectants
The ionic charge of many surfactants, such as carboxylate and zwitterionic surfactants, is
affected by the solution pH. A change in the pH of the contacting solution can lead to: (i) a
change in the micelle shape and aggregation number, and consequently, in the size, of the
surfactant micelles present in the contacting solution, and (ii) a change in the CMC, and
consequently, in the surfactant monomer concentration (11). Furthermore, tuning the pH of the
contacting solution can directly impact the skin barrier. Robbins and Fernee (19) examined the
effect of pH on surfactant-induced swelling of isolated epidermis for: (i) the anionic surfactants,
SDS and Linear Alkyl Benzenesulfonate (LAS), and (ii) the cationic surfactant Dodecyl
Trimethyl Ammonium Bromide (DTAB). Their results showed that for the anionic surfactants,
swelling decreased as the solution pH was reduced from a value of 9 (basic) to a value of 3
(acidic). However, the cationic surfactant exhibited an inverse relation between the solution pH
values and the extent of epidermal swelling. Ananthapadmanabhan et al. (20) found a direct
effect of the solution pH on the SC protein swelling and lipid rigidity, both of which increased as
the solution pH was increased from 6.5 (acidic) to 10 (basic).
Therefore, it would be interesting to study the effect of the solution pH on the barrier
properties of the skin. Future research should focus on conducting in vitro and in vivo skin
barrier measurements, including skin electrical current and transepidermal water loss (TEWL),
upon exposing skin to the following aqueous contacting solutions: (i) SDS (1-200 mM), (ii) SDS
(1-200 mM)+Glycerol (10 wt%), (iii) Glycerol (10 wt%), and (iv) PBS Control. These
measurements should be carried out at acidic (pH=5-6), neutral (pH=7), and basic (pH=9-10)
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solution conditions to determine an experimental correlation between the solution pH and
surfactant-induced skin barrier perturbation in the presence of humectants.
7.2.7. Developing Models to Incorporate Electrostatic Interactions between
the Charged Surfactant Micelles and the Skin Aqueous Pores
The generalized hindered-transport aqueous porous pathway model presented in Chapter
6 incorporates a pore-size distribution to appropriately model the variation in aqueous pore radii
induced by SDS and by SDS+10 wt% Glycerol aqueous solutions contacting the skin. However,
this model does not incorporate electrostatic interactions between the charged surfactant micelles
and the charged skin aqueous pores. Below, I discuss the development of a preliminary model
that takes into account electrostatic interactions between a charged permeant and the charged
aqueous pore walls in the SC. To test the new model, future research may focus on conducting in
vitro skin penetration measurements where the skin is contacted with an aqueous solution
containing charged mixed micelles consisting of two surfactants, for example, of the anionic
SDS and the nonionic C12E6 surfactants (11). In this case, the micelle charge density can be
controlled by tuning the composition of the resulting mixed micelles. In addition, SDS and C12E6
may be radiolabeled with different radioactive tracers, for example, 14C and 3H, such that the
amounts of each surfactant in the skin can be measured using dual-radiolabeled skin radioactivity
assays (12). Therefore, by measuring the amounts of 14C radiolabeled SDS and 3H radiolabeled
C 12E6 that have penetrated into the epidermis from aqueous contacting solutions containing
charged mixed micelles of tunable charge densities, one can implement the new model presented
below to determine the electrostatic interactions between the charged mixed micelles and the
charged skin aqueous pore walls.
284
Deen, and later Zydney (13-17), developed a comprehensive theory to evaluate the
permeant i-pore partition coefficient 4 between the skin aqueous pores and the aqueous
permeant i contacting solution. The theory for permeant partitioning into the aqueous pores can
predict 4i using molecular characteristics such as the size, the shape, and the electric charge of
permeant i and of the aqueous pores. In our case, the permeant is a charged mixed micelle
partitioning into the SC through the aqueous pores. The model discussed below uses the
following assumptions (16): (i) the center-line approximation, which neglects the effect of
variations in the radial position of the permeant on the diffusional hindrance parameter H(,),
where 'i' refers to the permeant (see Chapter 2), (ii) the ions are modeled as solid charged
spheres of known surface charge density or surface potential, (iii) a known surface charge
density or surface potential of the aqueous pores, and (iv) the permeant molecules are modeled as
spherical and the pores as cylindrical.
The theoretical analysis incorporates axisymmetric positions of the sphere, and the
linearized form of the Poisson-Boltzmann equation is used. Analytical expressions for the
potential energy of interaction are obtained, and subsequently used to calculate the equilibrium
permeant-pore partition coefficient. The key modeling equation relates the dimensionless
interaction energy between the charged permeant and the charged pore wall, V, to the permeant
and the pore molecular characteristics, including the permeant and the pore surface charge
densities and their sizes (16). Specifically,
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h(zyi ) = (1 + z i )e - 7 i -(1- ri
modified spherical Bessel function of the
)e:i So = r 2e- 2 r15 + , (s is2 r 16 512r
first kind,
the constant
surface charge density of the permeant modeled as a hard sphere, ac is the constant surface
charge density of the pore wall with the pore modeled as a hollow cylinder, 6 is the Debye-
Hiickel screening length, yi is the ratio of the permeant radius, ri , to the average pore radius, r,
r
and r = -
The dimensional interaction energy, E(O), is related to the dimensionless interaction
energy, V, in Eq.(l) as follows (15, 16):
E(O) = [RT]2 V (2)
where E is the dielectric constant, R is the universal gas constant, T is the temperature in K, and F
is the Faraday unit of charge. All the other quantities appearing in Eq.(2) have already been
defined.
Using the center-line approximation, one can write:
E(z) = E(O)exp(=z) (3)
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where z = r/rp is the dimensionless radial position of the sphere center, and 0 < z • 1 - yi, which
accounts for the excluded-volume interactions.
The permeant i-pore partition coefficient, 0, which is the ratio of the concentration of
permeant i in the pore, CP , to the concentration of permeant i in the dilute bulk solution, Cic,can
then be evaluated as follows (63, 65):
= 2 fe[-E(z)/kT]zdz (4)
10
Equation (4) indicates that in the case of weak electrostatic interactions for which V4O,
and hence, E(O) ; 0 and E(z) - 0 (see Eqs.(2) and (3)), the permeant i-pore partition coefficient,
0j, is equal to (1-7yd 2, which is the expression resulting from steric interactions that was used in
Chapter 2.
The calculation of the pore radius, res, reflecting the effects of both the long-range
electrostatic (e) and the short-range steric (s) interactions, involves an iterative procedure, as
illustrated in the flow chart presented in Figure 7-1, and discussed in detail below.
Once the pore radius, rs, is determined based solely on steric considerations (see the
appendix in Chapter 2), one can use this r, value as an input in r to determine the dimensionless
interaction energy, V, using Eq.(1), for both the permeant i and for the ion. Subsequently, using
Eqs.(2) and (3), one can determine the dimensional interaction energy, E(z), for both the
permeant i and for the ion. Having determined the two E(z) values in this manner, one can then
perform a numerical integration, according to Eq.(4), using a Simpson's algorithm, to determine
the pore-partition coefficients of permeant i and ion.
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The next step in the calculation involves using the corrected permeant-pore partition
coefficient value, bes (accounting for both the electrostatic and the steric interactions), to evaluate
the diffusional hindrance parameters, H(y)es for permeant i and for the ion, and hence, to
recalculate the pore radius, res, which now accounts for both the steric and the electrostatic
interactions. If the two pore radii values, that is, r, and res, calculated in this manner (one based
solely on steric considerations and the other based on both electrostatic and steric considerations)
are sufficiently close in magnitude (one needs to assign a reasonable preset tolerance value (tol)
for this comparison, see Figure 7-1), then, one may conclude that the electrostatic interactions
are not important. However, if this difference is significant, then, it is clear that the electrostatic
interactions are important for the system considered (either for permeant i or for the ion, or for
both), and therefore, need to be accounted for. The calculation will then involve an iterative
procedure in which the pore-partition coefficients of permeant i and of the ion, computed
considering both the electrostatic and the steric interactions, ,es, should be used to recalculate the
pore radius, res, with the iterative procedure continuing until the pore radii values obtained from
the previous and from the current iterations are sufficiently close, within the reasonable preset
tolerance value, tol (see Figure 7-1).
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Calculate the steric (s) permeant/ion-pore partition coefficient, s, and the
permeant/ion steric diffusional hindrance parameter, H(y,)
using Eqs. (4) and (5)
Perform experiments to determine log plots of Permeability vs. Resistivity
(see Chapter 2)
Calculate the steric pore radius,
rs
(see Chapter 2)
Calculate V, E(O), and E(z)
using Eqs. (1)-(3)
Calculate the electrostatic/steric partition coefficient, bes, and the electrostatic/steric diffusional
hindrance parameter, H(y)es, by numerical integration
using Eqs.(1)-(4)
Calculate the electrostatic/steric pore radius,
res
rs=res
Report either Report res
Figure 7-1. Flow Chart of the iteration procedure to determine the skin aqueous pore radius
which accounts for both electrostatic and steric interactions between the charged permeant/ion
and the charged pore wall. Note that 'tol' denotes the tolerance for error, which is an input to the
trial-and-error solution procedure.
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7.3. Impact of this Thesis
The fundamental understanding of surfactant-induced skin barrier perturbation in the
presence of humectants developed in this thesis is of particular relevance to the cosmetic industry
in enabling the formulation of milder, non-drying, skin care products that contain surfactants and
humectants. Specifically, at appropriate concentrations, humectants such as Glycerol can
mitigate SDS-induced skin barrier perturbation, and associated erythema (skin redness) and skin
dryness, by 'closing' aqueous pores through which SDS micelles penetrate into the epidermis. In
fact, cosmetic formulators can apply the fundamental knowledge gained in this thesis to design
surfactant-based skin care formulations that contain humectants such that the surfactant present
in micellar form does not penetrate into the skin and induce erythema and skin dryness, thereby:
(i) enhancing consumer experience of their products, and (ii) capturing market share in a rapidly
growing $50B market. 53
The novel two-photon fluorescence microscopy studies that visualize, as well as quantify,
skin morphology upon exposure of the skin to surfactant/humectant systems (see Chapter 5), has
the potential to be developed into a high-throughput in vivo imaging tool for the screening of
new skin-care formulations that can: (i) reduce or eliminate altogether costly and time
consuming testing operations used presently by the cosmetic industry, such as, human and
animal testing and trial-and-error screening, and (ii) simultaneously screen the skin-mildness
potential of many skin-care formulations, thereby significantly speeding up the effort and time
required to bring new skin-care formulations to the market.
53 Note that according to Colin A. Houston & Associates, Inc. (CAHA), a consulting firm in Brewster, NY, the size
of the North American market for cosmetic products, ranging from hair-care, skin-care, shaving gels, and
cosmeceuticals, was $50B in 2002. Furthermore, with the revival of the US economy in the period 2002-2006, this
market has expanded rapidly, both in the size and competitiveness of its products.
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In addition to the practical impact on the formulation of mild skin-care products which is
the central goal of cosmetic science, this thesis has also advanced fundamental research carried
out in the investigative dermatology and related health disciplines through the development of a
fundamental microscopic and macroscopic understanding of the skin barrier and its response to
the exposure to surfactants in the absence and in the presence of humectants. This fundamental
understanding has been achieved by bringing together concepts and methodologies from diverse
research areas, including: (i) surfactant physical chemistry in the presence and in the absence of
humectants, (ii) aqueous pore size distribution and hindered-transport models of the skin barrier,
(iii) two-photon microscopy visualization and quantification of images of the skin morphology,
and (iv) in vitro and in vivo bio-engineering assays to quantitatively determine modifications in
the skin barrier morphology that result from exposure of the skin to surfactants in the absence
and in the presence of humectants.
It is my hope that the fundamental advances made in this thesis on the effect of
surfactants and humectants on the skin barrier will stimulate the development of exciting new in
vitro and in vivo methods to characterize surfactant-induced skin barrier perturbation in the
absence and in the presence of humectants.
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